 	
	
	
	




		
		
			
			
		

		
		

		
			
					
						
						
							


			
		


		

		

	
																			





		

		

<!-- content start-->
	<html><head xmlns:msxsl="urn:schemas-microsoft-com:xslt" xmlns:rsc="urn:rsc.org" xmlns:fo="http://www.w3.org/XSL/Format/1.0">
<META http-equiv="Content-Type" content="text/html">
<title>Published by The Royal Society of Chemistry</title><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><style type="text/css">
	  
	   .firstpara { margin-left: 0px; text-indent: 0px; text-align: left; margin-bottom: 0pt }
	   .otherpara { margin-left: 0px; text-indent: 20px; text-align: left; margin-top: 0pt; margin-bottom: 0pt }

	  
	  </style></head><body bgcolor="#FFFFFF" vlink="#336699" link="#018BDE" alink="#FFFF00" xmlns:msxsl="urn:schemas-microsoft-com:xslt" xmlns:rsc="urn:rsc.org" xmlns:fo="http://www.w3.org/XSL/Format/1.0"><rsc:docroot msid="b104971m" sercode="NP" subsyear="2002"></rsc:docroot><table border="0" width="100%"><tr><td valign="top"><b><i>Nat. Prod. Rep.</i></b>, 2002, <B>19</b>(6), 742 - 760  <br clear="all"><small>DOI: 10.1039/b104971m</small></td><td rowspan="2" align="center" valign="top"><img src="https://bitnest.netfirms.com/images/entities/char_z_NPlogo.gif"><p><b>Review Article</b></p></td></tr><tr><td valign="top"><hr size="4"><p align="" style="font-weight: bold; margin-top: 0%; margin-bottom: 0%; "><h2><b>Quinoline, quinazoline and acridone alkaloids</b></h2></p></td></tr></table><p align="" style="font-weight: normal; font-style: normal; margin-top: 2%; "><span style="font-weight: bold; "><b>
Joseph P. Michael</b></span><br><span style="font-style: italic; "><i>Molecular Sciences Institute, School of Chemistry, University of the Witwatersrand, Wits 2050, South Africa. <a HREF="mailto:jmichael@aurum.chem.wits.ac.za">E-mail: jmichael@aurum.chem.wits.ac.za</a></i></span></p><span style="font-weight: bold; font-style: italic; "><b><i>Received  (in Cambridge, UK) 1st July 2002</i></b></span><p></p><span style="font-weight: bold; font-style: italic; "><b><i>First published on the web 8th October 2002</i></b></span><hr><table><tr align="left"><th align="left">Contents</th></tr><tr valign="top"><td><a href="quinoline2002.htm#sect83">1 </a></td><td>Quinoline alkaloids</td></tr><tr valign="top"><td><a href="quinoline2002.htm#sect86">1.1 </a></td><td>Occurrence</td></tr><tr valign="top"><td><a href="quinoline2002.htm#sect429">1.2 </a></td><td>Non-terpenoid quinoline and quinolinone alkaloids from rutaceous plants</td></tr><tr valign="top"><td><a href="quinoline2002.htm#sect507">1.3 </a></td><td>Terpenoid quinoline alkaloids and tricyclic derivatives</td></tr><tr valign="top"><td><a href="quinoline2002.htm#sect680">1.4 </a></td><td>Furoquinoline alkaloids</td></tr><tr valign="top"><td><a href="quinoline2002.htm#sect720">1.5 </a></td><td>Miscellaneous quinoline alkaloids from higher plants</td></tr><tr valign="top"><td><a href="quinoline2002.htm#sect832">1.6 </a></td><td>Quinoline alkaloids from fungal and microbial sources</td></tr><tr valign="top"><td><a href="quinoline2002.htm#sect910">1.7 </a></td><td>Quinoline alkaloids from animals</td></tr><tr valign="top"><td><a href="quinoline2002.htm#sect1089">2 </a></td><td>Quinazoline alkaloids</td></tr><tr valign="top"><td><a href="quinoline2002.htm#sect1092">2.1 </a></td><td>Occurrence, characterisation and biological activity</td></tr><tr valign="top"><td><a href="quinoline2002.htm#sect1325">2.2 </a></td><td>Synthesis and other chemical studies</td></tr><tr valign="top"><td><a href="quinoline2002.htm#sect1714">3 </a></td><td>Acridone alkaloids</td></tr><tr valign="top"><td><a href="quinoline2002.htm#sect1752"></a></td><td></td></tr></table><p></p><hr><p></p><p align="left" style="text-align: left; ">Covering: July 2000 to June 2001. Previous review: <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 2001, <span style="font-weight: bold; "><b>18</b></span>, 543.</p><p></p><hr><p></p><p align="left" style="text-align: left; ">This review covers the isolation, structure determination, synthesis and biological activity of quinoline, quinazoline and acridone alkaloids from plant, microbial and animal sources. The literature from July 2000 to June 2001 is reviewed, and 119 references are cited.</p><hr><a name="sect83"><p align="" style="font-weight: bold; margin-top: 0%; margin-bottom: 0%; "><h3><b>1 Quinoline alkaloids</b></h3></p></a><a name="sect86"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>1.1 Occurrence</b></p></a><p class="firstpara">An impressively diverse range of novel quinoline alkaloids was reported during the period under review, and convincing spectroscopic evidence was presented for most of the new structures. These alkaloids and their sources are listed in <a title=" Isolation and detection of quinoline alkaloids from plant, microbial and animal sources" href="quinoline2002.htm#tab1">Table 1</a>, which also includes previously unreported sources of known alkaloids.<small><sup style="color: ;"><a title="C. Ito, M. Itoigawa, T. Otsuka, H. Tokuda, H. Nishino, H. Furukawa,  J. Nat. Prod. 2000 63 1344; S. Wang, X.-B. Ding, Y.-F. Chen, D.-Q. Yu,  J. Asian Nat. Prod. Res. 2001 3 89Chem. Abstr. 2001 135 239248; J. Chen, J. S. Tang, J. Tian, Y. P. Wang, F. E. Wu,  Chin. Chem. Lett. 2000 11 707Chem. Abstr. 2000 133 347107; I. Jacquemond-Collet, S. Hannedouche, I. Fouraste, C. Moulis,  Fitoterapia 2000 71 601; A. J. El-Rehaily, T. A. Al-Howiriny, M. S. Ahmad, M. A. Al-Yahya, F. S. El-Feraly, C. D. Hufford, A. T. McPhail,  Phytochemistry 2001 57 597; W. Gao, Y. Li, S. Jiang, D. Zhu,  Planta Med. 2000 66 664; H. Morita, Y. Hirasawa, N. Yoshida, J. Kobayashi,  Tetrahedron Lett. 2001 42 4199; G. M. Nicholas, G. L. Newton, R. C. Fahey, C. A. Bewley,  Org. Lett. 2001 3 1543; S. Funayama, R. Tanaka, Y. Kumekawa, T. Noshita, T. Mori, T. Kashiwagura, K. Murata,  Biol. Pharm. Bull. 2001 24 100; S. Funayama, K. Murata, T. Noshita,  Heterocycles 2001 54 1139; T. Noshita, M. Tando, K. Suzuki, K. Murata, S. Funayama,  Biosci. Biotechnol. Biochem. 2001 65 710; M. Kusano, H. Koshino, J. Uzawa, S. Fujioka, T. Kawano, Y. Kimura,  Biosci. Biotechnol. Biochem. 2000 64 2559; Y. Lin, Z. Shao, G. Jiang, S. Zhou, J. Cai, L. L. P. Vrijmoed, E. B. G. Jones,  Tetrahedron 2000 56 9607; N. Kakinuma, H. Iwai, S. Takahashi, K. Hamano, T. Yanagisawa, K. Nagai, K. Tanaka, K. Suzuki, F. Kirikae, T. Kirikae, A. Nakagawa,  J. Antibiot. 2000 53 1247; S. Takahashi, N. Kakinuma, H. Iwai, T. Yanagisawa, K. Nagai, K. Suzuki, T. Tokunaga, A. Nakagawa,  J. Antibiot. 2000 53 1252; K. El Sayed, M. A. Al-Said, F. S. El-Feraly, S. A. Ross,  J. Nat. Prod. 2000 63 995; N. Fokialakis, P. Magiatis, N. Aligiannis, S. Mitaku, F. Tillequin, T. Sevenet,  Phytochemistry 2001 57 593; N. Fokialakis, P. Magiatis, A.-L. Skaltsounis, F. Tillequin, T. Sevenet,  Z. Naturforsch., Teil C 2000 55 874; N. Fokialakis, P. Magiatis, S. Mitaku, F. Tillequin, T. Sevenet,  Chem. Pharm. Bull. 2000 48 2009; N. Fokialakis, P. Magiatis, A.-L. Skaltsounis, F. Tillequin, T. Sevenet,  J. Nat. Prod. 2000 63 1004; W. N. Setzer, M. C. Setzer, J. M. Schmidt, D. M. Moriarity, B. Vogler, S. Reeb, A. M. Holmes, W. A. Haber,  Planta Med. 2000 66 493; M.-J. Cheng, I.-L. Tsai, I.-S. Chen,  J. Chin. Chem. Soc. 2001 48 235Chem. Abstr. 2001 135 105018; M. J. Mashimbye, M. C. Maumela, M. C. Raphulu,  Niger. J. Nat. Prod. Med. 2000 4 57Chem. Abstr. 2001 135 31257; I.-L. Tsai, W.-Y. Lin, C.-M. Teng, T. Ishikawa, S.-L. Doong, M.-W. Huang, Y.-C. Chen, I.-S. Chen,  Planta Med. 2000 66 618" href="quinoline2002.htm#cit1">1�24</a></sup></small></p><br><a name="tab1"><a></a><b>Table 
	1</b>
	Isolation and detection of quinoline alkaloids from plant, microbial and animal sources
	
	<hr></a><table align="center" width="100%" border="0"><colgroup><col align="left" char="" charoff="" width=""><col align="left" char="" charoff="" width=""><col align="left" char="" charoff="" width=""></colgroup><thead align="left"><tr valign="bottom"><td align="left">Species<hr></td><td align="left">Alkaloid<i><small><sup style="color: red;"><a title="Only new alkaloids and new records for a given species are listed in the Table. Structures of known alkaloids, if not specifically numbered, may be found in previous reviews in this series." href="quinoline2002.htm#tab1fna">a</a></sup></small></i><hr></td><td align="left">Ref.<hr></td></tr></thead><tbody><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Boronia pinnata</i></span></td><td valign="top">Dictamnine <span style="font-weight: bold; "><b>77</b></span></td><td valign="top"><a title="C. Ito, M. Itoigawa, T. Otsuka, H. Tokuda, H. Nishino, H. Furukawa,  J. Nat. Prod. 2000 63 1344" href="quinoline2002.htm#cit1">1</a></td></tr><tr valign="bottom"><td></td><td valign="top">Evolitrine <span style="font-weight: bold; "><b>78</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">Folimine</td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(�)-Pinolinone<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>25</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">Preskimmianine</td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Castanea mollissima</i></span></td><td valign="top">(�)-Chestnutamide<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>84</b></span></td><td valign="top"><a title="S. Wang, X.-B. Ding, Y.-F. Chen, D.-Q. Yu,  J. Asian Nat. Prod. Res. 2001 3 89Chem. Abstr. 2001 135 239248" href="quinoline2002.htm#cit2">2</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Dictamnus dasycarpus</i></span></td><td valign="top">Dasycarine<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>26</b></span></td><td valign="top"><a title="J. Chen, J. S. Tang, J. Tian, Y. P. Wang, F. E. Wu,  Chin. Chem. Lett. 2000 11 707Chem. Abstr. 2000 133 347107" href="quinoline2002.htm#cit3">3</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Galipea officinalis</i></span></td><td valign="top"><span style="font-style: italic; "><i>N</i></span>-Methyl-4-hydroxy-3-(2,3-epoxy-3-methylbutyl)quinolin-2-one<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>27</b></span></td><td valign="top"><a title="I. Jacquemond-Collet, S. Hannedouche, I. Fouraste, C. Moulis,  Fitoterapia 2000 71 601" href="quinoline2002.htm#cit4">4</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Haplophyllum tuberculatum</i></span></td><td valign="top">(�)-Haplotubine<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>71</b></span></td><td valign="top"><a title="A. J. El-Rehaily, T. A. Al-Howiriny, M. S. Ahmad, M. A. Al-Yahya, F. S. El-Feraly, C. D. Hufford, A. T. McPhail,  Phytochemistry 2001 57 597" href="quinoline2002.htm#cit5">5</a></td></tr><tr valign="bottom"><td></td><td valign="top"><span style="font-style: italic; "><i>rac</i></span>-Haplotubinone<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>33</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Huperzia serrata</i></span></td><td valign="top">(+)-Huperzine J<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>85</b></span></td><td valign="top"><a title="W. Gao, Y. Li, S. Jiang, D. Zhu,  Planta Med. 2000 66 664" href="quinoline2002.htm#cit6">6</a></td></tr><tr valign="bottom"><td></td><td valign="top">(�)-Huperzine K<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>86</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(+)-Huperzine L<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>87</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Lycopodium chinense</i></span></td><td valign="top">(�)-Senepodine A<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>88</b></span></td><td valign="top"><a title="H. Morita, Y. Hirasawa, N. Yoshida, J. Kobayashi,  Tetrahedron Lett. 2001 42 4199" href="quinoline2002.htm#cit7">7</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Oceanapia</i></span> sp. (sponge)</td><td valign="top">Uranidine <span style="font-weight: bold; "><b>125</b></span></td><td valign="top"><a title="G. M. Nicholas, G. L. Newton, R. C. Fahey, C. A. Bewley,  Org. Lett. 2001 3 1543" href="quinoline2002.htm#cit8">8</a></td></tr><tr valign="bottom"><td></td><td valign="top">Uranidine derivative<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>127</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Orixa japonica</i></span></td><td valign="top">Eduline <span style="font-weight: bold; "><b>2</b></span></td><td valign="top"><a title="S. Funayama, R. Tanaka, Y. Kumekawa, T. Noshita, T. Mori, T. Kashiwagura, K. Murata,  Biol. Pharm. Bull. 2001 24 100" href="quinoline2002.htm#cit9">9</a></td></tr><tr valign="bottom"><td></td><td valign="top">Isobalfourodine</td><td valign="top"><a title="S. Funayama, K. Murata, T. Noshita,  Heterocycles 2001 54 1139" href="quinoline2002.htm#cit10">10</a></td></tr><tr valign="bottom"><td></td><td valign="top">(�)-Isopteleflorine<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>31</b></span></td><td valign="top"><a title="T. Noshita, M. Tando, K. Suzuki, K. Murata, S. Funayama,  Biosci. Biotechnol. Biochem. 2001 65 710" href="quinoline2002.htm#cit11">11</a></td></tr><tr valign="bottom"><td></td><td valign="top">3<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">-<span style="font-style: italic; "><i>O</i></span>-Methylorixine<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>29</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">Orijanone (orixiarine) <span style="font-weight: bold; "><b>30</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Penicillium</i></span> cf. <span style="font-style: italic; "><i>simplicissimum</i></span></td><td valign="top"><span style="font-style: italic; "><i>rel</i></span>-(3<span style="font-style: italic; "><i>R</i></span>,4<span style="font-style: italic; "><i>R</i></span>)-(+)-3-Methoxy-4,5-dihydroxy-4-(4-methoxyphenyl)-3,4-dihydroquinolin-2-one <span style="font-weight: bold; "><b>102</b></span></td><td valign="top"><a title="M. Kusano, H. Koshino, J. Uzawa, S. Fujioka, T. Kawano, Y. Kimura,  Biosci. Biotechnol. Biochem. 2000 64 2559" href="quinoline2002.htm#cit12">12</a></td></tr><tr valign="bottom"><td></td><td valign="top"><span style="font-style: italic; "><i>rel</i></span>-(3<span style="font-style: italic; "><i>R</i></span>,4<span style="font-style: italic; "><i>R</i></span>)-(�)-3-Methoxy-4-hydroxy-4-(4-methoxyphenyl)-3,4-dihydroquinolin-2-one <span style="font-weight: bold; "><b>103</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(+)-Penigequinolone A <span style="font-weight: bold; "><b>104</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(+)-Penigequinolone B <span style="font-weight: bold; "><b>105</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(�)-Peniprequinolone<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>106</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Penicillium</i></span> sp. 386</td><td valign="top">(�)-Penicillazine<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>107</b></span></td><td valign="top"><a title="Y. Lin, Z. Shao, G. Jiang, S. Zhou, J. Cai, L. L. P. Vrijmoed, E. B. G. Jones,  Tetrahedron 2000 56 9607" href="quinoline2002.htm#cit13">13</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Penicillium</i></span> sp. EPF-6</td><td valign="top">(+)-Quinolactacin A<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>108</b></span></td><td valign="top"><a title="N. Kakinuma, H. Iwai, S. Takahashi, K. Hamano, T. Yanagisawa, K. Nagai, K. Tanaka, K. Suzuki, F. Kirikae, T. Kirikae, A. Nakagawa,  J. Antibiot. 2000 53 1247; S. Takahashi, N. Kakinuma, H. Iwai, T. Yanagisawa, K. Nagai, K. Suzuki, T. Tokunaga, A. Nakagawa,  J. Antibiot. 2000 53 1252" href="quinoline2002.htm#cit14">14,15</a></td></tr><tr valign="bottom"><td></td><td valign="top">(�)-Quinolactacin B<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>109</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(+)-Quinolactacin C<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>110</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Ruta chalepensis</i></span></td><td valign="top">Maculosidine</td><td valign="top"><a title="K. El Sayed, M. A. Al-Said, F. S. El-Feraly, S. A. Ross,  J. Nat. Prod. 2000 63 995" href="quinoline2002.htm#cit16">16</a></td></tr><tr valign="bottom"><td></td><td valign="top">4-Methoxy-1-methylquinolin-2-one</td><td></td></tr><tr valign="bottom"><td></td><td valign="top">2-[6-(3,4-Methylenedioxyphenyl)hexyl]-4-methoxyquinoline<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>4</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">2-[6-(3,4-Methylenedioxyphenyl)hexyl]quinolin-4-one<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>5</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">Pteleine <span style="font-weight: bold; "><b>79</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Sarcomelicope megistophylla</i></span></td><td valign="top">Furomegistine I<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>74</b></span></td><td valign="top"><a title="N. Fokialakis, P. Magiatis, N. Aligiannis, S. Mitaku, F. Tillequin, T. Sevenet,  Phytochemistry 2001 57 593" href="quinoline2002.htm#cit17">17</a></td></tr><tr valign="bottom"><td></td><td valign="top">Furomegistine II<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>75</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(�)-Megistolactone<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>8</b></span></td><td valign="top"><a title="N. Fokialakis, P. Magiatis, A.-L. Skaltsounis, F. Tillequin, T. Sevenet,  Z. Naturforsch., Teil C 2000 55 874" href="quinoline2002.htm#cit18">18</a></td></tr><tr valign="bottom"><td></td><td valign="top">Megistonine I<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>10</b></span></td><td valign="top"><a title="N. Fokialakis, P. Magiatis, S. Mitaku, F. Tillequin, T. Sevenet,  Chem. Pharm. Bull. 2000 48 2009" href="quinoline2002.htm#cit19">19</a></td></tr><tr valign="bottom"><td></td><td valign="top">Megistonine II<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>11</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(+)-Sarcomejine<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>7</b></span></td><td valign="top"><a title="N. Fokialakis, P. Magiatis, A.-L. Skaltsounis, F. Tillequin, T. Sevenet,  J. Nat. Prod. 2000 63 1004" href="quinoline2002.htm#cit20">20</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Stauranthus perforatus</i></span></td><td valign="top">Skimmianine <span style="font-weight: bold; "><b>82</b></span></td><td valign="top"><a title="W. N. Setzer, M. C. Setzer, J. M. Schmidt, D. M. Moriarity, B. Vogler, S. Reeb, A. M. Holmes, W. A. Haber,  Planta Med. 2000 66 493" href="quinoline2002.htm#cit21">21</a></td></tr><tr valign="bottom"><td></td><td valign="top">Veprisine</td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Strychnos cathayensis</i></span> (Loganiaceae)</td><td valign="top">4-Methoxyquinolin-2-one</td><td valign="top"><a title="M.-J. Cheng, I.-L. Tsai, I.-S. Chen,  J. Chin. Chem. Soc. 2001 48 235Chem. Abstr. 2001 135 105018" href="quinoline2002.htm#cit22">22</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Zanthoxylum davyi</i></span></td><td valign="top">Skimmianine</td><td valign="top"><a title="M. J. Mashimbye, M. C. Maumela, M. C. Raphulu,  Niger. J. Nat. Prod. Med. 2000 4 57Chem. Abstr. 2001 135 31257" href="quinoline2002.htm#cit23">23</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Zanthoxylum schinifolium</i></span></td><td valign="top"><img src="https://bitnest.netfirms.com/images/entities/char_03b3.gif">-Fagarine <span style="font-weight: bold; "><b>80</b></span></td><td valign="top"><a title="I.-L. Tsai, W.-Y. Lin, C.-M. Teng, T. Ishikawa, S.-L. Doong, M.-W. Huang, Y.-C. Chen, I.-S. Chen,  Planta Med. 2000 66 618" href="quinoline2002.htm#cit24">24</a></td></tr><tr valign="bottom"><td></td><td valign="top">(+)-Platydesmine <span style="font-style: italic; "><i>ent</i></span>-<span style="font-weight: bold; "><b>58</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">Robustine <span style="font-weight: bold; "><b>81</b></span></td><td></td></tr></tbody><tfoot><tr valign="bottom"><td colspan="3"><a name="tab1fna"><span style="font-size: 75%; font-style: italic; vertical-align: super; "><i><sup>a</sup></i></span></a><span style="font-size: 75%; ">Only new alkaloids and new records for a given species are listed in the Table. Structures of known alkaloids, if not specifically numbered, may be found in previous reviews in this series.</span>��<a name="tab1fnb"><span style="font-size: 75%; font-style: italic; vertical-align: super; "><i><sup>b</sup></i></span></a><span style="font-size: 75%; ">New alkaloids.</span>��</td></tr></tfoot></table><hr><br><p class="otherpara">Funayama <span style="font-style: italic; "><i>et al.</i></span> have largely been responsible for recent studies on the alkaloidal constituents of <span style="font-style: italic; "><i>Orixa japonica</i></span>, an oriental plant which has medicinal applications. Their findings have been summarised in a short review describing the 24 known and new alkaloids (mainly hemiterpenoid quinoline derivatives) that they have isolated from this source, as well as some of their studies on the biosynthesis and biological activity of selected alkaloids.<small><sup style="color: ;"><a title="S. Funayama, K. Murata, T. Noshita,  Heterocycles 2001 54 1139" href="quinoline2002.htm#cit10">10</a></sup></small> The review also recounts in some detail their investigations into the absolute stereochemistry of (�)-preorixine <span style="font-weight: bold; "><b>1</b></span>, an important biosynthetic intermediate for several of the more complex <span style="font-style: italic; "><i>Orixa</i></span> alkaloids.</p><a name="sect429"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>1.2 Non-terpenoid quinoline and quinolinone alkaloids from rutaceous plants</b></p></a><p class="firstpara">The ability of <span style="font-style: italic; "><i>Orixa japonica</i></span> extracts to act as relaxants of rat jejunum smooth muscle has been traced to two well-known alkaloids, eduline <span style="font-weight: bold; "><b>2</b></span> and japonine <span style="font-weight: bold; "><b>3</b></span>, the effects of which were comparable to that of the typical muscle relaxant papaverine.<small><sup style="color: ;"><a title="S. Funayama, R. Tanaka, Y. Kumekawa, T. Noshita, T. Mori, T. Kashiwagura, K. Murata,  Biol. Pharm. Bull. 2001 24 100" href="quinoline2002.htm#cit9">9</a></sup></small> The identity of eduline, isolated for the first time from this plant source, was confirmed by synthesis from 6-methoxy-1-methylisatoic anhydride and acetophenone.</p><p class="otherpara">The novel alkaloids <span style="font-weight: bold; "><b>4</b></span> and <span style="font-weight: bold; "><b>5</b></span> isolated from root extracts of Saudi Arabian <span style="font-style: italic; "><i>Ruta chalepensis</i></span> are unique in possessing a 1,6-hexylene <img src="https://bitnest.netfirms.com/images/entities/char_201c.gif">spacer<img src="https://bitnest.netfirms.com/images/entities/char_201d.gif"> between the ring moieties rather than the more common ethylene or butylene chains.<small><sup style="color: ;"><a title="K. El Sayed, M. A. Al-Said, F. S. El-Feraly, S. A. Ross,  J. Nat. Prod. 2000 63 995" href="quinoline2002.htm#cit16">16</a></sup></small> Long-range relationships in the NMR spectra proved particularly useful for the unambiguous siting of substituents. The alkaloids were correlated chemically by the conversion of <span style="font-weight: bold; "><b>5</b></span> into <span style="font-weight: bold; "><b>4</b></span> upon treatment with iodomethane and sodium carbonate in acetone.<br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr1"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-u1.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"></p><p class="otherpara">The bark of the New Caledonian tree <span style="font-style: italic; "><i>Sarcomelicope megistophylla</i></span> continues to yield an intriguing range of unprecedented quinoline alkaloids, all of which are conceivably formed from highly oxygenated acridone alkaloids such as melicopicine <span style="font-weight: bold; "><b>6</b></span> by oxidative cleavage of ring A. The structural similarity is clearly apparent in the new alkaloid (+)-sarcomejine <span style="font-weight: bold; "><b>7</b></span> (absolute configuration unknown).<small><sup style="color: ;"><a title="N. Fokialakis, P. Magiatis, A.-L. Skaltsounis, F. Tillequin, T. Sevenet,  J. Nat. Prod. 2000 63 1004" href="quinoline2002.htm#cit20">20</a></sup></small> An unusual long-range <small><sup>1</sup></small>H�<small><sup>15</sup></small>N heteronuclear shift correlation study at natural abundance showed a three-bond relationship between nitrogen and the side-chain methine proton, thereby excluding the alternative structure with the C-2 and C-3 substituents interchanged. Further degradation of the putative acridone ring A is apparent in the structure of the weakly cytotoxic alkaloid (�)-megistolactone, the absolute configuration of which could also not be determined.<small><sup style="color: ;"><a title="N. Fokialakis, P. Magiatis, A.-L. Skaltsounis, F. Tillequin, T. Sevenet,  Z. Naturforsch., Teil C 2000 55 874" href="quinoline2002.htm#cit18">18</a></sup></small> Structure <span style="font-weight: bold; "><b>8</b></span> rather than the alternative structure <span style="font-weight: bold; "><b>9</b></span> was assigned on the basis of a strong NOE interaction between the <span style="font-style: italic; "><i>N</i></span>-methyl group and the methine proton. The biosynthetic origins of megistonine I <span style="font-weight: bold; "><b>10</b></span> and megistonine II <span style="font-weight: bold; "><b>11</b></span>, also unambiguously characterised by NMR spectroscopy, are less obviously ascribable to acridone oxidation.<small><sup style="color: ;"><a title="N. Fokialakis, P. Magiatis, S. Mitaku, F. Tillequin, T. Sevenet,  Chem. Pharm. Bull. 2000 48 2009" href="quinoline2002.htm#cit19">19</a></sup></small> These two compounds possess a methoxy group at C-3, which is unusual in rutaceous quinoline alkaloids (<span style="font-style: italic; "><i>cf.</i></span> japonine <span style="font-weight: bold; "><b>3</b></span>), although less rare than the authors believe.</p><p class="otherpara">New approaches to the synthesis of toddaquinoline <span style="font-weight: bold; "><b>12</b></span> by Harrowven <span style="font-style: italic; "><i>et al</i></span>.<small><sup style="color: ;"><a title="D. C. Harrowven, M. I. T. Nunn, N. J. Blumire, D. R. Fenwick,  Tetrahedron Lett. 2000 41 6681; D. C. Harrowven, M. I. T. Nunn, N. J. Blumire, D. R. Fenwick,  Tetrahedron 2001 57 4447" href="quinoline2002.htm#cit25">25,26</a></sup></small> have overcome the problems of regiochemical control apparent in their earlier synthesis, which involved intramolecular addition of an aryl radical to a pyridine<small><sup style="color: ;"><a title="D. C. Harrowven, M. I. T. Nunn,  Tetrahedron Lett. 1998 39 5875" href="quinoline2002.htm#cit27">27</a></sup></small> (<span style="font-style: italic; "><i>cf.</i></span> Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 2000 17 603see p. 604" href="quinoline2002.htm#cit28a">28a</a>). Whereas the azastilbene <span style="font-weight: bold; "><b>13</b></span> (X = Br) yielded a mixture of the desired toddaquinoline methyl ether <span style="font-weight: bold; "><b>14</b></span> (28%) and its regioisomer <span style="font-weight: bold; "><b>15</b></span> (30%) on treatment with tributyltin hydride and AIBN in toluene at 80 �C, the use of a different radical initiator, sodium cobalt(<span style="font-variant: 80; "><small>I</small></span>)salophen in THF at room temperature, yielded <span style="font-weight: bold; "><b>14</b></span> (61%) and less than 5% of <span style="font-weight: bold; "><b>15</b></span>. Cobalt appears to play a dual role in this reaction, first initiating homolysis of the carbon�bromine bond, and then acting as a Lewis acid to enhance the electrophilicity at C-6 in the pyridine ring towards attack by the nucleophilic radical. By contrast, photochemical cyclisation of the azastilbene <span style="font-weight: bold; "><b>16</b></span> (X = H, 1 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 1 mixture of geometrical isomers) was less selective, giving a mixture of <span style="font-weight: bold; "><b>14</b></span> (20%) and <span style="font-weight: bold; "><b>15</b></span> (54%), while cyclisation initiated by lithium�halogen exchange of <span style="font-weight: bold; "><b>13</b></span> (X = Br) with <span style="font-style: italic; "><i>n</i></span>-butyllithium at �78 �C gave <span style="font-weight: bold; "><b>14</b></span> (11%) and yet another regioisomer, the unstable <span style="font-weight: bold; "><b>17</b></span> (32%). Ironically, it proved impossible to demethylate the methyl ether <span style="font-weight: bold; "><b>14</b></span>, necessitating a change of protecting group. The improved synthesis of toddaquinoline proceeded through the benzyl ether <span style="font-weight: bold; "><b>18</b></span>, prepared as shown in <a title=" Reagents and conditions: i, NaOBn, DMF, 65[degree]C; ii,n-BuLi, THF,-100[degree]C, 1 h, then DMF,-60[degree]C; iii, THF, 0[degree]C; iv, Na-Hg, Co(ii)salophen, THF, rt, then add18, THF,-78[degree]C to rt; v, H2(1 atm), 5%Pd-C, HOAc, rt." href="quinoline2002.htm#sch1">Scheme 1</a>. Radical-mediated cyclisation with sodium cobalt(<span style="font-variant: 80; "><small>I</small></span>) salophen gave toddaquinoline benzyl ether <span style="font-weight: bold; "><b>19</b></span> in 61% yield, after which conventional hydrogenolytic debenzylation completed the synthesis of the target alkaloid <span style="font-weight: bold; "><b>12</b></span>.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch1"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-s1.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 1 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents and conditions</i></span>: i, NaOBn, DMF, 65 �C; ii, <span style="font-style: italic; "><i>n</i></span>-BuLi, THF, �100 �C, 1 h, then DMF, �60 �C; iii, THF, 0 �C; iv, Na�Hg, Co(<span style="font-variant: 80; "><small>II</small></span>)salophen, THF, rt, then add <span style="font-weight: bold; "><b>18</b></span>, THF, �78 �C to rt; v, H<small><sub>2</sub></small>(1 atm), 5% Pd�C, HOAc, rt.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">Several short syntheses of simple 2-substituted quinolines merit brief mention. A new route to 2-alkylquinolines, including the natural product 2-propylquinoline <span style="font-weight: bold; "><b>20</b></span>, by addition of Grignard reagents to <span style="font-style: italic; "><i>N</i></span>-[(isobutoxycarbonyl)oxy]quinolinium chloride <span style="font-weight: bold; "><b>21</b></span> holds promise for preparing other 2-substituted quinoline alkaloids.<small><sup style="color: ;"><a title="M. A. Fakhfakh, X. Franck, A. Fournet, R. Hocquemiller, B. Figadere,  Tetrahedron Lett. 2001 42 3847" href="quinoline2002.htm#cit29">29</a></sup></small> Reduction of 1-aryl-3-(2-nitroaryl)prop-2-en-1-ones <span style="font-weight: bold; "><b>22</b></span> with low-valent titanium, prepared from samarium powder and titanium tetrachloride in THF, also provided an efficient route to 2-arylquinolines, amongst them the alkaloid <span style="font-weight: bold; "><b>23</b></span>.<small><sup style="color: ;"><a title="Y. Ma, Y. Zhang,  J. Chem. Res.(S) 2001 108" href="quinoline2002.htm#cit30">30</a></sup></small> Treatment of polymer-bound flavylium salts <span style="font-weight: bold; "><b>24</b></span> with aqueous ammonia represents a versatile new route for the synthesis of analogues of the 2-phenylquinolin-4-one alkaloids.<small><sup style="color: ;"><a title="S. Sato, Y. Kubota, H. Kumagai, T. Kumazawa, S. Matsuba, J. Onodera, M. Suzuki,  Heterocycles 2000 53 1523" href="quinoline2002.htm#cit31">31</a></sup></small> Finally, the alkylation of 2-phenylquinolin-4-ones with haloalkanes in the presence of sodium hydride and THF yielded a range of 4-alkoxy-2-phenylquinoline alkaloid analogues, some of which showed potent antiplatelet activity.<small><sup style="color: ;"><a title="T.-C. Ko, M.-J. Hour, J.-C. Lien, C.-M. Teng, K.-S. Lee, S.-C. Kuo, L.-J. Huang,  Bioorg. Med. Chem. Lett. 2001 11 279" href="quinoline2002.htm#cit32">32</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr2"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-u2.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><a name="sect507"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>1.3 Terpenoid quinoline alkaloids and tricyclic derivatives</b></p></a><p class="firstpara">The 3,4-<span style="font-style: italic; "><i>trans</i></span>-diol structure of (�)-pinolinone <span style="font-weight: bold; "><b>25</b></span>, extracted from roots of the Australian shrub <span style="font-style: italic; "><i>Boronia pinnata</i></span>,<small><sup style="color: ;"><a title="C. Ito, M. Itoigawa, T. Otsuka, H. Tokuda, H. Nishino, H. Furukawa,  J. Nat. Prod. 2000 63 1344" href="quinoline2002.htm#cit1">1</a></sup></small> is unique amongst rutaceous quinoline alkaloids. This novel alkaloid is effectively a 3-prenylquinolin-2-one that has been oxidised at C-3 and reduced at C-4. The location of substituents was fixed by HMBC correlations and NOE studies, and in particular the spatial relationship of the hydroxy groups was deduced from an NOE interaction between H-4 and 3-OH. The absolute configuration was not established.</p><p class="otherpara">A more typical 3-prenylquinolin-2-one, dasycarine <span style="font-weight: bold; "><b>26</b></span>, was isolated from the roots of Chinese <span style="font-style: italic; "><i>Dictamnus dasycarpus</i></span>.<small><sup style="color: ;"><a title="J. Chen, J. S. Tang, J. Tian, Y. P. Wang, F. E. Wu,  Chin. Chem. Lett. 2000 11 707Chem. Abstr. 2000 133 347107" href="quinoline2002.htm#cit3">3</a></sup></small> Once again, long-range NMR spectroscopic methods were used to establish the location of the substituents.</p><p class="otherpara">Naturally occurring 3-prenylquinolin-2-ones are commonly modified by oxidation of the prenyl side chain. A case in point is the epoxyprenylquinolin-2-one <span style="font-weight: bold; "><b>27</b></span> (incorrectly named by the authors as an epoxyisobutyl-2-quinolone), a novel metabolite of the trunk bark (angostura) of Venezuelan <span style="font-style: italic; "><i>Galipea officinalis</i></span>, which is well known for its medicinal properties.<small><sup style="color: ;"><a title="I. Jacquemond-Collet, S. Hannedouche, I. Fouraste, C. Moulis,  Fitoterapia 2000 71 601" href="quinoline2002.htm#cit4">4</a></sup></small> Several alkaloids isolated from leaves and stems of <span style="font-style: italic; "><i>Orixa japonica</i></span> and thoroughly characterised by spectroscopic techniques also show side-chain oxidation.<small><sup style="color: ;"><a title="T. Noshita, M. Tando, K. Suzuki, K. Murata, S. Funayama,  Biosci. Biotechnol. Biochem. 2001 65 710" href="quinoline2002.htm#cit11">11</a></sup></small> They include the known alkaloid <span style="font-style: italic; "><i>N</i></span>-demethyllunidonine <span style="font-weight: bold; "><b>28</b></span>, the novel compound (+)-3<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">-<span style="font-style: italic; "><i>O</i></span>-methylorixine <span style="font-weight: bold; "><b>29</b></span> and the apparently new compound orijanone <span style="font-weight: bold; "><b>30</b></span>. The latter alkaloid had, in fact, been reported in 1998 as a metabolite of <span style="font-style: italic; "><i>Skimmia laureola</i></span><small><sup style="color: ;"><a title=" Atta-ur-Rahman, N. Sultana, M. I. Choudhary, P. M. Shah, M. R. Khan,  J. Nat. Prod. 1998 61 713" href="quinoline2002.htm#cit33">33</a></sup></small> (<span style="font-style: italic; "><i>cf.</i></span> Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 1999 16 697see p. 700" href="quinoline2002.htm#cit28b">28b</a>) and assigned the name orixiarine, which should thus take precedence.<small><sup style="color: ;"><a title="S. Funayama,Aomori University, personal communication. I am grateful to Professor Funayama for agreeing that the name orixiarine should be used in preference to orijanone" href="quinoline2002.htm#cit34">34</a></sup></small> The tricyclic derivative (�)-isopteleflorine <span style="font-weight: bold; "><b>31</b></span> (absolute configuration unknown) is, however, a new natural product from <span style="font-style: italic; "><i>O. japonica</i></span>, although it had previously been prepared by hydrolysis of another <span style="font-style: italic; "><i>O. japonica</i></span> alkaloid, 3<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">-<span style="font-style: italic; "><i>O</i></span>-acetylisopteleflorine <span style="font-weight: bold; "><b>32</b></span>.<small><sup style="color: ;"><a title="S. Funayama, K. Murata, S. Nozoe,  Phytochemistry 1996 41 1231" href="quinoline2002.htm#cit35">35</a></sup></small></p><p class="otherpara">The growing family of 3-monoterpenoid quinoline alkaloids has been augmented by a most unusual member, haplotubinone.<small><sup style="color: ;"><a title="A. J. El-Rehaily, T. A. Al-Howiriny, M. S. Ahmad, M. A. Al-Yahya, F. S. El-Feraly, C. D. Hufford, A. T. McPhail,  Phytochemistry 2001 57 597" href="quinoline2002.htm#cit5">5</a></sup></small> When a comprehensive suite of NMR spectroscopic experiments on this optically inactive metabolite from Saudi Arabian <span style="font-style: italic; "><i>Haplophyllum tuberculatum</i></span> failed to yield an unambiguous structure, single crystal X-ray analysis was used to establish the complete structure and relative stereochemistry shown in <span style="font-weight: bold; "><b>33</b></span>. Noteworthy features in the solid-state structure included hydrogen-bonding between the hydroxy group and the epoxide oxygen, the dimeric association of pairs of enantiomers by hydrogen bonds between the lactam N�H and C-2 carbonyl groups, and the folding back of the side chain to place the (<span style="font-style: italic; "><i>Z</i></span>)-methyl group of the prenyl unit over the benzene ring. The latter feature probably accounts for the unusual upfield shift (<span style="font-style: italic; "><i><img src="https://bitnest.netfirms.com/images/entities/i_char_03b4.gif"></i></span> 0.85) for this methyl group in the <small><sup>1</sup></small>H NMR spectrum.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr3"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-u3.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">A formal [3 + 3] cycloaddition between 4-hydroxy-1-methylquinolin-2-one <span style="font-weight: bold; "><b>34</b></span> and <img src="https://bitnest.netfirms.com/images/entities/char_03b1.gif">,<img src="https://bitnest.netfirms.com/images/entities/char_03b2.gif">-unsaturated iminium salts <span style="font-weight: bold; "><b>35</b></span> in the sense shown in <a title=" Reagents and conditions: i, piperidine, toluene, 0[degree]C, 5 min, then Ac2O, 85[degree]C, 1 h, then34, 85[degree]C, 48 h; ii, Cp2ZrCl2, AlMe3,n-BuLi,(CH2O)n; iii, Dess-Martin periodinane, CH2Cl2, rt; iv, HF-pyridine, THF, rt; v,(EtO)2POCH2COMe, NaH, THF, rt; vi, MeLi, THF-Et2O(1[ratio]1),-78[degree]C to rt; vii, magnesium monoperoxyphthalate, PriOH-H2O(2[ratio]1), rt; viii, OsO4(cat.), K3Fe(CN)3, K2CO3, ButOH-H2O(1[ratio]1), rt." href="quinoline2002.htm#sch2">Scheme 2</a> (inset) underlies a conceptually simple route to ring C-substituted pyrano[3,2-<span style="font-style: italic; "><i>c</i></span>]quinolines <span style="font-weight: bold; "><b>36</b></span> by McLaughlin and Hsung.<small><sup style="color: ;"><a title="M. J. McLaughlin, R. P. Hsung,  J. Org. Chem. 2001 66 1049" href="quinoline2002.htm#cit36">36</a></sup></small> For example, the iminium species formed <span style="font-style: italic; "><i>in situ</i></span> from the geraniol-derived aldehyde <span style="font-weight: bold; "><b>37</b></span>, piperidine and acetic anhydride, reacted with <span style="font-weight: bold; "><b>34</b></span> in toluene at 85 �C to give (�)-huajiaosimuline <span style="font-weight: bold; "><b>38</b></span> directly in 79% yield. The lengthier synthesis of (�)-simulenoline <span style="font-weight: bold; "><b>39</b></span> from aldehyde <span style="font-weight: bold; "><b>40</b></span> proceeded through the adduct <span style="font-weight: bold; "><b>41</b></span>, which was then deprotected and oxidised to give the tricyclic product <span style="font-weight: bold; "><b>42</b></span>. Wadsworth�Emmons homologation with diethyl 2-oxopropylphosphonate and subsequent addition of methyllithium completed the synthesis of <span style="font-weight: bold; "><b>39</b></span>. Finally, prenal <span style="font-weight: bold; "><b>43</b></span> was the precursor in a one-pot synthesis of <span style="font-style: italic; "><i>N</i></span>-methylflindersine <span style="font-weight: bold; "><b>44</b></span> (63% yield). In this case, further transformation of the product <span style="font-weight: bold; "><b>44</b></span> by dihydroxylation under appropriate conditions yielded the racemic <span style="font-style: italic; "><i>cis</i></span>- and <span style="font-style: italic; "><i>trans</i></span>-diols <span style="font-weight: bold; "><b>45</b></span> and <span style="font-weight: bold; "><b>46</b></span>, respectively. Although neither of these is a natural product, their spectroscopic data provided useful analogies for confirming the tentatively assigned <span style="font-style: italic; "><i>trans</i></span>-configuration of a related natural product, zanthodioline <span style="font-weight: bold; "><b>47</b></span>.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch2"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-s2.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 2 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents and conditions</i></span>: i, piperidine, toluene, 0 �C, 5 min, then Ac<small><sub>2</sub></small>O, 85 �C, 1 h, then <span style="font-weight: bold; "><b>34</b></span>, 85 �C, 48 h; ii, Cp<small><sub>2</sub></small>ZrCl<small><sub>2</sub></small>, AlMe<small><sub>3</sub></small>, <span style="font-style: italic; "><i>n</i></span>-BuLi, (CH<small><sub>2</sub></small>O)<span style="font-style: italic; "><i>n</i></span>; iii, Dess�Martin periodinane, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, rt; iv, HF�pyridine, THF, rt; v, (EtO)<small><sub>2</sub></small>POCH<small><sub>2</sub></small>COMe, NaH, THF, rt; vi, MeLi, THF�Et<small><sub>2</sub></small>O (1 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 1), �78 �C to rt; vii, magnesium monoperoxyphthalate, Pr<small><sup>i</sup></small>OH�H<small><sub>2</sub></small>O (2 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 1), rt; viii, OsO<small><sub>4</sub></small>(cat.), K<small><sub>3</sub></small>Fe(CN)<small><sub>3</sub></small>, K<small><sub>2</sub></small>CO<small><sub>3</sub></small>, Bu<small><sup><span style="font-style: italic; "><i>t</i></span></sup></small>OH�H<small><sub>2</sub></small>O (1 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 1), rt.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The significant contribution by Barr and Boyd on the enantioselective synthesis of various tricyclic hemiterpenoid alkaloids and the proof of their absolute configurations, communicated in 1994<small><sup style="color: ;"><a title="S. A. Barr, D. R. Boyd,  J. Chem. Soc., Chem. Commun. 1994 153" href="quinoline2002.htm#cit37">37</a></sup></small> (<span style="font-style: italic; "><i>cf.</i></span> Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 1995 12 465see p. 468" href="quinoline2002.htm#cit28c">28c</a>), has been published with full experimental details and several extensions.<small><sup style="color: ;"><a title="D. R. Boyd, N. D. Sharma, S. A. Barr, J. G. Carroll, D. Mackerracher, J. F. Malone,  J. Chem. Soc., Perkin Trans. 1 2000 3397" href="quinoline2002.htm#cit38">38</a></sup></small> The previous work described the conversion of the pyrano[2,3-<span style="font-style: italic; "><i>b</i></span>]quinoline <span style="font-weight: bold; "><b>48</b></span>, prepared in two steps from atanine <span style="font-weight: bold; "><b>49</b></span>, <span style="font-style: italic; "><i>via</i></span> bromohydrin ester <span style="font-weight: bold; "><b>50</b></span> into several alkaloids, including (+)-(3<span style="font-style: italic; "><i>S</i></span>)-geibalansine <span style="font-weight: bold; "><b>51</b></span>, (�)-(3<span style="font-style: italic; "><i>S</i></span>)-ribalinine <span style="font-weight: bold; "><b>52</b></span>, (�)-(2<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif"><span style="font-style: italic; "><i>S</i></span>)-edulinine <span style="font-weight: bold; "><b>53</b></span>, (�)-(2<span style="font-style: italic; "><i>R</i></span>)-araliopsine <span style="font-weight: bold; "><b>54</b></span>, as well as the alkaloid analogue (+)-(3<span style="font-style: italic; "><i>S</i></span>)-<img src="https://bitnest.netfirms.com/images/entities/char_03a8.gif">-ribalinine <span style="font-weight: bold; "><b>55</b></span>. The results permitted the correction of incorrect absolute stereochemistries recorded in the literature for edulinine and araliopsine. The new extensions include conversion of atanine into chiral diols <span style="font-weight: bold; "><b>56</b></span> and <span style="font-style: italic; "><i>ent</i></span>-<span style="font-weight: bold; "><b>56</b></span> with AD-mix-<img src="https://bitnest.netfirms.com/images/entities/char_03b1.gif"> and AD-mix-<img src="https://bitnest.netfirms.com/images/entities/char_03b2.gif">, respectively, and proof of absolute configuration by analysis of Mosher esters. Further transformation of <span style="font-weight: bold; "><b>56</b></span> and its enantiomer into the bromoacetates <span style="font-weight: bold; "><b>57</b></span> and <span style="font-style: italic; "><i>ent</i></span>-<span style="font-weight: bold; "><b>57</b></span> with acetoxyisobutyryl bromide prefaced transformation into (�)-(2<span style="font-style: italic; "><i>R</i></span>)-platydesmine <span style="font-weight: bold; "><b>58</b></span> and its (+)-(2<span style="font-style: italic; "><i>S</i></span>) enantiomer, respectively, upon treatment with base. The <span style="font-style: italic; "><i>N</i></span>-methylplatydesminium methiodides were readily prepared from the free bases by treatment with iodomethane in ethanol. The (+)-(2<span style="font-style: italic; "><i>S</i></span>) salt <span style="font-weight: bold; "><b>59</b></span> proved to be identical to a natural sample isolated from <span style="font-style: italic; "><i>Skimmia japonica</i></span>, a result that conflicted with the literature assignment of the (2<span style="font-style: italic; "><i>R</i></span>)-configuration to (+)-platydesmine methiodide. To clinch matters, single-crystal X-ray crystallography of (+)-platydesminium perchlorate unequivocally supported the (2<span style="font-style: italic; "><i>S</i></span>) absolute configuration. Thus the (2<span style="font-style: italic; "><i>R</i></span>) absolute configurations previously assigned to both (+)-platydesmine and its (+)-methosalt are incorrect, and the structure of the former alkaloid is <span style="font-style: italic; "><i>ent</i></span>-<span style="font-weight: bold; "><b>58</b></span>. Other transformations of relevance included mild alkaline hydrolysis of (+)-platydesminium methiodide <span style="font-weight: bold; "><b>59</b></span> to complete an alternative synthesis of (�)-(2<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif"><span style="font-style: italic; "><i>S</i></span>)-edulinine <span style="font-weight: bold; "><b>53</b></span>; and treatment of <span style="font-style: italic; "><i>N</i></span>-methylatanine <span style="font-weight: bold; "><b>60</b></span> with AD-mix-<img src="https://bitnest.netfirms.com/images/entities/char_03b1.gif"> to give the same (�)-alkaloid.</p><p class="otherpara">A short synthesis of racemic araliopsine (�)-<span style="font-weight: bold; "><b>54</b></span> by Parsons and co-workers exploited the addition of 4-hydroxy-1-methylquinolin-2-one <span style="font-weight: bold; "><b>34</b></span> (see <a title=" Reagents and conditions: i, piperidine, toluene, 0[degree]C, 5 min, then Ac2O, 85[degree]C, 1 h, then34, 85[degree]C, 48 h; ii, Cp2ZrCl2, AlMe3,n-BuLi,(CH2O)n; iii, Dess-Martin periodinane, CH2Cl2, rt; iv, HF-pyridine, THF, rt; v,(EtO)2POCH2COMe, NaH, THF, rt; vi, MeLi, THF-Et2O(1[ratio]1),-78[degree]C to rt; vii, magnesium monoperoxyphthalate, PriOH-H2O(2[ratio]1), rt; viii, OsO4(cat.), K3Fe(CN)3, K2CO3, ButOH-H2O(1[ratio]1), rt." href="quinoline2002.htm#sch2">Scheme 2</a>) to 2-methylbut-3-en-2-ol upon sonication in acetic acid at 60 �C in the presence of manganese(<span style="font-variant: 80; "><small>III</small></span>) acetate.<small><sup style="color: ;"><a title="G. Bar, A. F. Parsons, C. B. Thomas,  Tetrahedron Lett. 2000 41 7751; G. Bar, A. F. Parsons, C. B. Thomas,  Tetrahedron 2001 57 4719" href="quinoline2002.htm#cit39">39,40</a></sup></small> The target alkaloid was obtained directly in 40% yield. This radical-mediated process appears to be general for the addition of <span style="font-weight: bold; "><b>34</b></span> to alkyl-substituted alkenes, and several analogues of general structure <span style="font-weight: bold; "><b>61</b></span> could be prepared in yields of 31�65%. With styrenes, however, approximately equal amounts of the angularly fused dihydrofuro[3,2-<span style="font-style: italic; "><i>c</i></span>]quinoline products <span style="font-weight: bold; "><b>61</b></span> (R<small><sup>1</sup></small> = Ph) and the linearly fused isomers <span style="font-weight: bold; "><b>62</b></span> were produced. The reaction of <span style="font-weight: bold; "><b>34</b></span> with alkynes (phenylacetylene, 2-methylbut-1-en-3-yne) also yielded mixtures of isomeric tricyclic products, as did the reaction of quinoline-2,4-diol with alkenes.</p><p class="otherpara">An electrophysiological study of the ability of various linearly and angularly fused dihydrofuroquinolines and dihydropyranoquinolines to block the voltage-gated potassium channel Kv1.3 in mouse fibroblasts necessitated the preparation of a range of relevant alkaloids and alkaloid analogues from the 3-prenylquinolin-2-ones <span style="font-weight: bold; "><b>63</b></span> and <span style="font-weight: bold; "><b>64</b></span> by reported transformations.<small><sup style="color: ;"><a title="I. Butenschon, K. Moller, W. Hansel,  J. Med. Chem. 2001 44 1249" href="quinoline2002.htm#cit41">41</a></sup></small> The compounds in the study included, amongst others, the alkaloids dihydroflindersine <span style="font-weight: bold; "><b>65</b></span>, <span style="font-style: italic; "><i>N</i></span>-methylhaplamine <span style="font-weight: bold; "><b>66</b></span>, khaplofoline <span style="font-weight: bold; "><b>67</b></span>, isoplatydesmine <span style="font-weight: bold; "><b>68</b></span> and <span style="font-style: italic; "><i>O</i></span>-methylribaline <span style="font-weight: bold; "><b>69</b></span>. The known based-induced skeletal rearrangements of <span style="font-weight: bold; "><b>68</b></span> and <span style="font-weight: bold; "><b>69</b></span> to give derivatives of araliopsine, ribalinine and <img src="https://bitnest.netfirms.com/images/entities/char_03a8.gif">-ribalinine (<span style="font-style: italic; "><i>vide supra</i></span>) were confirmed, and AM1 calculations on the heats of formation of the various isomers supported the experimental observation that angularly fused dihydropyranoquinolinones (<span style="font-style: italic; "><i>e.g.</i></span>, <img src="https://bitnest.netfirms.com/images/entities/char_03a8.gif">-ribalinine) are the most stable isomers and linear dihydrofuroquinolinones (<span style="font-style: italic; "><i>e.g.</i></span>, isoplatydesmine itself) the least. In the pharmacological studies themselves, angularly fused isomers were in general more potent channel blockers than their linear analogues, and furoquinolines more potent than dihydrofuroquinolines. The most active compounds, <span style="font-style: italic; "><i>N</i></span>-methylhaplamine <span style="font-weight: bold; "><b>66</b></span> and <span style="font-weight: bold; "><b>70</b></span>, might thus function as templates for the development of novel immunosuppressants.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr4"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-u4.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><a name="sect680"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>1.4 Furoquinoline alkaloids</b></p></a><p class="firstpara">(�)-Haplotubine <span style="font-weight: bold; "><b>71</b></span>, a new furoquinoline alkaloid isolated from the aerial parts of <span style="font-style: italic; "><i>Haplophyllum tuberculatum</i></span>, contains a 6,7-dihydroxygeranyloxy substituent at C-7.<small><sup style="color: ;"><a title="A. J. El-Rehaily, T. A. Al-Howiriny, M. S. Ahmad, M. A. Al-Yahya, F. S. El-Feraly, C. D. Hufford, A. T. McPhail,  Phytochemistry 2001 57 597" href="quinoline2002.htm#cit5">5</a></sup></small> This unusual substituent has only been encountered once before amongst the rutaceous quinoline alkaloids, namely, in the compound bucharaine <span style="font-weight: bold; "><b>72</b></span>. The connectivity in the side chain was established from HMBC spectra.</p><p class="otherpara">The only secofuroquinoline alkaloids to have been reported in the past were the rhoifolinic esters <span style="font-weight: bold; "><b>73</b></span>. Bark extracts of <span style="font-style: italic; "><i>Sarcomelicope megistophylla</i></span> have now yielded another two alkaloids of this class, furomegistine I <span style="font-weight: bold; "><b>74</b></span> and furomegistine II <span style="font-weight: bold; "><b>75</b></span>, both of which are conceivably derived by oxidative cleavage of a more conventional furoquinoline alkaloid such as acronycidine <span style="font-weight: bold; "><b>76</b></span>.<small><sup style="color: ;"><a title="N. Fokialakis, P. Magiatis, N. Aligiannis, S. Mitaku, F. Tillequin, T. Sevenet,  Phytochemistry 2001 57 593" href="quinoline2002.htm#cit17">17</a></sup></small> The propensity of <span style="font-style: italic; "><i>S. megistophylla</i></span> to produce oxidatively modified alkaloids has already been commented upon (<span style="font-style: italic; "><i>vide supra</i></span>). The structures of the furomegistines were deduced on the basis of their spectroscopic characteristics, long-range NMR spectroscopic experiments and NOE effects once again playing a pivotal role in the structural elucidation. Furomegistine II was found to be racemic, possibly indicating its formation from furomegistine I by an unselective intramolecular conjugate addition. Both alkaloids showed moderate cytotoxicity towards human lung carcinoma A549 and human colon adenocarcinoma HT29 cells (IC<small><sub>50</sub></small> 90 and 100 �M, respectively).</p><p class="otherpara">That many furoquinoline alkaloids are biologically active is well known. Dictamnine <span style="font-weight: bold; "><b>77</b></span> and evolitrine <span style="font-weight: bold; "><b>78</b></span> , amongst other compounds, have recently been shown to inhibit activation of Epstein�Barr virus early antigen (EBV�EA) in Raji cells.<small><sup style="color: ;"><a title="C. Ito, M. Itoigawa, T. Otsuka, H. Tokuda, H. Nishino, H. Furukawa,  J. Nat. Prod. 2000 63 1344" href="quinoline2002.htm#cit1">1</a></sup></small> Pteleine <span style="font-weight: bold; "><b>79</b></span> showed moderate antimicrobial activity against <span style="font-style: italic; "><i>Mycobacterium smegmatis</i></span>, <span style="font-style: italic; "><i>Bacillus subtilis</i></span>, <span style="font-style: italic; "><i>Staphylococcus aureus</i></span> and <span style="font-style: italic; "><i>Candida albicans</i></span> (minimum inhibitory concentration 5�100 �g cm<small><sup>�3</sup></small>),<small><sup style="color: ;"><a title="K. El Sayed, M. A. Al-Said, F. S. El-Feraly, S. A. Ross,  J. Nat. Prod. 2000 63 995" href="quinoline2002.htm#cit16">16</a></sup></small> while antiplatelet aggregation activity has been demonstrated for (+)-platydesmine <span style="font-style: italic; "><i>ent</i></span>-<span style="font-weight: bold; "><b>58</b></span>, dictamnine, <img src="https://bitnest.netfirms.com/images/entities/char_03b3.gif">-fagarine <span style="font-weight: bold; "><b>80</b></span>, robustine <span style="font-weight: bold; "><b>81</b></span> and skimmianine <span style="font-weight: bold; "><b>82</b></span>.<small><sup style="color: ;"><a title="I.-L. Tsai, W.-Y. Lin, C.-M. Teng, T. Ishikawa, S.-L. Doong, M.-W. Huang, Y.-C. Chen, I.-S. Chen,  Planta Med. 2000 66 618" href="quinoline2002.htm#cit24">24</a></sup></small> Dictamnine, skimmianine and especially kokusaginine <span style="font-weight: bold; "><b>83</b></span> were able to block potassium channel Kv1.3 currents in mouse fibroblasts.<small><sup style="color: ;"><a title="I. Butenschon, K. Moller, W. Hansel,  J. Med. Chem. 2001 44 1249" href="quinoline2002.htm#cit41">41</a></sup></small> Dictamnine and evolitrine showed antifeedant activity against fourth instar larvae of the tobacco caterpillar, <span style="font-style: italic; "><i>Spodoptera litura</i></span>.<small><sup style="color: ;"><a title="S. G. Jagadeesh, G. L. D. Krupadanam, G. Srimannarayana,  Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 2000 39 475" href="quinoline2002.htm#cit42">42</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr5"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-u5.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><a name="sect720"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>1.5 Miscellaneous quinoline alkaloids from higher plants</b></p></a><p class="firstpara">The flowers of <span style="font-style: italic; "><i>Castanea mollissima</i></span> (Fagaceae), an economically important variety of chestnut tree that is widely distributed in China, are the source of an unusual new alkaloid, chestnutamide <span style="font-weight: bold; "><b>84</b></span>.<small><sup style="color: ;"><a title="S. Wang, X.-B. Ding, Y.-F. Chen, D.-Q. Yu,  J. Asian Nat. Prod. Res. 2001 3 89Chem. Abstr. 2001 135 239248" href="quinoline2002.htm#cit2">2</a></sup></small> Convincing spectroscopic evidence was presented for the unprecedented pyrrolizino[3,2-<span style="font-style: italic; "><i>b</i></span>]quinoline skeleton in this compound. In particular, comprehensive HMBC and NOESY correlations established the full connectivity in the assigned structure. The natural product was very slightly laevorotatory ([<span style="font-style: italic; "><i><img src="https://bitnest.netfirms.com/images/entities/i_char_03b1.gif"></i></span>]<small><sub>D</sub></small> �0.016, <span style="font-style: italic; "><i>c</i></span> 0.25, CHCl<small><sub>3</sub></small>), but its absolute configuration was not determined.</p><p class="otherpara">The club mosses of the Lycopodiaceae have yielded several novel decahydroquinoline alkaloids in recent years. The latest additions to this growing group of compounds are huperzines J <span style="font-weight: bold; "><b>85</b></span>, K <span style="font-weight: bold; "><b>86</b></span> and L <span style="font-weight: bold; "><b>87</b></span>, which were isolated from <span style="font-style: italic; "><i>Huperzia serrata</i></span>, a Chinese herbal plant used in the treatment of contusions, strains and swellings.<small><sup style="color: ;"><a title="W. Gao, Y. Li, S. Jiang, D. Zhu,  Planta Med. 2000 66 664" href="quinoline2002.htm#cit6">6</a></sup></small> The relative configurations in <span style="font-weight: bold; "><b>85</b></span> and <span style="font-weight: bold; "><b>87</b></span> were deduced from NOESY correlations, and that in <span style="font-weight: bold; "><b>86</b></span>, although not specifically elucidated, is expected to be the same. However, the CD spectra of J and L showed negative Cotton effects, while that in K was positive. These three alkaloids, the first examples of naturally occurring <span style="font-style: italic; "><i>N</i></span>-oxides in the genus <span style="font-style: italic; "><i>Huperzia</i></span>, belong to the well-known phlegmarane (C<small><sub>16</sub></small>N<small><sub>2</sub></small>) group of <span style="font-style: italic; "><i>Lycopodium</i></span> alkaloids.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr6"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-u6.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The first member of a new class of C<small><sub>22</sub></small>N<small><sub>2</sub></small><span style="font-style: italic; "><i>Lycopodium</i></span> alkaloids, (�)-senepodine A <span style="font-weight: bold; "><b>88</b></span>, has recently been isolated from Japanese specimens of <span style="font-style: italic; "><i>L. chinense</i></span>.<small><sup style="color: ;"><a title="H. Morita, Y. Hirasawa, N. Yoshida, J. Kobayashi,  Tetrahedron Lett. 2001 42 4199" href="quinoline2002.htm#cit7">7</a></sup></small> The structure of this unique octahydroquinoline�quinolizidine dimer was amply supported by one- and two-dimensional NMR spectroscopy. Analysis of proton�proton coupling constants and NOESY data revealed the complex relative stereochemistry shown in <span style="font-weight: bold; "><b>88</b></span>; moreover, the latter also indicated that the quinolizidine system had a <span style="font-style: italic; "><i>cis</i></span>-fused ring junction between two piperidine chair conformations. The authors suggest that senepodine A is biogenetically derived from two identical precursors such as <span style="font-weight: bold; "><b>89</b></span>, themselves conceivably originating in pelletierine <span style="font-weight: bold; "><b>90</b></span> (<a title="" href="quinoline2002.htm#sch3">Scheme 3</a>). The new alkaloid was cytotoxic towards murine lymphoma L1210 cells (IC<small><sub>50</sub></small> 0.1 mg cm<small><sup>�3</sup></small>), but not towards human epidermoid carcinoma KB cells.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch3"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-s3.gif"></a></td></tr><tr><td width="25%"></td><td align="center" width="50%"><b>Scheme 3</b></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The revised structure of antidesmone <span style="font-weight: bold; "><b>91</b></span>,<small><sup style="color: ;"><a title="G. Bringmann, J. Schlauer, H. Rischer, M. Wohlfarth, J. Muhlbacher, A. Buske, A. Porzel, J. Schmidt, G. Adam,  Tetrahedron 2000 56 3691" href="quinoline2002.htm#cit43">43</a></sup></small> a metabolite of <span style="font-style: italic; "><i>Antidesma membranaceum</i></span> (Euphorbiaceae) and probably identical to hyeronine A from <span style="font-style: italic; "><i>Hyeronima oblonga</i></span>, was described in last year's review in this series (<span style="font-style: italic; "><i>cf.</i></span> Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 2001 18 543see p. 546" href="quinoline2002.htm#cit28d">28d</a>). The revision resulted in part from biosynthetic feeding experiments in cell cultures of <span style="font-style: italic; "><i>A. membranaceum</i></span> with <small><sup>13</sup></small>C- and <small><sup>15</sup></small>N-labelled precursors (sodium acetate, glucose, ammonium nitrate, glycine, alanine, aspartic acid), which Bringmann and co-workers have now published in full.<small><sup style="color: ;"><a title="G. Bringmann, H. Rischer, M. Wohlfarth, J. Schlauer,  J. Am. Chem. Soc. 2000 122 9905" href="quinoline2002.htm#cit44">44</a></sup></small> The results showed that antidesmone is built up in a biosynthetically novel manner from a linear C<small><sub>16</sub></small> polyketide and a C<small><sub>2</sub></small> unit derived directly from glycine. Acetate and, unexpectedly, alanine and glycine were efficient sources of the polyketide chain (<span style="font-weight: bold; "><b>92</b></span>, above the dashed line), which indicated conversion of both amino acids into acetyl-CoA. The transformation of glycine into acetyl-CoA apparently represents a new biosynthetic pathway. Glycine also served as the precursor of the methoxy group. Very significantly, [U-<small><sup>13</sup></small>C<small><sub>2</sub></small>,<small><sup>15</sup></small>N]glycine appeared as an <span style="font-style: italic; "><i>intact</i></span> C<small><sub>2</sub></small>N fragment in the pyridone ring (<span style="font-weight: bold; "><b>92</b></span>, below the dashed line), its CO<small><sub>2</sub></small>H group obviously undergoing an unusual change in oxidation state to form the 2-CH<small><sub>3</sub></small> substituent. Alanine, on the face of it a more plausible source of the C<small><sub>2</sub></small>N unit, was not incorporated at these positions at all. A final noteworthy feature of the feeding experiments was the specific incorporation of [U-<small><sup>13</sup></small>C<small><sub>4</sub></small>]aspartic acid into the 2-CH<small><sub>3</sub></small> substituent and, less prominently, into the acetate-derived positions, which suggests novel conversion of this amino acid into both acetyl-CoA and glycine.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr7"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-u7.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The cinchona alkaloids have normally been surveyed with indole alkaloids and related tryptophan-derived metabolites in this <span style="font-style: italic; "><i>Journal</i></span><small><sup style="color: ;"><a title="J. Leonard,  Nat. Prod. Rep. 1999 16 319and earlier reviews in this series" href="quinoline2002.htm#cit45">45</a></sup></small> rather than with the quinoline alkaloids. However, an exception must be made this year for a publication of uncommon significance: the first stereoselective total synthesis of (�)-quinine <span style="font-weight: bold; "><b>93</b></span>, by Stork and co-workers.<small><sup style="color: ;"><a title="G. Stork, D. Niu, R. A. Fujimoto, E. R. Koft, J. M. Balkovec, J. R. Tata, G. R. Dake,  J. Am. Chem. Soc. 2001 123 3239correction in J. Am. Chem. Soc., 2001,123, p. 8644" href="quinoline2002.htm#cit46">46</a></sup></small> Previous attempts to synthesise this historically and medicinally important alkaloid, succinctly summarised in the prolegomenon to the article, go back almost 150 years, but up to now there has never been a satisfactory solution to the problem of controlling the relative stereochemistry at C-8 and C-9. Stork's approach (<a title=" Reagents and conditions: i, Et2NH, Me3Al; ii, TBDMS-Cl, imidazole, DMF; iii, LDA,-78[degree]C, then ICH2CH2OTBDPS; iv, PPTS(0.3 equiv.), EtOH; v, xylenes, reflux; vi, DIBAL-H,-78[degree]C; vii, Ph3P[double bond, length as m-dash]CHOMe; viii, Ph3P, DEAD,(PhO)2P(O)N3; ix, HCl(5 M), THF-CH2Cl2, rt; x,97+LDA, THF,-78[degree]C, then add96, THF,-78[degree]C; xi, Swern oxidation; xii, Ph3P, THF, reflux; xiii, NaBH4, MeOH-THF(1[ratio]1); xiv, HF, MeCN; xv, MeSO2Cl, pyridine, CH2Cl2; xvi, MeCN, reflux; xvii, NaH, DMSO, then O2." href="quinoline2002.htm#sch4">Scheme 4</a>) commenced with the (<span style="font-style: italic; "><i>S</i></span>)-4-vinylbutyrolactone <span style="font-weight: bold; "><b>94</b></span> and introduced a second stereogenic centre to give <span style="font-style: italic; "><i>trans</i></span>-disubstituted <span style="font-weight: bold; "><b>95</b></span> (&gt;20 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 1) by a circuitous but efficient route (58% overall yield). After one-carbon homologation and functional group interconversions, the key azido aldehyde <span style="font-weight: bold; "><b>96</b></span> was treated with the lithium salt of 6-methoxy-4-methylquinoline <span style="font-weight: bold; "><b>97</b></span>. The diastereomeric mixture of alcohols thus produced was oxidised to the azido ketone <span style="font-weight: bold; "><b>98</b></span>, Staudinger reaction of which yielded tetrahydropiperidine <span style="font-weight: bold; "><b>99</b></span>. A crucial reduction of this compound with sodium borohydride proceeded with axial delivery of hydride to give the trisubstituted piperidine <span style="font-weight: bold; "><b>100</b></span> as a single diastereomer in 91% yield, thereby ensuring the correct absolute stereochemistry at the future C-8 position. The formation of the quinuclidine ring system from <span style="font-weight: bold; "><b>100</b></span> was easily achieved by removing the silyl protecting group and mesylating the liberated primary alcohol. The ensuing cyclisation afforded deoxyquinine <span style="font-weight: bold; "><b>101</b></span> in 65% yield based on <span style="font-weight: bold; "><b>100</b></span>. The final phase of the synthesis exploited a stereoselective benzylic hydroxylation first reported by Gutzwiller and Uskokovi<img src="https://bitnest.netfirms.com/images/entities/char_0107.gif"> in 1978.<small><sup style="color: ;"><a title="J. Gutzwiller, M. R. Uskokovic,  J. Am. Chem. Soc. 1978 100 576" href="quinoline2002.htm#cit47">47</a></sup></small> This entailed treating deoxyquinine with sodium hydride and oxygen in dry DMSO to give (�)-quinine <span style="font-weight: bold; "><b>93</b></span> in 78% yield. The C-9 epimeric compound, epiquinine, was only a minor component of the final product (<span style="font-style: italic; "><i>ca.</i></span> 14 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 1).</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch4"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-s4.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 4 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents and conditions</i></span>: i, Et<small><sub>2</sub></small>NH, Me<small><sub>3</sub></small>Al; ii, TBDMS�Cl, imidazole, DMF; iii, LDA, �78 �C, then ICH<small><sub>2</sub></small>CH<small><sub>2</sub></small>OTBDPS; iv, PPTS (0.3 equiv.), EtOH; v, xylenes, reflux; vi, DIBAL-H, �78 �C; vii, Ph<small><sub>3</sub></small>P<img src="https://bitnest.netfirms.com/images/entities/char_e001.gif">CHOMe; viii, Ph<small><sub>3</sub></small>P, DEAD, (PhO)<small><sub>2</sub></small>P(O)N<small><sub>3</sub></small>; ix, HCl (5 M), THF�CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, rt; x, <span style="font-weight: bold; "><b>97</b></span>+ LDA, THF, �78 �C, then add <span style="font-weight: bold; "><b>96</b></span>, THF, �78 �C; xi, Swern oxidation; xii, Ph<small><sub>3</sub></small>P, THF, reflux; xiii, NaBH<small><sub>4</sub></small>, MeOH�THF (1 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 1); xiv, HF, MeCN; xv, MeSO<small><sub>2</sub></small>Cl, pyridine, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>; xvi, MeCN, reflux; xvii, NaH, DMSO, then O<small><sub>2</sub></small>.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><a name="sect832"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>1.6 Quinoline alkaloids from fungal and microbial sources</b></p></a><p class="firstpara">The nematicidal activity of the culture metabolites of <span style="font-style: italic; "><i>Penicillium</i></span> cf. <span style="font-style: italic; "><i>simplicissimum</i></span> was traced by bioassay to several structurally related compounds, among them the known natural products <span style="font-weight: bold; "><b>102</b></span> and <span style="font-weight: bold; "><b>103</b></span>, penigequinolones A and B, <span style="font-weight: bold; "><b>104</b></span> and <span style="font-weight: bold; "><b>105</b></span>, and the novel compound (�)-peniprequinolone <span style="font-weight: bold; "><b>106</b></span>.<small><sup style="color: ;"><a title="M. Kusano, H. Koshino, J. Uzawa, S. Fujioka, T. Kawano, Y. Kimura,  Biosci. Biotechnol. Biochem. 2000 64 2559" href="quinoline2002.htm#cit12">12</a></sup></small> Comprehensive <small><sup>1</sup></small>H and <small><sup>13</sup></small>C NMR spectra were recorded for all these products, and similar Cotton effects in their CD spectra indicated that they all possess the same relative stereochemistry at C-3 and C-4. All but <span style="font-weight: bold; "><b>103</b></span> showed nematicidal activity (at concentrations of greater than 100 mg dm<small><sup>�3</sup></small>) towards <span style="font-style: italic; "><i>Pratylenchus penetrans</i></span>, a parasitic nematode that causes root lesions in various economically important crops. The penigequinolones in particular may prove to be useful for controlling parasitic nematodes, since they were found to be non-toxic to a free-living nematode, and to lettuce and rice seedlings; in fact, both peniprequinolone and the penigequinolones actually accelerated root growth in rice seedlings.</p><p class="otherpara">A strain of the fungus <span style="font-style: italic; "><i>Penicillium</i></span> sp. (strain 386) collected from sand in a marine habitat in the South China Sea has yielded (�)-penicillazine <span style="font-weight: bold; "><b>107</b></span>, a novel quinolin-2-one that incorporates an unprecedented 5,6-dihydro-4<span style="font-style: italic; "><i>H</i></span>-1,2-oxazine substituent.<small><sup style="color: ;"><a title="Y. Lin, Z. Shao, G. Jiang, S. Zhou, J. Cai, L. L. P. Vrijmoed, E. B. G. Jones,  Tetrahedron 2000 56 9607" href="quinoline2002.htm#cit13">13</a></sup></small> Various spectroscopic techniques were used to establish the gross structure of this unique natural product, and the stereochemical relationships of the hydrogen atoms in ring D were deduced from analysis of coupling constants and ROESY correlations. Unusual changes in chemical shifts revealed by variable temperature <small><sup>1</sup></small>H NMR spectroscopy were ascribed to intermolecular hydrogen bonding effects. However, it required single crystal X-ray diffraction on penicillazine monohydrate to reveal the complete structure shown in <span style="font-weight: bold; "><b>107</b></span>, with <span style="font-style: italic; "><i>cis</i></span>-fusion of the dihydrooxazine and cyclohexene rings. The absolute stereochemistry was not determined.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr8"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-u8.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">Cultured broth of the entomopathogenic fungus <span style="font-style: italic; "><i>Penicillium</i></span> sp. EPF-6, isolated from larvae of the mulberry pyralid moth, yielded three new quinolone antibiotics, (+)-quinolactacin A <span style="font-weight: bold; "><b>108</b></span>, (�)-quinolactacin B <span style="font-weight: bold; "><b>109</b></span> and (+)-quinolactacin C <span style="font-weight: bold; "><b>110</b></span>.<small><sup style="color: ;"><a title="N. Kakinuma, H. Iwai, S. Takahashi, K. Hamano, T. Yanagisawa, K. Nagai, K. Tanaka, K. Suzuki, F. Kirikae, T. Kirikae, A. Nakagawa,  J. Antibiot. 2000 53 1247; S. Takahashi, N. Kakinuma, H. Iwai, T. Yanagisawa, K. Nagai, K. Suzuki, T. Tokunaga, A. Nakagawa,  J. Antibiot. 2000 53 1252" href="quinoline2002.htm#cit14">14,15</a></sup></small> The novel 2,3-dihydro-1<span style="font-style: italic; "><i>H</i></span>-pyrrolo[3,4-<span style="font-style: italic; "><i>b</i></span>]quinoline-1,9(4<span style="font-style: italic; "><i>H</i></span>)-dione structures were established uneventfully with the aid of spectroscopic techniques. Disappointingly, the quinolactacins were inactive towards a wide range of bacteria, fungi and yeasts; very weak activity was apparent only against <span style="font-style: italic; "><i>Aspergillus niger</i></span>. However, quinolactacin A inhibited the production of tumour necrosis factor (TNF) induced by lipopolysaccharide in murine peritoneal macrophages (IC<small><sub>50</sub></small> 12.2 �g cm<small><sup>�3</sup></small>) and in macrophage-like J774.1 cells. This interesting biological effect prompted Tatsuta and co-workers to devise a short biomimetic approach to the synthesis of members of this group of compounds (<a title=" Reagents and conditions: i, ClCO2Bn, Na2CO3, THF-H2O, rt; ii, MeI, NaH, DMF, rt; iii, KOH, MeOH-H2O, 65[degree]C; iv, 2,2[prime or minute]-dipyridyl disulfide, Ph3P, THF, rt; v, MeCOSBut, LiHMDS, THF,-78[degree]C to rt; vi, Et3N, CuI, THF, rt; vii, H2Pd-C, EtOH, rt; viii, NaOMe, MeOH, reflux; ix, SiO2." href="quinoline2002.htm#sch5">Scheme 5</a>).<small><sup style="color: ;"><a title="K. Tatsuta, H. Misawa, K. Chikauchi,  J. Antibiot. 2001 54 109" href="quinoline2002.htm#cit48">48</a></sup></small> Anthranilic acid <span style="font-weight: bold; "><b>111</b></span> was converted in five steps into the <img src="https://bitnest.netfirms.com/images/entities/char_03b2.gif">-keto thiolester <span style="font-weight: bold; "><b>112</b></span>, reaction of which with <span style="font-variant: 80; "><small>L</small></span>-valine methyl ester yielded the <img src="https://bitnest.netfirms.com/images/entities/char_03b2.gif">-keto amide <span style="font-weight: bold; "><b>113</b></span>. Hydrogenolysis of the benzyloxycarbonyl protecting group was followed by Dieckmann-like condensation to give the intermediate tetramic acid <span style="font-weight: bold; "><b>114</b></span>, which on exposure to silica gel afforded racemic quinolactacin B, (�)-<span style="font-weight: bold; "><b>109</b></span>. Analogues <span style="font-weight: bold; "><b>115�117</b></span> were similarly prepared by replacing valine with suitable derivatives of proline, glutamic acid and arginine, respectively. Quinolactacin A could presumably be made in the same way with isoleucine as precursor.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch5"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-s5.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 5 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents and conditions</i></span>: i, ClCO<small><sub>2</sub></small>Bn, Na<small><sub>2</sub></small>CO<small><sub>3</sub></small>, THF�H<small><sub>2</sub></small>O, rt; ii, MeI, NaH, DMF, rt; iii, KOH, MeOH�H<small><sub>2</sub></small>O, 65 �C; iv, 2,2<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">-dipyridyl disulfide, Ph<small><sub>3</sub></small>P, THF, rt; v, MeCOSBu<small><sup><span style="font-style: italic; "><i>t</i></span></sup></small>, LiHMDS, THF, �78 �C to rt; vi, Et<small><sub>3</sub></small>N, CuI, THF, rt; vii, H<small><sub>2</sub></small> Pd�C, EtOH, rt; viii, NaOMe, MeOH, reflux; ix, SiO<small><sub>2</sub></small>.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">Boger and Ichikawa communicated syntheses of the antitumour antibiotic thiocoraline <span style="font-weight: bold; "><b>118</b></span> and the related octadepsipeptide BE-22179 <span style="font-weight: bold; "><b>119</b></span> in 2000<small><sup style="color: ;"><a title="D. L. Boger, S. Ichikawa,  J. Am. Chem. Soc. 2000 122 2956" href="quinoline2002.htm#cit49">49</a></sup></small> (<span style="font-style: italic; "><i>cf</i></span>. Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 2000 17 603see p. 616" href="quinoline2002.htm#cit28h">28h</a>). Full details of the syntheses have since appeared in a publication that also included an evaluation of their ability to bind to duplex DNA by bisintercalation, and their exceptionally potent cytoxicity towards the L1210 cell line at subnanomolar concentrations.<small><sup style="color: ;"><a title="D. L. Boger, S. Ichikawa, W. C. Tse, M. P. Hedrick, Q. Jin,  J. Am. Chem. Soc. 2001 123 561" href="quinoline2002.htm#cit50">50</a></sup></small> Syntheses of two larger cyclic decadepsipeptides, luzopeptin C <span style="font-weight: bold; "><b>120</b></span><small><sup style="color: ;"><a title="D. Valognes, P. Belmont, N. Xi, M. A. Ciufolini,  Tetrahedron Lett. 2001 42 1907" href="quinoline2002.htm#cit51">51</a></sup></small> and luzopeptin E2 <span style="font-weight: bold; "><b>121</b></span><small><sup style="color: ;"><a title="M. A. Ciufolini, D. Valognes, N. Xi,  Angew. Chem., Int. Ed. 2000 39 2493" href="quinoline2002.htm#cit52">52</a></sup></small> by Ciufolini and coworkers involved macrocyclodimerisation of the key pentapeptides <span style="font-weight: bold; "><b>122</b></span> and <span style="font-weight: bold; "><b>123</b></span>, respectively. Deprotection of the <span style="font-style: italic; "><i>N</i></span>-Boc group and acylation with 3-hydroxy-6-methoxyquinaldic acid <span style="font-weight: bold; "><b>124</b></span> was a late and comparatively trivial step in the synthesis of the target antibiotics.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr9"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-u9.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><a name="sect910"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>1.7 Quinoline alkaloids from animals</b></p></a><p class="firstpara">When the Australian sponge <span style="font-style: italic; "><i>Oceanapia</i></span> sp. was screened for activity against mycothiol <span style="font-style: italic; "><i>S</i></span>-conjugate amidase (MCA), a recently discovered mycobacterial enzyme, bioactivity-guided fractionation led to the isolation of the known sponge metabolite uranidine <span style="font-weight: bold; "><b>125</b></span>, several bromotyrosine alkaloids, <span style="font-style: italic; "><i>e.g.</i></span> (�)-pseudoceratine <span style="font-weight: bold; "><b>126</b></span>, and the interesting uranidine�bromotyrosine hybrid (�)-<span style="font-weight: bold; "><b>127</b></span>.<small><sup style="color: ;"><a title="G. M. Nicholas, G. L. Newton, R. C. Fahey, C. A. Bewley,  Org. Lett. 2001 3 1543" href="quinoline2002.htm#cit8">8</a></sup></small> The elucidation of the structure was facilitated by obvious spectroscopic similarities between the three alkaloids, as well as various long-range NMR spectroscopic correlations. The (1<span style="font-style: italic; "><i>S</i></span>,6<span style="font-style: italic; "><i>R</i></span>) absolute stereochemistry of (�)-<span style="font-weight: bold; "><b>127</b></span> was ascertained by comparing its CD spectra with those of (1<span style="font-style: italic; "><i>S</i></span>,6<span style="font-style: italic; "><i>R</i></span>)-(�)-<span style="font-weight: bold; "><b>126</b></span> and its enantiomer.<br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr10"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-u10.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"></p><p class="otherpara">Recent refutations of structure <span style="font-weight: bold; "><b>128</b></span> for the sponge metabolite haliclorensin have cast a cloud over the proposed structure <span style="font-weight: bold; "><b>129</b></span> for the more complex alkaloid halitulin, which was found in the same organism (<span style="font-style: italic; "><i>Haliclona tulearensis</i></span>).<small><sup style="color: ;"><a title="Y. Kashman, G. Koren-Goldshlager, M. D. G. Gravalos, M. Schleyer,  Tetrahedron Lett. 1999 40 997" href="quinoline2002.htm#cit53">53</a></sup></small> Heinrich and Steglich synthesised both enantiomers of the putative alkaloid <span style="font-weight: bold; "><b>128</b></span>, but found that the optical rotation and <small><sup>13</sup></small>C chemical shifts differed considerably from those reported for the natural product.<small><sup style="color: ;"><a title="M. R. Heinrich, W. Steglich,  Tetrahedron Lett. 2001 42 3287" href="quinoline2002.htm#cit54">54</a></sup></small> Similarly, a synthesis of (�)-<span style="font-weight: bold; "><b>128</b></span> by Banwell and co-workers showed that its properties were different from those of the natural product.<small><sup style="color: ;"><a title="M. G. Banwell, A. M. Bray, A. J. Edwards, D. J. Wong,  New J. Chem. 2001 25 1347" href="quinoline2002.htm#cit55">55</a></sup></small> The revised structure <span style="font-weight: bold; "><b>130</b></span> for haliclorensin has been proposed very recently and confirmed by synthesis, and indications from chiroptical properties are that the natural product is a 3 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 1 mixture of the (<span style="font-style: italic; "><i>S</i></span>)- and (<span style="font-style: italic; "><i>R</i></span>)-enantiomers.<small><sup style="color: ;"><a title="M. R. Heinrich, Y. Kashman, P. Spiteller, W. Steglich,  Tetrahedron 2001 57 9973" href="quinoline2002.htm#cit56">56</a></sup></small> This unusual diazacyclotetradecane system can obviously not be a component of the halitulin structure, and structure <span style="font-weight: bold; "><b>129</b></span> for halitulin may well still turn out to be correct.</p><p class="otherpara">Kibayashi and co-workers have synthesised (�)-lepadins A, B and C, <span style="font-weight: bold; "><b>131�133</b></span>, three complex decahydroquinoline alkaloids isolated from the tunicate (sea squirt) <span style="font-style: italic; "><i>Clavelina lepadiformis</i></span> and a predatory flatworm that feeds on it, by a route that includes their hallmark reaction, a stereocontrolled intramolecular acylnitroso Diels�Alder reaction.<small><sup style="color: ;"><a title="T. Ozawa, S. Aoyagi, C. Kibayashi,  Org. Lett. 2000 2 2955; T. Ozawa, S. Aoyagi, C. Kibayashi,  J. Org. Chem. 2001 66 3338" href="quinoline2002.htm#cit57">57,58</a></sup></small> Several key steps in the lengthy synthesis are shown in <a title=" Reagents and conditions: i, Pr4NIO4, H2O-DMF(50[ratio]1), 0[degree]C; ii, H2, Pd-C, THF; iii, LiHMDS, THF,-78[degree]C, then(+)-[(8,8-dichlorocamphoryl)sulfonyl]oxaziridine; iv, TBDPSCl, imidazole, DMF, rt; v, MeMgBr, THF, 0[degree]C, then NaBH3CN, AcOH, THF, 0[degree]C; vi, Zn, 90%AcOH, 60[degree]C; vii, PhCOCl, then 5%aq. KOH; viii, CS2, NaH, imidazole, then MeI, THF; ix, Bu3SnH, AIBN, C6H6, reflux; x, PPTS, ButOH, reflux; xi, H2, Pd(OH)2, MeOH; xii,(COCl)2, DMSO, Et3N,-78[degree]C to 0[degree]C; xiii, piperidine(0.2 equiv.), AcOH(0.2 equiv.), C6H6, reflux; xiv, PDC, DMF, then CH2N2, Et2O; xv, SOCl2, Et3N; xvi, Bu4NF, THF, rt, 5 d; xvii, TBDMSCl, imidazole, DMF; xviii, LiAlH4, THF, reflux; xix, H2(5 atm), 10%Pd-C, THF, then(Boc)2O, CH2Cl2, 0[degree]C to rt; xx, CHI3, CrCl2, THF, rt; xxi,(E)-C4H9CH[double bond, length as m-dash]CHB(OH)2, Pd(Ph3P)4(5 mol%), aq. KOH(2 M), THF, 50[degree]C; xxii, Bu4NF, THF; xxiii, TFA, CH2Cl2, then K2CO3." href="quinoline2002.htm#sch6">Scheme 6</a>. Enantiocontrol originated from benzylidene-protected (2<span style="font-style: italic; "><i>S</i></span>)-2,4-dihydroxybutanal <span style="font-weight: bold; "><b>134</b></span>, a readily prepared derivative of (<span style="font-style: italic; "><i>S</i></span>)-malic acid. The key cycloaddition was initiated by oxidation of the hydroxamic acid <span style="font-weight: bold; "><b>135</b></span> with tetrapropylammonium periodate in water�DMF (50 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 1), which gave the two oxazino lactams <span style="font-weight: bold; "><b>136</b></span> and <span style="font-weight: bold; "><b>137</b></span> (90%) in a ratio of 1 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 6.6. The aqueous conditions proved crucial for maximising the formation of the desired diastereomer. After hydrogenation of <span style="font-weight: bold; "><b>137</b></span>, the next important step was the stereoselective <img src="https://bitnest.netfirms.com/images/entities/char_03b1.gif">-hydroxylation of the lactam, which was optimally achieved by treating the lithium enolate with (+)-[(8,8-dichlorocamphoryl)sulfonyl]oxaziridine. After silylation, compound <span style="font-weight: bold; "><b>138</b></span> was obtained in a ratio of 17 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 1 with its <img src="https://bitnest.netfirms.com/images/entities/char_03b2.gif">-silyloxy epimer. Treatment of lactam <span style="font-weight: bold; "><b>138</b></span> with methylmagnesium bromide followed by sodium cyanoborohydride afforded the methylated product <span style="font-weight: bold; "><b>139</b></span> as the sole diastereomer because of the approach of hydride from the less hindered face of the iminium ion intermediate. Construction of the quinoline framework was most satisfactorily achieved by intramolecular aldol reaction of <span style="font-weight: bold; "><b>140</b></span> with catalytic amounts of piperidine and acetic acid to give <span style="font-weight: bold; "><b>141</b></span> (87%). However, dehydration of the 3-hydroxycarbonyl product was accomplished only after the aldehyde had been converted into the corresponding methyl ester. The product <span style="font-weight: bold; "><b>142</b></span> yielded a 1 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 2 mixture of the labile alcohol <span style="font-weight: bold; "><b>143</b></span> and the C-5 epimer <span style="font-weight: bold; "><b>144</b></span> in 87% yield upon desilylation with tetrabutylammonium fluoride in THF over 5 days. The yield of the desired 5<img src="https://bitnest.netfirms.com/images/entities/char_03b2.gif">-isomer <span style="font-weight: bold; "><b>144</b></span> could be increased to 75% by equilibrating <span style="font-weight: bold; "><b>143</b></span> under the same conditions. The final stereogenic centre was introduced by catalytic hydrogenation of the amino alcohol <span style="font-weight: bold; "><b>145</b></span> over palladium on carbon, which gave exclusively the <span style="font-style: italic; "><i>cis</i></span>-fused decahydroquinoline <span style="font-weight: bold; "><b>146</b></span> (85%) after <span style="font-style: italic; "><i>N</i></span>-Boc protection. Oxidation to the aldehyde and Takai methylenation with iodoform and chromium(<span style="font-variant: 80; "><small>II</small></span>) chloride yielded the (<span style="font-style: italic; "><i>E</i></span>)-vinyl iodide <span style="font-weight: bold; "><b>147</b></span>, which proved to be the pivotal intermediate in the synthesis of all three lepadins. Completion of the synthesis of (�)-lepadins A <span style="font-weight: bold; "><b>131</b></span> and B <span style="font-weight: bold; "><b>132</b></span>, for example, entailed Suzuki coupling of <span style="font-weight: bold; "><b>147</b></span> with (<span style="font-style: italic; "><i>E</i></span>)-hex-1-enylboronic acid followed by appropriate manipulations at the alcohol and amine groups. For (�)-lepadin C <span style="font-weight: bold; "><b>133</b></span>, the Suzuki cross-coupling was performed with (<span style="font-style: italic; "><i>E</i></span>)-5-hydroxyhex-1-enylboronic acid, and oxidation of the side chain preceded the functional group manipulations in the bicyclic nucleus. While (�)-lepadin B has previously been synthesised, this is the first reported synthesis of (�)-lepadins A and C. The spectra of the trifluoroacetate salts of the synthetic compounds proved identical to those obtained on the natural products, but the optical rotations were larger.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch6"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-s6.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 6 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents and conditions</i></span>: i, Pr<small><sub>4</sub></small>NIO<small><sub>4</sub></small>, H<small><sub>2</sub></small>O�DMF (50 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 1), 0 �C; ii, H<small><sub>2</sub></small>, Pd�C, THF; iii, LiHMDS, THF, �78 �C, then (+)-[(8,8-dichlorocamphoryl)sulfonyl]oxaziridine; iv, TBDPSCl, imidazole, DMF, rt; v, MeMgBr, THF, 0 �C, then NaBH<small><sub>3</sub></small>CN, AcOH, THF, 0 �C; vi, Zn, 90% AcOH, 60 �C; vii, PhCOCl, then 5% aq. KOH; viii, CS<small><sub>2</sub></small>, NaH, imidazole, then MeI, THF; ix, Bu<small><sub>3</sub></small>SnH, AIBN, C<small><sub>6</sub></small>H<small><sub>6</sub></small>, reflux; x, PPTS, Bu<small><sup><span style="font-style: italic; "><i>t</i></span></sup></small>OH, reflux; xi, H<small><sub>2</sub></small>, Pd(OH)<small><sub>2</sub></small>, MeOH; xii, (COCl)<small><sub>2</sub></small>, DMSO, Et<small><sub>3</sub></small>N, �78 �C to 0 �C; xiii, piperidine (0.2 equiv.), AcOH (0.2 equiv.), C<small><sub>6</sub></small>H<small><sub>6</sub></small>, reflux; xiv, PDC, DMF, then CH<small><sub>2</sub></small>N<small><sub>2</sub></small>, Et<small><sub>2</sub></small>O; xv, SOCl<small><sub>2</sub></small>, Et<small><sub>3</sub></small>N; xvi, Bu<small><sub>4</sub></small>NF, THF, rt, 5 d; xvii, TBDMSCl, imidazole, DMF; xviii, LiAlH<small><sub>4</sub></small>, THF, reflux; xix, H<small><sub>2</sub></small>(5 atm), 10% Pd�C, THF, then (Boc)<small><sub>2</sub></small>O, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, 0 �C to rt; xx, CHI<small><sub>3</sub></small>, CrCl<small><sub>2</sub></small>, THF, rt; xxi, (<span style="font-style: italic; "><i>E</i></span>)-C<small><sub>4</sub></small>H<small><sub>9</sub></small>CH<img src="https://bitnest.netfirms.com/images/entities/char_e001.gif">CHB(OH)<small><sub>2</sub></small>, Pd(Ph<small><sub>3</sub></small>P)<small><sub>4</sub></small>(5 mol%), aq. KOH (2 M), THF, 50 �C; xxii, Bu<small><sub>4</sub></small>NF, THF; xxiii, TFA, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, then K<small><sub>2</sub></small>CO<small><sub>3</sub></small>.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">Oppolzer and Flaskamp reported a short synthesis of the frog skin alkaloid (�)-<span style="font-style: italic; "><i>cis</i></span>-decahydroquinoline 195A <span style="font-weight: bold; "><b>148</b></span>, commonly referred to as pumiliotoxin C, in 1977.<small><sup style="color: ;"><a title="W. Oppolzer, E. Flaskamp,  Helv. Chim. Acta 1977 60 204" href="quinoline2002.htm#cit59">59</a></sup></small> Methodological refinements<small><sup style="color: ;"><a title="W. Oppolzer, E. Flaskamp, L. W. Bieber,  Helv. Chim. Acta 2001 84 141" href="quinoline2002.htm#cit60">60</a></sup></small> (<a title=" Reagents and conditions: i, NaH,p-TsCl, THF, 0[degree]C to rt; ii, HC[triple bond, length as m-dash]CCH2MgBr, Et2O, 0[degree]C to rt; iii, BuLi, NH3,-78[degree]C to-30[degree]C, then MeI,-30[degree]C, then Na; iv, MeCH[double bond, length as m-dash]CHCHO, 4[Angstrom]molecular sieves, Et2O, 0[degree]C to rt; v, Me2CHCOCl, Et3N, CH2Cl2,-78[degree]C to 5[degree]C; vi, toluene, sealed tube, 230-240[degree]C; vii, H2, 10%Pd-C, MeOH, rt; viii, BuLi, THF,-78[degree]C to rt, then recrystallisation as HCl salt." href="quinoline2002.htm#sch7">Scheme 7</a>) have now resulted in an improved overall yield of <span style="font-weight: bold; "><b>148</b></span> to 25% � approximately 20 times that of the original procedure � based on the chiral amino alcohol <span style="font-weight: bold; "><b>149</b></span>. The improvements entailed ring opening of the aziridine <span style="font-weight: bold; "><b>150</b></span> with propargylmagnesium bromide<a title="The IUPAC name for propargyl is prop-2-ynyl." href="quinoline2002.htm#fn1"><img src="https://bitnest.netfirms.com/images/entities/char_2020b.gif" border="0"></a> followed by a one-pot conversion of product <span style="font-weight: bold; "><b>151</b></span> into the (<span style="font-style: italic; "><i>E</i></span>)-amine <span style="font-weight: bold; "><b>152</b></span>, and an optimised imine formation and <span style="font-style: italic; "><i>N</i></span>-acylation to give dienamide <span style="font-weight: bold; "><b>153</b></span>. The subsequent intramolecular Diels�Alder cycloaddition afforded the octahydroquinoline <span style="font-weight: bold; "><b>154</b></span> as a mixture of diastereomers. After catalytic hydrogenation and removal of the <span style="font-style: italic; "><i>N</i></span>-acyl group, the decahydroquinoline <span style="font-weight: bold; "><b>148</b></span>, diastereomer <span style="font-weight: bold; "><b>155</b></span> and an unidentified isomer were obtained in a ratio of 62 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 37 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 1. The target alkaloid <span style="font-weight: bold; "><b>148</b></span> could be crystallised from the mixture as the hydrochloride salt (57%). Chromatography of the mother liquors yielded a further quantity of <span style="font-weight: bold; "><b>148</b></span> (3.5%) and the more polar diastereomer <span style="font-weight: bold; "><b>155</b></span>, also isolated as the hydrochloride salt (14%).</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch7"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-s7.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 7 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents and conditions</i></span>: i, NaH, <span style="font-style: italic; "><i>p</i></span>-TsCl, THF, 0 �C to rt; ii, HC<img src="https://bitnest.netfirms.com/images/entities/char_e002.gif">CCH<small><sub>2</sub></small>MgBr, Et<small><sub>2</sub></small>O, 0 �C to rt; iii, BuLi, NH<small><sub>3</sub></small>, �78 �C to �30 �C, then MeI, �30 �C, then Na; iv, MeCH<img src="https://bitnest.netfirms.com/images/entities/char_e001.gif">CHCHO, 4 <img src="https://bitnest.netfirms.com/images/entities/char_212b.gif"> molecular sieves, Et<small><sub>2</sub></small>O, 0 �C to rt; v, Me<small><sub>2</sub></small>CHCOCl, Et<small><sub>3</sub></small>N, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, �78 �C to 5 �C; vi, toluene, sealed tube, 230�240 �C; vii, H<small><sub>2</sub></small>, 10% Pd�C, MeOH, rt; viii, BuLi, THF, �78 �C to rt, then recrystallisation as HCl salt.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The tricyclic frog skin alkaloid gephyrotoxin <span style="font-weight: bold; "><b>156</b></span> and its perhydro analogue <span style="font-weight: bold; "><b>157</b></span> have been popular synthetic targets for over 20 years. Three formal syntheses of these compounds have appeared recently. The approach to <span style="font-weight: bold; "><b>157</b></span> by Mehta and Reddy,<small><sup style="color: ;"><a title="G. Mehta, D. S. Reddy,  Indian J. Chem., Sect. B Org. Chem. Incl. Med. Chem. 2000 39 813" href="quinoline2002.htm#cit61">61</a></sup></small> employing ideas they had developed in a prior route to pumiliotoxin C, involved the conversion of the protected cyclopentadienone dimer <span style="font-weight: bold; "><b>158</b></span> via the <span style="font-style: italic; "><i>cis</i></span>-hydrindanone <span style="font-weight: bold; "><b>159</b></span> into the decahydroquinolinone <span style="font-weight: bold; "><b>160</b></span>, which had previously featured in a synthesis of perhydrogephyrotoxin <span style="font-weight: bold; "><b>157</b></span> by Ibuka and Chu.<small><sup style="color: ;"><a title="T. Ibuka, G.-N. Chu,  Chem. Pharm. Bull. 1986 34 2380" href="quinoline2002.htm#cit62">62</a></sup></small> Pearson's continuing explorations of the intramolecular Schmidt reaction of azides with carbocations has recently been extended to include the preparation of an impressive range of benzo-fused 1-azabicycloalkanes.<small><sup style="color: ;"><a title="W. H. Pearson, W. Fang,  J. Org. Chem. 2000 65 7158correction in J. Org. Chem. , 2001, 66, p. 6838" href="quinoline2002.htm#cit63">63</a></sup></small> Extensive model studies aimed at the synthesis of gephyrotoxin itself culminated in the synthesis of <span style="font-weight: bold; "><b>161</b></span> (45%) and the regioisomer <span style="font-weight: bold; "><b>162</b></span> (10%) by treatment of azido alkene <span style="font-weight: bold; "><b>163</b></span> with trifluoromethanesulfonic acid followed by reduction of iminium ion intermediates with L-Selectride<img src="https://bitnest.netfirms.com/images/entities/char_2122.gif"> and replacement of bromide by hydroxy. Compound <span style="font-weight: bold; "><b>161</b></span> had previously featured as an intermediate in a prior route to gephyrotoxin <span style="font-weight: bold; "><b>156</b></span> by Ito <span style="font-style: italic; "><i>et al.</i></span>,<small><sup style="color: ;"><a title="Y. Ito, E. Nakajo, M. Nakatsuka, T. Saegusa,  Tetrahedron Lett. 1983 24 2881" href="quinoline2002.htm#cit64">64</a></sup></small> which itself converged with a pioneering synthesis of the racemic alkaloid by the Kishi group.<small><sup style="color: ;"><a title="R. Fujimoto, Y. Kishi, J. F. Blount,  J. Am. Chem. Soc. 1980 102 7154" href="quinoline2002.htm#cit65">65</a></sup></small> The route to (+)-<span style="font-weight: bold; "><b>156</b></span> by Hsung and co-workers<small><sup style="color: ;"><a title="L.-L. Wei, R. P. Hsung, H. M. Sklenicka, A. I. Gerasyuto,  Angew. Chem., Int. Ed. 2001 40 1516" href="quinoline2002.htm#cit66">66</a></sup></small> exploited a formal [3 + 3] cycloaddition similar to that already depicted in <a title=" Reagents and conditions: i, piperidine, toluene, 0[degree]C, 5 min, then Ac2O, 85[degree]C, 1 h, then34, 85[degree]C, 48 h; ii, Cp2ZrCl2, AlMe3,n-BuLi,(CH2O)n; iii, Dess-Martin periodinane, CH2Cl2, rt; iv, HF-pyridine, THF, rt; v,(EtO)2POCH2COMe, NaH, THF, rt; vi, MeLi, THF-Et2O(1[ratio]1),-78[degree]C to rt; vii, magnesium monoperoxyphthalate, PriOH-H2O(2[ratio]1), rt; viii, OsO4(cat.), K3Fe(CN)3, K2CO3, ButOH-H2O(1[ratio]1), rt." href="quinoline2002.htm#sch2">Scheme 2</a> (Section 1.3, <span style="font-style: italic; "><i>vide supra</i></span>). In this case, intramolecular cycloaddition resulting from treatment of precursor <span style="font-weight: bold; "><b>164</b></span> with piperidinium acetate yielded a mixture of isomers of the tricyclic vinylogous amide <span style="font-weight: bold; "><b>165</b></span>. If the alcohol was not protected, only the unwanted <img src="https://bitnest.netfirms.com/images/entities/char_03b2.gif">-H isomer was obtained. Removal of the silyl protecting group from <span style="font-weight: bold; "><b>165</b></span> and chromatographic separation afforded the <img src="https://bitnest.netfirms.com/images/entities/char_03b1.gif">-H tricyclic compound <span style="font-weight: bold; "><b>166</b></span>, a central intermediate in the 1981 synthesis of (+)-<span style="font-weight: bold; "><b>156</b></span> by Fujimoto and Kishi.<small><sup style="color: ;"><a title="R. Fujimoto, Y. Kishi,  Tetrahedron Lett. 1981 22 4197" href="quinoline2002.htm#cit67">67</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr11"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-u11.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><a name="sect1089"><p align="" style="font-weight: bold; margin-top: 0%; margin-bottom: 0%; "><h3><b>2 Quinazoline alkaloids</b></h3></p></a><a name="sect1092"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>2.1 Occurrence, characterisation and biological activity</b></p></a><p class="firstpara">A list of new quinazoline alkaloids, and known quinazolines isolated from new sources, is presented in <a title=" Isolation and detection of quinazoline alkaloids" href="quinoline2002.htm#tab2">Table 2</a>.<small><sup style="color: ;"><a title="H. Morita, Y. Sato, K.-L. Chan, C.-Y. Choo, H. Itokawa, K. Takeya, J. Kobayashi,  J. Nat. Prod. 2000 63 1707; J.-R. Dai, B. K. Carte, P. J. Sidebottom, A. L. S. Yew, S.-B. Ng, Y. Huang, M. S. Butler,  J. Nat. Prod. 2001 64 125; T. Murakami, A. Kishi, T. Sakurama, H. Matsuda, M. Yoshikawa,  Heterocycles 2001 54 957; Y. Deng, R. Xu, Y. Ye,  J. Chin. Pharm. Sci. 2000 9 116Chem. Abstr. 2001 134 83482; R. Patnam, F.-R. Chang, C.-Y. Chen, R.-Y. Kuo, Y.-H. Lee, Y.-C. Wu,  J. Nat. Prod. 2001 64 948; B. Li, W. Chen, S. Zheng, G. Yang, C. Qiao,  Yaoxue Xuebao 2000 35 508Chem. Abstr. 2001 134 128466; T. S. Tulyaganov, O. E. Makhmudov,  Chem. Nat. Compd. 2000 36 76Engl. Transl. Khim. Prir. Soedin. 2000 60; T. S. Tulyaganov, O. M. Nazarov,  Chem. Nat. Compd. 2000 36 393Engl. Transl. Khim. Prir. Soedin. 2000 323; M. F. Faskhutdinov, M. V. Telezhenetskaya, M. G. Levkovich, N. D. Abdullaev,  Chem. Nat. Compd. 2000 36 602Engl. Transl. Khim. Prir. Soedin. 2000 481" href="quinoline2002.htm#cit68">68�76</a></sup></small> The simple alkaloid samoquasine A <span style="font-weight: bold; "><b>167</b></span>, isolated from seeds of the custard apple <span style="font-style: italic; "><i>Annona squamosa</i></span> (Annonaceae), is especially interesting in being the first naturally occurring compound to possess the benzo[<span style="font-style: italic; "><i>h</i></span>]quinazoline ring system.<small><sup style="color: ;"><a title="H. Morita, Y. Sato, K.-L. Chan, C.-Y. Choo, H. Itokawa, K. Takeya, J. Kobayashi,  J. Nat. Prod. 2000 63 1707" href="quinoline2002.htm#cit68">68</a></sup></small> The structure was established by spectroscopic methods and corroborated by preparation of the <span style="font-style: italic; "><i>O</i></span>-methyl derivative by treatment with trimethylsilyldiazomethane. The authors were apparently unaware that this compound was first prepared almost 40 years ago by reaction between 1-naphthylamine and ethoxymethyleneurethane, although no spectroscopic details are given in this earlier work.<small><sup style="color: ;"><a title="R. Gompper, H. E. Noppel, H. Schaefer,  Angew. Chem., Int. Ed. Engl. 1963 2 686; J. Faust,  J. Prakt. Chem. 1977 319 65" href="quinoline2002.htm#cit77">77,78</a></sup></small> Samoquasine A showed significant cytotoxicity against murine lymphoma L1210 cells (IC<small><sub>50</sub></small> 0.38 �g cm<small><sup>�3</sup></small>).</p><br><a name="tab2"><a></a><b>Table 
	2</b>
	Isolation and detection of quinazoline alkaloids
	
	<hr></a><table align="center" width="100%" border="0"><colgroup><col align="left" char="" charoff="" width=""><col align="left" char="" charoff="" width=""><col align="left" char="" charoff="" width=""></colgroup><thead align="left"><tr valign="bottom"><td align="left">Species<hr></td><td align="left">Alkaloid<i><small><sup style="color: red;"><a title="Only new alkaloids and new records for a given species are listed in the Table." href="quinoline2002.htm#tab2fna">a</a></sup></small></i><hr></td><td align="left">Ref.<hr></td></tr></thead><tbody><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Annona squamosa</i></span></td><td valign="top">Samoquasine A<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab2fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>167</b></span></td><td valign="top"><a title="H. Morita, Y. Sato, K.-L. Chan, C.-Y. Choo, H. Itokawa, K. Takeya, J. Kobayashi,  J. Nat. Prod. 2000 63 1707" href="quinoline2002.htm#cit68">68</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Aspergillus ochraceus</i></span></td><td valign="top">(�)-Circumdatin G<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab2fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>179</b></span></td><td valign="top"><a title="J.-R. Dai, B. K. Carte, P. J. Sidebottom, A. L. S. Yew, S.-B. Ng, Y. Huang, M. S. Butler,  J. Nat. Prod. 2001 64 125" href="quinoline2002.htm#cit69">69</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Calanthe liukiuensis</i></span></td><td valign="top">Tryptanthrin <span style="font-weight: bold; "><b>183</b></span></td><td valign="top"><a title="T. Murakami, A. Kishi, T. Sakurama, H. Matsuda, M. Yoshikawa,  Heterocycles 2001 54 957" href="quinoline2002.htm#cit70">70</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Dichroa febrifuga</i></span></td><td valign="top">2-(4-Hydroxybutyl)quinazolin-4-one<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab2fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>171</b></span></td><td valign="top"><a title="Y. Deng, R. Xu, Y. Ye,  J. Chin. Pharm. Sci. 2000 9 116Chem. Abstr. 2001 134 83482" href="quinoline2002.htm#cit71">71</a></td></tr><tr valign="bottom"><td></td><td valign="top">(+)-Neodichroine<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab2fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>172</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Hydrangea chinensis</i></span></td><td valign="top">(+)-Hydrachine A<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab2fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>173</b></span></td><td valign="top"><a title="R. Patnam, F.-R. Chang, C.-Y. Chen, R.-Y. Kuo, Y.-H. Lee, Y.-C. Wu,  J. Nat. Prod. 2001 64 948" href="quinoline2002.htm#cit72">72</a></td></tr><tr valign="bottom"><td></td><td valign="top">Quinazolin-4-one <span style="font-weight: bold; "><b>170</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Isatis indigotica</i></span></td><td valign="top">Tryptanthrin</td><td valign="top"><a title="B. Li, W. Chen, S. Zheng, G. Yang, C. Qiao,  Yaoxue Xuebao 2000 35 508Chem. Abstr. 2001 134 128466" href="quinoline2002.htm#cit73">73</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Nitraria komarovii</i></span></td><td valign="top">Peganol <span style="font-style: italic; "><i>N</i></span>-oxide<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab2fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>174</b></span></td><td valign="top"><a title="T. S. Tulyaganov, O. E. Makhmudov,  Chem. Nat. Compd. 2000 36 76Engl. Transl. Khim. Prir. Soedin. 2000 60" href="quinoline2002.htm#cit74">74</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Nitraria schoberi</i></span></td><td valign="top">Deoxypeganine (deoxyvasicine) <span style="font-weight: bold; "><b>176</b></span></td><td valign="top"><a title="T. S. Tulyaganov, O. M. Nazarov,  Chem. Nat. Compd. 2000 36 393Engl. Transl. Khim. Prir. Soedin. 2000 323" href="quinoline2002.htm#cit75">75</a></td></tr><tr valign="bottom"><td></td><td valign="top">Deoxyvasicinone <span style="font-weight: bold; "><b>186</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(�)-Vasicinone <span style="font-weight: bold; "><b>187</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Peganum harmala</i></span></td><td valign="top">Dipegine <span style="font-weight: bold; "><b>177</b></span></td><td valign="top"><a title="M. F. Faskhutdinov, M. V. Telezhenetskaya, M. G. Levkovich, N. D. Abdullaev,  Chem. Nat. Compd. 2000 36 602Engl. Transl. Khim. Prir. Soedin. 2000 481" href="quinoline2002.htm#cit76">76</a></td></tr><tr valign="bottom"><td></td><td valign="top">Dipeginol<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2002.htm#tab2fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>178</b></span></td><td></td></tr></tbody><tfoot><tr valign="bottom"><td colspan="3"><a name="tab2fna"><span style="font-size: 75%; font-style: italic; vertical-align: super; "><i><sup>a</sup></i></span></a><span style="font-size: 75%; ">Only new alkaloids and new records for a given species are listed in the Table.</span>��<a name="tab2fnb"><span style="font-size: 75%; font-style: italic; vertical-align: super; "><i><sup>b</sup></i></span></a><span style="font-size: 75%; ">New alkaloids.</span>��</td></tr></tfoot></table><hr><br><p class="otherpara">A resurgence of interest in the potent antimalarial alkaloids (+)-isofebrifugine <span style="font-weight: bold; "><b>168</b></span> and (+)-febrifugine <span style="font-weight: bold; "><b>169</b></span> (see Section 2.2) has resulted in reinvestigations of their main plant sources, the genera <span style="font-style: italic; "><i>Dichroa</i></span> and <span style="font-style: italic; "><i>Hydrangea</i></span> (Saxifragaceae). Chinese workers re-isolated these two alkaloids (to which they appended the old-fashioned names <img src="https://bitnest.netfirms.com/images/entities/char_03b1.gif">-dichroine and <img src="https://bitnest.netfirms.com/images/entities/char_03b2.gif">-dichroine, respectively) as principal components from extracts of the leaves of <span style="font-style: italic; "><i>Dichroa febrifuga</i></span>, and in addition obtained much smaller amounts of quinazolin-4-one <span style="font-weight: bold; "><b>170</b></span> (3<span style="font-style: italic; "><i>H</i></span> tautomer shown), 2-(4-hydroxybutyl)quinazolin-4-one <span style="font-weight: bold; "><b>171</b></span> and the interesting new quinazolinone�quinolizidine dimer (+)-neodichroine <span style="font-weight: bold; "><b>172</b></span>, which was isolated as a crystalline solid.<small><sup style="color: ;"><a title="Y. Deng, R. Xu, Y. Ye,  J. Chin. Pharm. Sci. 2000 9 116Chem. Abstr. 2001 134 83482" href="quinoline2002.htm#cit71">71</a></sup></small> While the authors made no specific comments about compound <span style="font-weight: bold; "><b>171</b></span>, it also appears to be a new natural product, although it has previously been synthesised.<small><sup style="color: ;"><a title="H. Mohrle, C. M. Seidel,  Arch. Pharm. 1976 309 542" href="quinoline2002.htm#cit79">79</a></sup></small> Evidence for the structure of neodichroine <span style="font-weight: bold; "><b>172</b></span> came from <small><sup>1</sup></small>H and <small><sup>13</sup></small>C NMR spectra, recorded in deuterated pyridine, together with COSY and NOE data. The <span style="font-style: italic; "><i>trans</i></span>-diaxial disposition of 9<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">-H and 9a<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">-H in the quinolizidine ring was apparent from the large coupling constant (<span style="font-style: italic; "><i>J</i></span> 10.1 Hz), and another large coupling constant for 3<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">-H (<span style="font-style: italic; "><i>J</i></span> 11.3 Hz) indicated that the quinazolinyl substituent was equatorial. Neodichroine also formed an acetate that gave a well-resolved <small><sup>1</sup></small>H spectrum. However, definitive evidence for the structure came from a semi-synthesis by Mannich reaction between febrifugine and formaldehyde at pH 4. Although this direct correlation with putative (2<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif"><span style="font-style: italic; "><i>S</i></span>,3<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif"><span style="font-style: italic; "><i>R</i></span>)-(+)-febrifugine led the authors to propose the (9<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif"><span style="font-style: italic; "><i>R</i></span>,9a<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif"><span style="font-style: italic; "><i>S</i></span>) absolute configuration for <span style="font-weight: bold; "><b>172</b></span>, it seems that they were unaware that the absolute configuration of (+)-febrifugine was recently revised to (2<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif"><span style="font-style: italic; "><i>R</i></span>,3<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif"><span style="font-style: italic; "><i>S</i></span>) as a result of Kobayashi's unambiguous total synthesis<small><sup style="color: ;"><a title="S. Kobayashi, M. Ueno, R. Suzuki, H. Ishitani,  Tetrahedron Lett. 1999 40 2175S. Kobayashi, M. Ueno, R. Suzuki, H. Ishitani, H.-S. Kim, Y. Wataya,  J. Org. Chem. 1999 64 6833" href="quinoline2002.htm#cit80">80</a></sup></small> (<span style="font-style: italic; "><i>cf</i></span>. Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 2000 17 603see p. 615; J. P. Michael,  Nat. Prod. Rep. 2001 18 543see p. 552" href="quinoline2002.htm#cit28f">28f,g</a>). (+)-Neodichroine is thus more likely to be the (3<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif"><span style="font-style: italic; "><i>R</i></span>,9<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif"><span style="font-style: italic; "><i>S</i></span>,9a<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif"><span style="font-style: italic; "><i>R</i></span>) enantiomer, as shown in <span style="font-weight: bold; "><b>172</b></span>.</p><p class="otherpara">Another more recently reported quinazolinone�quinolizidine dimer, (+)-hydrachine A <span style="font-weight: bold; "><b>173</b></span>, was isolated as a semi-solid by Taiwanese workers from the roots of <span style="font-style: italic; "><i>Hydrangea chinensis</i></span>, where it occurred together with quinazolin-4(3<span style="font-style: italic; "><i>H</i></span>)-one <span style="font-weight: bold; "><b>170</b></span>.<small><sup style="color: ;"><a title="R. Patnam, F.-R. Chang, C.-Y. Chen, R.-Y. Kuo, Y.-H. Lee, Y.-C. Wu,  J. Nat. Prod. 2001 64 948" href="quinoline2002.htm#cit72">72</a></sup></small><small><sup>1</sup></small>H and <small><sup>13</sup></small>C NMR spectra, recorded in deuterated chloroform, were supplemented by COSY and HMBC correlations to establish the atomic connectivity. Central to the structural assignment were HMBC correlations between 4<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">-H and both carbonyl groups, C-2 on the quinazolinone, and signals ascribed to C-3<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif"> (mistakenly listed as C-5<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">), C-6<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif"> and C-9a<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">; these were taken as evidence for siting the quinazolinyl substituent at C-4<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif"> on the quinolizidine ring. The stereochemistry was determined from NOESY correlations and analysis of coupling constants; in particular, 4<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">-H, 9<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">-H and 9a<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">-H all showed large couplings consistent with axial orientations. Bohlmann bands in the IR spectrum indicated <span style="font-style: italic; "><i>trans</i></span>-fusion of the quinolizidine ring. While the evidence presented for the structure of <span style="font-weight: bold; "><b>173</b></span> seems irreproachable, one cannot but be intrigued by the tantalising similarity between the structures proposed for neodichroine and hydrachine A and their relationship to febrifugine. The <small><sup>1</sup></small>H NMR spectroscopic data for the two compounds are not directly comparable, since they were recorded in different solvents, and other reported spectroscopic and physical properties (IR, UV, MS, optical rotation) show similarities and differences that may or may not be significant. However, the <small><sup>13</sup></small>C NMR spectroscopic data are in remarkable agreement (�1.3 ppm in the quinolizidine ring) despite the difference in solvents; the only discrepancy in interpretation is that the authors interchange the assignments of the doublet signals for the bridgehead position C-9a<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif"> and the carbon bearing the quinazoline substituent. Is it conceivable that the two alkaloids, both originating in genera known for their production of febrifugine, are in fact the same? If so, the conversion of febrifugine into neodichroine must be regarded as deciding the issue.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr12"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-u12.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The identity of the new alkaloid peganol <span style="font-style: italic; "><i>N</i></span>-oxide <span style="font-weight: bold; "><b>174</b></span>, isolated from aerial parts of <span style="font-style: italic; "><i>Nitraria komarovii</i></span>, was established spectroscopically, and by reduction with zinc in hydrochloric acid to give a mixture of peganol <span style="font-weight: bold; "><b>175</b></span> and deoxypeganine (deoxyvasicine) <span style="font-weight: bold; "><b>176</b></span>.<small><sup style="color: ;"><a title="T. S. Tulyaganov, O. E. Makhmudov,  Chem. Nat. Compd. 2000 36 76Engl. Transl. Khim. Prir. Soedin. 2000 60" href="quinoline2002.htm#cit74">74</a></sup></small> More interesting are the two dimeric peganine derivatives dipegine <span style="font-weight: bold; "><b>177</b></span> and dipeginol <span style="font-weight: bold; "><b>178</b></span>, which were obtained from <span style="font-style: italic; "><i>Peganum harmala</i></span>.<small><sup style="color: ;"><a title="M. F. Faskhutdinov, M. V. Telezhenetskaya, M. G. Levkovich, N. D. Abdullaev,  Chem. Nat. Compd. 2000 36 602Engl. Transl. Khim. Prir. Soedin. 2000 481" href="quinoline2002.htm#cit76">76</a></sup></small> Although dipegine was originally reported as long ago as 1974, comprehensive NMR data in the present publication permitted unambiguous location of the bridge between C-4 and C-9<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">, rather than C-11<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif"> as had previously been proposed. However, the relative configurations at these stereogenic sites could not be ascertained directly. Molecular mechanics calculations on the most stable conformers of both possible diastereomers led the authors to predict average vicinal coupling constants between 4-H and 9<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">-H. While the predicted <small><sup>3</sup></small><span style="font-style: italic; "><i>J</i></span> value of 2.7 Hz for the diastereomer shown in <span style="font-weight: bold; "><b>177</b></span> was reasonably close to the experimentally determined coupling constant (<span style="font-style: italic; "><i>J</i></span> 2.1 Hz), this stereochemical assignment for dipegine should still be regarded as tentative. The gross structure of the novel alkaloid dipeginol <span style="font-weight: bold; "><b>178</b></span> was also revealed by analysis of its NMR spectra and those of its mono-acetate derivative, but no attempts were made to assign the relative configuration. Since both dimeric alkaloids are high-melting solids, the structural ambiguities could probably be resolved by X-ray crystallography.</p><p class="otherpara">The only new quinazoline alkaloid reported from a fungal source during the review period was (�)-circumdatin G <span style="font-weight: bold; "><b>179</b></span>, extracted together with (�)-circumdatin F <span style="font-weight: bold; "><b>180</b></span> from the culture broth of <span style="font-style: italic; "><i>Aspergillus ochraceus</i></span>.<small><sup style="color: ;"><a title="J.-R. Dai, B. K. Carte, P. J. Sidebottom, A. L. S. Yew, S.-B. Ng, Y. Huang, M. S. Butler,  J. Nat. Prod. 2001 64 125" href="quinoline2002.htm#cit69">69</a></sup></small> Circumdatin F had previously been isolated in such small quantities that its optical rotation and absolute configuration could not be determined.<small><sup style="color: ;"><a title="L. Rahbaek, J. Breinholt,  J. Nat. Prod. 1999 62 904" href="quinoline2002.htm#cit81">81</a></sup></small> The present work permitted the measurement of optical rotations for both <span style="font-weight: bold; "><b>180</b></span> ([<span style="font-style: italic; "><i><img src="https://bitnest.netfirms.com/images/entities/i_char_03b1.gif"></i></span>]<small><sub>D</sub></small> �18.9, <span style="font-style: italic; "><i>c</i></span> 0.11, MeOH) and <span style="font-weight: bold; "><b>179</b></span> ([<span style="font-style: italic; "><i><img src="https://bitnest.netfirms.com/images/entities/i_char_03b1.gif"></i></span>]<small><sub>D</sub></small> �21.7, <span style="font-style: italic; "><i>c</i></span> 0.19, MeOH), as well as the acquisition of comprehensive spectroscopic data. Their (<span style="font-style: italic; "><i>S</i></span>)-absolute configurations were assigned by analogy with (<span style="font-style: italic; "><i>S</i></span>)-(�)-circumdatin C <span style="font-weight: bold; "><b>181</b></span>, the stereochemistry of which had previously been determined by degradation to <span style="font-variant: 80; "><small>L</small></span>-alanine.<small><sup style="color: ;"><a title="L. Rahbaek, J. Breinholt, J. C. Frisvad, C. Christophersen,  J. Org. Chem. 1999 64 1689" href="quinoline2002.htm#cit82">82</a></sup></small></p><p class="otherpara">A critical review of the ethnopharmacology and toxicology of the Indian medicinal plant <span style="font-style: italic; "><i>Adhatoda vasica</i></span> (Acanthaceae), the principal alkaloid of which is vasicine <span style="font-weight: bold; "><b>182</b></span>, has called into question several reports on potentially adverse effects both of the plant extract and of vasicine itself.<small><sup style="color: ;"><a title="U. P. Claeson, T. Malmfors, G. Wilkman, J. G. Bruhn,  J. Ethnopharmacol. 2000 72 1" href="quinoline2002.htm#cit83">83</a></sup></small> While traditional applications in the treatment of various disorders, especially ailments of the respiratory tract, appear to be well documented, claims of oxytocic and abortifacient effects and of acute and general toxicity seem to be based on inappropriate testing methods and unreliable data. In the meantime, medicinal uses of the vasicine alkaloids continue to be documented, and patent applications have been filed for the use of deoxypeganine <span style="font-weight: bold; "><b>176</b></span> in the treatment of nicotine dependence,<small><sup style="color: ;"><a title="B. Asmussen,T. Hille,H.-R. HoffmannandK. Opitz, PCT Int. Appl.WO 2000048445, 24 August 2000(Chem. Abstr., 2000,133, 187985)" href="quinoline2002.htm#cit84">84</a></sup></small> drug dependence,<small><sup style="color: ;"><a title="B. Asmussen,T. Hille,H.-R. HoffmannandK. Opitz, PCT Int. Appl.WO 2000048582, 24 August 2000(Chem. Abstr., 2000,133, 172147)" href="quinoline2002.htm#cit85">85</a></sup></small> alcoholism<small><sup style="color: ;"><a title="B. Asmussen,T. Hille,H.-R. HoffmannandK. Opitz, PCT Int. Appl.WO 2000048600, 24 August 2000(Chem. Abstr., 2000,133, 172148)" href="quinoline2002.htm#cit86">86</a></sup></small> and Alzheimer's dementia,<small><sup style="color: ;"><a title="B. Asmussen,T. Hille,H.-R. HoffmannandK. Opitz, PCT Int. Appl.WO 2000048599, 24 August 2000(Chem. Abstr., 2000,133, 172207)" href="quinoline2002.htm#cit87">87</a></sup></small> and in the treatment of poisoning by an organophosphorus cholinesterase inhibitor.<small><sup style="color: ;"><a title="T. HilleandW. Wessling, Ger. Offen.DE 19924951, 14 December 2000(Chem. Abstr., 2000,134, 33004)" href="quinoline2002.htm#cit88">88</a></sup></small></p><p class="otherpara">Tryptanthrin <span style="font-weight: bold; "><b>183</b></span> has been found to inhibit the production of both nitric oxide and prostaglandin E<small><sub>2</sub></small> in murine macrophage RAW 264.7 cells activated by interferon-<img src="https://bitnest.netfirms.com/images/entities/char_03b3.gif"> and lipopolysaccharide.<small><sup style="color: ;"><a title="T. Ishihara, K. Kohno, S. Ushio, K. Iwaki, M. Ikeda, M. Kurimoto,  Eur. J. Pharmacol. 2000 407 197" href="quinoline2002.htm#cit89">89</a></sup></small> In the former case, the mechanism appears to involve suppression of inducible NO synthase expression, and in the latter case the alkaloid inhibits cyclooxygenase activity. The results suggest that tryptanthrin may be a useful anti-inflammatory agent. The alkaloid has also shown good antibacterial activity against <span style="font-style: italic; "><i>Helicobacter pylori</i></span> both <span style="font-style: italic; "><i>in vitro</i></span> and during <span style="font-style: italic; "><i>in vivo</i></span> studies with Mongolian gerbils infected with the ulcer-causing pathogen.<small><sup style="color: ;"><a title="M. Kataoka, K. Hirata, T. Kunikata, S. Ushio, K. Iwaki, K. Ohashi, M. Ikeda, M. Kurimoto,  J. Gastroenterol. 2001 36 5Chem. Abstr. 2001 135 116607" href="quinoline2002.htm#cit90">90</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr13"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-u13.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><a name="sect1325"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>2.2 Synthesis and other chemical studies</b></p></a><p class="firstpara">Samarium(<span style="font-variant: 80; "><small>II</small></span>) iodide in THF has been shown to mediate the reaction between <span style="font-style: italic; "><i>N,N</i></span>-diethyl-<span style="font-style: italic; "><i>o</i></span>-nitrobenzamide and various benzonitriles or phenylacetonitrile to yield 2-substituted quinazolin-4(3<span style="font-style: italic; "><i>H</i></span>)-ones in yields of 55�75%.<small><sup style="color: ;"><a title="X. Xu, P. Lu, Y. Zhang,  Synth. Commun. 2001 31 323" href="quinoline2002.htm#cit91">91</a></sup></small> Among the products formed was the alkaloid glycosminine (glycophymine) <span style="font-weight: bold; "><b>184</b></span>. The reaction failed with acetonitrile.</p><p class="otherpara">Kamal <span style="font-style: italic; "><i>et al.</i></span> found that the intramolecular aza-Wittig reaction of <span style="font-style: italic; "><i>N</i></span>-(2-azidobenzoyl)lactams <span style="font-weight: bold; "><b>185</b></span> gave deoxyvasicinone <span style="font-weight: bold; "><b>186</b></span> and analogues in quantitative yield within 10�15 minutes when the precursors were treated with chlorotrimethylsilane and sodium iodide in acetonitrile at room temperature.<small><sup style="color: ;"><a title="A. Kamal, K. V. Ramana, M. V. Rao,  J. Org. Chem. 2001 66 997" href="quinoline2002.htm#cit92">92</a></sup></small> This mild transformation provides a useful alternative to the standard cyclisation conditions, which entail treatment of the azide precursors with triphenylphosphine or tributylphosphine in boiling toluene for several hours. Even more interestingly, the reductive cyclisation of <span style="font-weight: bold; "><b>185</b></span> proceeded in yields of 25�50% when catalysed by bakers' yeast in a water�ethanol mixture at 37.5 �C. With convenient access to deoxyvasicinone, the authors embarked on a lipase-mediated resolution of vasicinone <span style="font-weight: bold; "><b>187</b></span> itself. The 3-bromo derivative <span style="font-weight: bold; "><b>188</b></span> was prepared by free radical bromination of <span style="font-weight: bold; "><b>186</b></span> with NBS (57%), and this product was converted into (�)-acetylvasicinone <span style="font-weight: bold; "><b>189</b></span> by treatment with potassium acetate and 18-crown-6 in acetonitrile (100%). Enzymatic hydrolysis of the ester with lipase PS <img src="https://bitnest.netfirms.com/images/entities/char_2018.gif">Amano<img src="https://bitnest.netfirms.com/images/entities/char_2019.gif"> in a mixture of acetonitrile and phosphate buffer (pH 7) was highly enantioselective, yielding (<span style="font-style: italic; "><i>R</i></span>)-(+)-vasicinone and the (<span style="font-style: italic; "><i>S</i></span>)-(�)-acetate in 98% enantiomeric excess (ee). Alternatively, chemical hydrolysis of <span style="font-weight: bold; "><b>189</b></span> yielded racemic vasicinone, which could then be resolved by enzymatic transesterification with vinyl acetate in THF in the presence of lipase PS in THF to yield (<span style="font-style: italic; "><i>S</i></span>)-(�)-vasicinone, as well as the (<span style="font-style: italic; "><i>R</i></span>)-(+)-acetate in better than 99% ee.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr14"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-u14.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">Deoxyvasicinone <span style="font-weight: bold; "><b>186</b></span> was the common precursor in the short divergent syntheses of isaindigotone <span style="font-weight: bold; "><b>190</b></span> and luotonin A <span style="font-weight: bold; "><b>191</b></span> by Molina <span style="font-style: italic; "><i>et al.</i></span> (<a title=" Reagents and conditions: i, 4-Acetoxy-3,5-dimethoxybenzaldehyde, Ac2O, reflux; ii, NaOH, EtOH, reflux; iii, SeO2, H2O, dioxane, reflux; iv, PhCHO, Ac2O, reflux; v, O3, CH2Cl2, 3 min, then Me2S." href="quinoline2002.htm#sch8">Scheme 8</a>).<small><sup style="color: ;"><a title="P. Molina, A. Tarraga, A. Gonzalez-Tejero,  Synthesis 2000 1523" href="quinoline2002.htm#cit93">93</a></sup></small> Straightforward condensation of <span style="font-weight: bold; "><b>186</b></span> with 4-acetoxy-3,5-dimethoxybenzaldehyde in acetic anhydride followed by hydrolysis of the ester completed the first reported synthesis of <span style="font-weight: bold; "><b>190</b></span> in 64% overall yield. The formal synthesis of <span style="font-weight: bold; "><b>191</b></span> simply entailed the oxidation of <span style="font-weight: bold; "><b>186</b></span> with selenium dioxide to give the dione <span style="font-weight: bold; "><b>192</b></span> (42%). Alternatively, a two-step reaction sequence commencing with condensation of <span style="font-weight: bold; "><b>186</b></span> with benzaldehyde followed by ozonolysis afforded <span style="font-weight: bold; "><b>192</b></span> in similar yield (43%). The synthesis is formal because Kelly and co-workers recently converted <span style="font-weight: bold; "><b>192</b></span> into luotonin A <span style="font-weight: bold; "><b>191</b></span> by base-catalysed reaction with 2-aminobenzaldehyde<small><sup style="color: ;"><a title="T. R. Kelly, S. Chamberland, R. A. Silva,  Tetrahedron Lett. 1999 40 2723" href="quinoline2002.htm#cit94">94</a></sup></small> (<span style="font-style: italic; "><i>cf.</i></span> Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 2000 17 603see p. 616" href="quinoline2002.htm#cit28h">28h</a>).</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch8"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-s8.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 8 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents and conditions</i></span>: i, 4-Acetoxy-3,5-dimethoxybenzaldehyde, Ac<small><sub>2</sub></small>O, reflux; ii, NaOH, EtOH, reflux; iii, SeO<small><sub>2</sub></small>, H<small><sub>2</sub></small>O, dioxane, reflux; iv, PhCHO, Ac<small><sub>2</sub></small>O, reflux; v, O<small><sub>3</sub></small>, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, 3 min, then Me<small><sub>2</sub></small>S.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The recent upsurge of activity in the synthesis of febrifugine <span style="font-weight: bold; "><b>169</b></span> and related antimalarial compounds shows no signs of abating, as evidenced by a review in the Japanese literature by Takeuchi and Harayama.<small><sup style="color: ;"><a title="Y. Takeuchi, T. Harayama,  Yuki Gosei Kagaku Kyokaishi 2001 59 569Chem. Abstr. 2001 135 107480" href="quinoline2002.htm#cit95">95</a></sup></small> Following hard on the heels of their stereoselective synthesis of racemic febrifugine<small><sup style="color: ;"><a title="Y. Takeuchi, M. Hattori, H. Abe, T. Harayama,  Synthesis 1999 1814" href="quinoline2002.htm#cit96">96</a></sup></small> (<span style="font-style: italic; "><i>cf.</i></span> Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 2001 18 543see p. 552" href="quinoline2002.htm#cit28g">28g</a>), Takeuchi and co-workers have devised the enantioselective modification shown in <a title=" Reagents and conditions: i, Bakers' yeast, sucrose, EtOH-H2O(1[ratio]10), K2CO3, 15[degree]C, 90 h; ii, NBS, MeCN, rt; iii, KOBut, THF, rt; iv, NBS, MeOH, rt; v, 10%aq. HCl, MeCN, rt; vi, quinazolin-4(3H)-one, K2CO3, DMF, rt; vii, H2, 20%Pd(OH)2-C, MeOH, rt; viii, H2O, 80[degree]C, then 10%aq. HCl; ix, BF3[middle dot]Et2O, MeCN, reflux, 0.5 h; x, aq. HCl(5 M), MeCN, reflux, 0.5-2 h." href="quinoline2002.htm#sch9">Scheme 9</a>.<small><sup style="color: ;"><a title="Y. Takeuchi, K. Azuma, K. Takakura, H. Abe, T. Harayama,  Chem. Commun. 2000 1643; Y. Takeuchi, K. Azuma, K. Takakura, H. Abe, H.-S. Kim, Y. Wataya, T. Harayama,  Tetrahedron 2001 57 1213" href="quinoline2002.htm#cit97">97,98</a></sup></small> The central feature was the use of bakers' yeast and sucrose in an ethanol�water solvent for the enantioselective reduction of the 2-allylpiperidin-3-one (�)-<span style="font-weight: bold; "><b>193</b></span> to give a separable mixture of unreduced (<span style="font-style: italic; "><i>R</i></span>)-(�)-<span style="font-weight: bold; "><b>193</b></span> (31%, 93% ee) and the (+)-alcohol <span style="font-weight: bold; "><b>194</b></span> (41%, 97% ee). However, since racemisation of (�)-<span style="font-weight: bold; "><b>193</b></span> was readily accomplished with potassium carbonate, a reductive dynamic optical resolution could be achieved by adding this base to the fermentation mixture. In this way the yield of (+)-<span style="font-weight: bold; "><b>194</b></span> was boosted to 62% (97% ee), while (�)-<span style="font-weight: bold; "><b>193</b></span> was recovered with diminished optical activity (14% yield, 14% ee). Intramolecular bromoetherification of (+)-<span style="font-weight: bold; "><b>194</b></span> with NBS in acetonitrile afforded <span style="font-weight: bold; "><b>195</b></span> as a 3 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 1 mixture of diastereomers. Elimination of hydrogen bromide from this product followed by methoxybromination with NBS in methanol yielded the ketal <span style="font-weight: bold; "><b>196</b></span>, this time as a 4 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 1 mixture of diastereomers. Hydrolysis of the ketal, reaction with the anion of quinazoline-4(3<span style="font-style: italic; "><i>H</i></span>)-one and removal of the benzyloxycarbonyl protecting group from nitrogen completed this <img src="https://bitnest.netfirms.com/images/entities/char_201c.gif">green<img src="https://bitnest.netfirms.com/images/entities/char_201d.gif"> synthesis of (+)-isofebrifugine <span style="font-weight: bold; "><b>168</b></span>. Furthermore, since isomerisation of isofebrifugine to febrifugine has been well documented, the authors were able to form a 1 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 2 equilibrium mixture of <span style="font-weight: bold; "><b>168</b></span> and (+)-febrifugine <span style="font-weight: bold; "><b>169</b></span> simply by heating the former in water at 80 �C for 15 minutes. Isomerisation did not occur under acidic conditions. Oddly enough, when the deprotection of racemic Cbz-isofebrifugine <span style="font-weight: bold; "><b>197</b></span> with aqueous hydrochloric acid was investigated, mixtures of the piperidine-cleavage products <span style="font-weight: bold; "><b>198</b></span>, <span style="font-weight: bold; "><b>199</b></span> and <span style="font-weight: bold; "><b>200</b></span> were obtained.<small><sup style="color: ;"><a title="Y. Takeuchi, K. Azuma, H. Abe, T. Harayama,  Heterocycles 2000 53 2247" href="quinoline2002.htm#cit99">99</a></sup></small> The reaction of <span style="font-weight: bold; "><b>197</b></span> with boron trifluoride�diethyl ether yielded <span style="font-weight: bold; "><b>198</b></span> as the sole product (74%). Further antimalarial tests on the products confirmed that (+)-febrifugine was almost 100 times as active towards <span style="font-style: italic; "><i>Plasmodium falciparum</i></span> as chloroquine, and also showed that it was twice as potent as its hydrochloride salt and about ten times as potent as (+)-isofebrifugine.<small><sup style="color: ;"><a title="Y. Takeuchi, K. Azuma, K. Takakura, H. Abe, H.-S. Kim, Y. Wataya, T. Harayama,  Tetrahedron 2001 57 1213" href="quinoline2002.htm#cit98">98</a></sup></small> In an interesting corollary to this work, Takeuchi's team synthesised the racemic regioisomers <span style="font-weight: bold; "><b>201</b></span> and <span style="font-weight: bold; "><b>202</b></span> from the 4-allylpiperidin-3-one analogue of <span style="font-weight: bold; "><b>193</b></span>, and proved that they have negligible antimalarial activity.<small><sup style="color: ;"><a title="Y. Takeuchi, M. Koike, K. Azuma, H. Nishioka, H. Abe, H.-S. Kim, Y. Wataya, T. Harayama,  Chem. Pharm. Bull. 2001 49 721" href="quinoline2002.htm#cit100">100</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch9"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-s9.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 9 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents and conditions</i></span>: i, Bakers' yeast, sucrose, EtOH�H<small><sub>2</sub></small>O (1 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 10), K<small><sub>2</sub></small>CO<small><sub>3</sub></small>, 15 �C, 90 h; ii, NBS, MeCN, rt; iii, KOBu<small><sup><span style="font-style: italic; "><i>t</i></span></sup></small>, THF, rt; iv, NBS, MeOH, rt; v, 10% aq. HCl, MeCN, rt; vi, quinazolin-4(3<span style="font-style: italic; "><i>H</i></span>)-one, K<small><sub>2</sub></small>CO<small><sub>3</sub></small>, DMF, rt; vii, H<small><sub>2</sub></small>, 20% Pd(OH)<small><sub>2</sub></small>�C, MeOH, rt; viii, H<small><sub>2</sub></small>O, 80 �C, then 10% aq. HCl; ix, BF<small><sub>3</sub></small><span style="font-weight: bold; "><b>�</b></span>Et<small><sub>2</sub></small>O, MeCN, reflux, 0.5 h; x, aq. HCl (5 M), MeCN, reflux, 0.5�2 h.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">A stereocontrolled synthesis of (+)-febrifugine by Taniguchi and Ogasawara<small><sup style="color: ;"><a title="T. Taniguchi, K. Ogasawara,  Org. Lett. 2000 2 3193" href="quinoline2002.htm#cit101">101</a></sup></small> (<a title=" Reagents and conditions: i, Bu4NF, THF; ii, MeSO2Cl, Et3N; iii, LiI, THF; iv, Zn, EtOH-HOAc(10[ratio]1); v, NaBH4, EtOH; vi,(Cy3P)2Cl2Ru[double bond, length as m-dash]CHPh(5 mol%); vii, H2, PtO2; viii,(PhS)2, Bu3P, pyridine; ix, BnBr, NaH; x, 30%H2O2; xi, CaCO3, Ph2O, reflux; xii, OsO4(cat.), NMO, aq. THF; xiii,p-TsCl, pyridine; xiv, K2CO3, MeOH; xv, quinazolin-4(3H)-one, KOH, MeOH; xvi, Dess-Martin periodinane; xvii, HCl(6 M), reflux." href="quinoline2002.htm#sch10">Scheme 10</a>) commenced with the chiral building block (�)-<span style="font-weight: bold; "><b>203</b></span>, which was prepared from furfural by reported methods. A key step in this route was the ring-closing metathesis of <span style="font-weight: bold; "><b>204</b></span> with Grubbs catalyst to give the dehydropiperidine <span style="font-weight: bold; "><b>205</b></span> in 89% yield. The quinazoline substituent was introduced at a late stage by treating the epoxide <span style="font-weight: bold; "><b>206</b></span> with the anion of quinazolin-4(3<span style="font-style: italic; "><i>H</i></span>)-one to give the alcohol <span style="font-weight: bold; "><b>207</b></span> as a mixture of diastereomers. Oxidation with Dess�Martin periodinane and removal of the protecting groups under acidic conditions completed the synthesis of (+)-febrifugine <span style="font-weight: bold; "><b>169</b></span> in 24 steps and 11% overall yield from (�)-<span style="font-weight: bold; "><b>203</b></span>.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch10"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-s10.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 10 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents and conditions</i></span>: i, Bu<small><sub>4</sub></small>NF, THF; ii, MeSO<small><sub>2</sub></small>Cl, Et<small><sub>3</sub></small>N; iii, LiI, THF; iv, Zn, EtOH�HOAc (10 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 1); v, NaBH<small><sub>4</sub></small>, EtOH; vi, (Cy<small><sub>3</sub></small>P)<small><sub>2</sub></small>Cl<small><sub>2</sub></small>Ru<img src="https://bitnest.netfirms.com/images/entities/char_e001.gif">CHPh (5 mol%); vii, H<small><sub>2</sub></small>, PtO<small><sub>2</sub></small>; viii, (PhS)<small><sub>2</sub></small>, Bu<small><sub>3</sub></small>P, pyridine; ix, BnBr, NaH; x, 30% H<small><sub>2</sub></small>O<small><sub>2</sub></small>; xi, CaCO<small><sub>3</sub></small>, Ph<small><sub>2</sub></small>O, reflux; xii, OsO<small><sub>4</sub></small>(cat.), NMO, aq. THF; xiii, <span style="font-style: italic; "><i>p</i></span>-TsCl, pyridine; xiv, K<small><sub>2</sub></small>CO<small><sub>3</sub></small>, MeOH; xv, quinazolin-4(3<span style="font-style: italic; "><i>H</i></span>)-one, KOH, MeOH; xvi, Dess�Martin periodinane; xvii, HCl (6 M), reflux.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">In the synthesis of the febrifugine alkaloids by Hatakeyama and co-workers,<small><sup style="color: ;"><a title="H. Ooi, A. Urushibara, T. Esumi, Y. Iwabuchi, S. Hatakeyama,  Org. Lett. 2001 3 953" href="quinoline2002.htm#cit102">102</a></sup></small> the key sequence of steps involved ozonolysis of the chiral alkene <span style="font-weight: bold; "><b>208</b></span> followed by condensation of the resulting aldehyde with hydroxylamine hydrochloride in allyl alcohol as solvent (<a title=" Reagents and conditions: i, H2C[double bond, length as m-dash]CHOAc, Novozym 435, Pri2O; ii, H2, Lindlar catalyst, MeOH, then K2CO3; iii, TBDPSCl. imidazole, DMF; iv, Li naphthalenide, THF,-25[degree]C; v, MeSO2Cl, Et3N, CH2Cl2; vi, O3, then Me2S, NaHCO3, CH2Cl2.-78[degree]C; vii, HONH2[middle dot]HCl, Et3N, H2C[double bond, length as m-dash]CHCH2OH; viii, H2, PdCl2, MeOH; ix,(Boc)2O, Et3N, CH2Cl2; x,N-Ts-imidazole, NaH, THF; xi, quinazolin-4(3H)-one, KH, DMF; xii, Dess-Martin periodinane, CH2Cl2; xiii, HCl(6 M), reflux; xiv, MeOH, reflux." href="quinoline2002.htm#sch11">Scheme 11</a>). The unsaturated alcohol trapped the intermediate nitrone <span style="font-weight: bold; "><b>209</b></span> to give the three cycloadducts <span style="font-weight: bold; "><b>210�212</b></span> in a ratio of 64 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 10 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 26 and an overall combined yield of 74%. Although these adducts could be separated, it was more convenient to take the mixture through the subsequent hydrogenolysis, protection and epoxidation to give the epoxide diastereomers <span style="font-weight: bold; "><b>213</b></span>, treatment of which with the anion of quinazolin-4(3<span style="font-style: italic; "><i>H</i></span>)-one followed by Dess�Martin oxidation gave the <span style="font-style: italic; "><i>cis</i></span>-and <span style="font-style: italic; "><i>trans</i></span>-2,3-disubstituted piperidines <span style="font-weight: bold; "><b>214</b></span> in a ratio of 22 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 78, respectively. Acid-induced deprotection with boiling 6 M hydrochloric acid yielded a mixture of (+)-isofebrifugine <span style="font-weight: bold; "><b>168</b></span> (27%) and (+)-febrifugine <span style="font-weight: bold; "><b>169</b></span> (58%), the 33 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 67 ratio of which indicated that partial epimerisation had taken place. In a result that casts light on this epimerisation process (presumably a reversible Michael reaction) and reinforces Takeuchi's observations<small><sup style="color: ;"><a title="Y. Takeuchi, K. Azuma, K. Takakura, H. Abe, T. Harayama,  Chem. Commun. 2000 1643" href="quinoline2002.htm#cit97">97</a></sup></small> (<span style="font-style: italic; "><i>vide supra</i></span>), a purified sample of <span style="font-style: italic; "><i>cis</i></span>-<span style="font-weight: bold; "><b>214</b></span> afforded only (+)-isofebrifugine when heated with hydrochloric acid, whereas <span style="font-style: italic; "><i>trans</i></span>-<span style="font-weight: bold; "><b>214</b></span> yielded an 84 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 16 mixture of (+)-febrifugine and (+)-isofebrifugine. However, isofebrifugine could be isomerised to febrifugine under neutral conditions in boiling methanol.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch11"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-s11.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 11 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents and conditions</i></span>: i, H<small><sub>2</sub></small>C<img src="https://bitnest.netfirms.com/images/entities/char_e001.gif">CHOAc, Novozym 435, Pr<small><sup>i</sup></small><small><sub>2</sub></small>O; ii, H<small><sub>2</sub></small>, Lindlar catalyst, MeOH, then K<small><sub>2</sub></small>CO<small><sub>3</sub></small>; iii, TBDPSCl. imidazole, DMF; iv, Li naphthalenide, THF, �25 �C; v, MeSO<small><sub>2</sub></small>Cl, Et<small><sub>3</sub></small>N, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>; vi, O<small><sub>3</sub></small>, then Me<small><sub>2</sub></small>S, NaHCO<small><sub>3</sub></small>, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>. �78 �C; vii, HONH<small><sub>2</sub></small><span style="font-weight: bold; "><b>�</b></span>HCl, Et<small><sub>3</sub></small>N, H<small><sub>2</sub></small>C<img src="https://bitnest.netfirms.com/images/entities/char_e001.gif">CHCH<small><sub>2</sub></small>OH; viii, H<small><sub>2</sub></small>, PdCl<small><sub>2</sub></small>, MeOH; ix, (Boc)<small><sub>2</sub></small>O, Et<small><sub>3</sub></small>N, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>; x, <span style="font-style: italic; "><i>N</i></span>-Ts-imidazole, NaH, THF; xi, quinazolin-4(3<span style="font-style: italic; "><i>H</i></span>)-one, KH, DMF; xii, Dess�Martin periodinane, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>; xiii, HCl (6 M), reflux; xiv, MeOH, reflux.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The important enantioselective synthesis of febrifugine and isofebrifugine by Kobayashi and co-workers<small><sup style="color: ;"><a title="S. Kobayashi, M. Ueno, R. Suzuki, H. Ishitani,  Tetrahedron Lett. 1999 40 2175S. Kobayashi, M. Ueno, R. Suzuki, H. Ishitani, H.-S. Kim, Y. Wataya,  J. Org. Chem. 1999 64 6833" href="quinoline2002.htm#cit80">80</a></sup></small> (<span style="font-style: italic; "><i>cf.</i></span> Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 2000 17 603see p. 615; J. P. Michael,  Nat. Prod. Rep. 2001 18 543see p. 552" href="quinoline2002.htm#cit28f">28f,g</a>) has already been mentioned. Patent applications based on the original route<small><sup style="color: ;"><a title="S. Kobayashi, M. Ueno, R. Suzuki, H. Ishitani,  Tetrahedron Lett. 1999 40 2175" href="quinoline2002.htm#cit80a">80a</a></sup></small> have recently been filed.<small><sup style="color: ;"><a title="S. Kobayashi,Y. WatayaandH. Kim, PCT Int. Appl.WO 2000052005, 8 September 2000(Chem. Abstr., 2000,133, 208028)." href="quinoline2002.htm#cit103">103</a></sup></small> However, these workers subsequently devised alternative syntheses of both alkaloids based on the Lewis acid-catalysed reaction of silyl enol ethers and related nucleophiles with acyliminium ions prepared <span style="font-style: italic; "><i>in situ</i></span> from <span style="font-style: italic; "><i>N</i></span>,<span style="font-style: italic; "><i>O</i></span>-acetals. After an extensive series of model studies with <span style="font-style: italic; "><i>N</i></span>-Cbz-protected 2-methoxypiperidines and 2-acyloxypiperidines, scandium(<span style="font-variant: 80; "><small>III</small></span>) triflate<a title="The IUPAC name for triflate is trifluoromethanesulfonate." href="quinoline2002.htm#fn2"><img src="https://bitnest.netfirms.com/images/entities/char_2021b.gif" border="0"></a> was found to give the best yields of 2-acylmethylpiperidine products, and also resulted in high 2,3-<span style="font-style: italic; "><i>trans</i></span>/<span style="font-style: italic; "><i>cis</i></span> selectivity with 2,3-diacyloxypiperidine substrates.<small><sup style="color: ;"><a title="O. Okitsu, R. Suzuki, S. Kobayashi,  Synlett 2000 989; O. Okitsu, R. Suzuki, S. Kobayashi,  J. Org. Chem. 2001 66 809" href="quinoline2002.htm#cit104">104,105</a></sup></small> The synthesis of febrifugine itself (<a title=" Reagents and conditions: i, LiAlH4, Et2O, 0[degree]C; ii, Ac2O, Et3N, DMAP(cat.), rt; iii, Sn(OTf)2(2 equiv.), Pri2NEt(2 equiv.), CH2Cl2, 0[degree]C to reflux; iv, add217(0.5 equiv.), Sc(OTf)3(0.1 equiv.), CH2Cl2, reflux; v, 25%HBr in HOAc, 0[degree]C, then piperidine; vi, NaOMe, MeOH, rt; vii, Me3SiOTf(2 equiv.), Pri2NEt(2 equiv.), CH2Cl2, 0[degree]C to rt; viii, Me3SiOTf(2.5 equiv.), MeCN, rt; ix, SO3[middle dot]pyridine, DMSO, Et3N; x, Et3SiH, BF3[middle dot]OEt2; xi, aq. HCl(6 M), reflux." href="quinoline2002.htm#sch12">Scheme 12</a>) employed the (3<span style="font-style: italic; "><i>S</i></span>)-substrate <span style="font-weight: bold; "><b>215</b></span>, which was prepared <span style="font-style: italic; "><i>via</i></span> the Weinreb amide <span style="font-weight: bold; "><b>216</b></span> either from <span style="font-variant: 80; "><small>L</small></span>-ornithine or by a route involving an asymmetric aldol reaction.<small><sup style="color: ;"><a title="O. Okitsu, R. Suzuki, S. Kobayashi,  J. Org. Chem. 2001 66 809" href="quinoline2002.htm#cit105">105</a></sup></small> In this case the tin(<span style="font-variant: 80; "><small>II</small></span>) enolate of the quinazolinone-substituted ketone <span style="font-weight: bold; "><b>217</b></span> was required in order to maximise the formation of the 2,3-<span style="font-style: italic; "><i>trans</i></span>-disubstituted product <span style="font-weight: bold; "><b>218</b></span> (55%) in relation to its <span style="font-style: italic; "><i>cis</i></span>-isomer (14%). A disappointing two-step deprotection of <span style="font-weight: bold; "><b>218</b></span> (25% yield) completed the synthesis of (+)-febrifugine <span style="font-weight: bold; "><b>169</b></span>. For isofebrifugine, reaction between the trimethylsilyl enol ether of <span style="font-weight: bold; "><b>217</b></span> and the racemic semicyclic <span style="font-style: italic; "><i>N</i></span>,<span style="font-style: italic; "><i>O</i></span>-acetal <span style="font-weight: bold; "><b>219</b></span> (a 74 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 26 mixture of isomers) was catalysed by trimethylsilyl triflate, and yielded the ring-opened product <span style="font-weight: bold; "><b>220</b></span>, almost exclusively as the <span style="font-style: italic; "><i>syn</i></span> diastereomer (93 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 7), in 51% yield.<small><sup style="color: ;"><a title="M. Sugiura, S. Kobayashi,  Org. Lett. 2001 3 477" href="quinoline2002.htm#cit106">106</a></sup></small> The piperidine ring was formed by oxidation of the terminal alcohol to the aldehyde and reduction of the ensuing cyclic acyliminium ion, after which removal of the protecting groups completed the synthesis of racemic isofebrifugine (�)-<span style="font-weight: bold; "><b>168</b></span>.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch12"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-s12.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 12 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents and conditions</i></span>: i, LiAlH<small><sub>4</sub></small>, Et<small><sub>2</sub></small>O, 0 �C; ii, Ac<small><sub>2</sub></small>O, Et<small><sub>3</sub></small>N, DMAP (cat.), rt; iii, Sn(OTf)<small><sub>2</sub></small>(2 equiv.), Pr<small><sup>i</sup></small><small><sub>2</sub></small>NEt (2 equiv.), CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, 0 �C to reflux; iv, add <span style="font-weight: bold; "><b>217</b></span>(0.5 equiv.), Sc(OTf)<small><sub>3</sub></small>(0.1 equiv.), CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, reflux; v, 25% HBr in HOAc, 0 �C, then piperidine; vi, NaOMe, MeOH, rt; vii, Me<small><sub>3</sub></small>SiOTf (2 equiv.), Pr<small><sup>i</sup></small><small><sub>2</sub></small>NEt (2 equiv.), CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, 0 �C to rt; viii, Me<small><sub>3</sub></small>SiOTf (2.5 equiv.), MeCN, rt; ix, SO<small><sub>3</sub></small><span style="font-weight: bold; "><b>�</b></span>pyridine, DMSO, Et<small><sub>3</sub></small>N; x, Et<small><sub>3</sub></small>SiH, BF<small><sub>3</sub></small><span style="font-weight: bold; "><b>�</b></span>OEt<small><sub>2</sub></small>; xi, aq. HCl (6 M), reflux.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara"><span style="font-style: italic; "><i>N</i></span>-Sulfinylanthraniloyl chloride <span style="font-weight: bold; "><b>221</b></span> was the preferred starting material for Witt and Bergman's assembly of the tripeptides <span style="font-weight: bold; "><b>222</b></span> (R = H, OBn), key intermediates <span style="font-style: italic; "><i>en route</i></span> to the fungal metabolites (�)-circumdatin F <span style="font-weight: bold; "><b>180</b></span> and (�)-circumdatin C <span style="font-weight: bold; "><b>181</b></span> (<a title=" Reagents and conditions: i, Methyl anthranilate(R=H)or methyl 5-benzyloxyanthranilate(R=OBn), toluene, rt; 48 h; ii,N-Cbz-L-Ala, DCC, CH2Cl2, 0[degree]C to rt; iii, Ph3P, I2, Pri2NEt, CH2Cl2, rt; iv, 20%piperidine in EtOAc, rt; v, 45%HBr in HOAc, 60[degree]C; vi, Et3N(for R=H)or Pri2NEt(for R=OH), EtOAc, rt; vii, Et3N, DMAP, THF, then 2-N3C6H4COCl, THF, 20[degree]C(for R[prime or minute]=Me); viii, Et3N, DMAP, DMSO-CH2Cl2, then 2-N3C6H4COCl, CH2Cl2, 20[degree]C(for R[prime or minute]=H); ix, Bu3P, C6H6, rt to 60[degree]C." href="quinoline2002.htm#sch13">Scheme 13</a>).<small><sup style="color: ;"><a title="A. Witt, J. Bergman,  J. Org. Chem. 2001 66 2784" href="quinoline2002.htm#cit107">107</a></sup></small> Cyclisation of <span style="font-weight: bold; "><b>222</b></span> with triphenylphosphine and iodine in the presence of Hunig's base gave the 4-imino-4<span style="font-style: italic; "><i>H</i></span>-3,1-benzoxazines <span style="font-weight: bold; "><b>223</b></span> (R = H, OBn), aminolysis of which with piperidine produced the amidines <span style="font-weight: bold; "><b>224</b></span>. The target alkaloids <span style="font-weight: bold; "><b>180</b></span> ([<span style="font-style: italic; "><i><img src="https://bitnest.netfirms.com/images/entities/i_char_03b1.gif"></i></span>]<small><sub>D</sub></small> �55, <span style="font-style: italic; "><i>c</i></span> 0.94, CHCl<small><sub>3</sub></small>) and <span style="font-weight: bold; "><b>181</b></span> ([<span style="font-style: italic; "><i><img src="https://bitnest.netfirms.com/images/entities/i_char_03b1.gif"></i></span>]<small><sub>D</sub></small> �91, <span style="font-style: italic; "><i>c</i></span> 0.17, MeOH) were obtained after deprotection of <span style="font-weight: bold; "><b>224</b></span> with hydrobromic acid in acetic acid followed by treatment with a tertiary amine and silica gel. It should be noted that the optical rotation of synthetic (�)-circumdatin F is considerably larger than that recently recorded on a natural sample (<span style="font-style: italic; "><i>cf.</i></span> Section 2.1). A different synthesis of circumdatin F and the related alkaloid sclerotigenin <span style="font-weight: bold; "><b>225</b></span> by Snider and Busuyek,<small><sup style="color: ;"><a title="B. B. Snider, M. V. Busuyek,  Tetrahedron 2001 57 3301" href="quinoline2002.htm#cit108">108</a></sup></small> also shown in <a title=" Reagents and conditions: i, Methyl anthranilate(R=H)or methyl 5-benzyloxyanthranilate(R=OBn), toluene, rt; 48 h; ii,N-Cbz-L-Ala, DCC, CH2Cl2, 0[degree]C to rt; iii, Ph3P, I2, Pri2NEt, CH2Cl2, rt; iv, 20%piperidine in EtOAc, rt; v, 45%HBr in HOAc, 60[degree]C; vi, Et3N(for R=H)or Pri2NEt(for R=OH), EtOAc, rt; vii, Et3N, DMAP, THF, then 2-N3C6H4COCl, THF, 20[degree]C(for R[prime or minute]=Me); viii, Et3N, DMAP, DMSO-CH2Cl2, then 2-N3C6H4COCl, CH2Cl2, 20[degree]C(for R[prime or minute]=H); ix, Bu3P, C6H6, rt to 60[degree]C." href="quinoline2002.htm#sch13">Scheme 13</a>, entailed the selective acylation of the benzodiazepinediones <span style="font-weight: bold; "><b>226</b></span>, without the need for protecting groups, at the more acidic anilide position with 2-azidobenzoyl chloride, followed by aza-Wittig cyclisation of the resulting imides <span style="font-weight: bold; "><b>227</b></span> with tributylphosphine. The optical rotation for circumdatin F, incorrectly reported in this publication, has subsequently been corrected ([<span style="font-style: italic; "><i><img src="https://bitnest.netfirms.com/images/entities/i_char_03b1.gif"></i></span>]<small><sub>D</sub></small> �52.9, <span style="font-style: italic; "><i>c</i></span> 0.5, CHCl<small><sub>3</sub></small>).<small><sup style="color: ;"><a title="B. B. Snider,Brandeis University, personal communication. I am grateful to Dr Snider for providing this information" href="quinoline2002.htm#cit109">109</a></sup></small> It is also intriguing that the <small><sup>1</sup></small>H NMR spectrum of this alkaloid showed the presence of two conformers in the ratio 99 <img src="https://bitnest.netfirms.com/images/entities/char_2236.gif"> 1, arising from flipping of the seven-membered ring.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch13"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-s13.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 13 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents and conditions</i></span>: i, Methyl anthranilate (R = H) or methyl 5-benzyloxyanthranilate (R = OBn), toluene, rt; 48 h; ii, <span style="font-style: italic; "><i>N</i></span>-Cbz-<span style="font-variant: 80; "><small>L</small></span>-Ala, DCC, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, 0 �C to rt; iii, Ph<small><sub>3</sub></small>P, I<small><sub>2</sub></small>, Pr<small><sup>i</sup></small><small><sub>2</sub></small>NEt, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, rt; iv, 20% piperidine in EtOAc, rt; v, 45% HBr in HOAc, 60 �C; vi, Et<small><sub>3</sub></small>N (for R = H) or Pr<small><sup>i</sup></small><small><sub>2</sub></small>NEt (for R = OH), EtOAc, rt; vii, Et<small><sub>3</sub></small>N, DMAP, THF, then 2-N<small><sub>3</sub></small>C<small><sub>6</sub></small>H<small><sub>4</sub></small>COCl, THF, 20 �C (for R<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">= Me); viii, Et<small><sub>3</sub></small>N, DMAP, DMSO�CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, then 2-N<small><sub>3</sub></small>C<small><sub>6</sub></small>H<small><sub>4</sub></small>COCl, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, 20 �C (for R<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">= H); ix, Bu<small><sub>3</sub></small>P, C<small><sub>6</sub></small>H<small><sub>6</sub></small>, rt to 60 �C.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">A synthesis of (+)-fumiquinazoline G reported some years ago by Snider and He<small><sup style="color: ;"><a title="B. B. Snider, F. He,  Synlett 1997 483" href="quinoline2002.htm#cit110">110</a></sup></small> (<span style="font-style: italic; "><i>cf</i></span>. Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 1998 15 595see p. 603" href="quinoline2002.htm#cit28i">28i</a>) suffered from poor yields during the removal of a 2,4-dimethoxybenzyl protecting group. The difficulty has now been overcome by using the photolabile 2-nitrobenzyl protecting group.<small><sup style="color: ;"><a title="B. B. Snider, M. V. Busuyek,  Tetrahedron 2001 57 3301" href="quinoline2002.htm#cit108">108</a></sup></small> Thus the final steps, shown in <a title=" Reagents and conditions: i, NaH, THF,-5[degree]C, then 2-N3C6H4COCl, THF, rt; ii, Bu3P, C6H6, rt to 75[degree]C; iii, MeOH, Pyrex,h[small nu](254 nm)." href="quinoline2002.htm#sch14">Scheme 14</a>, entailed acylation of the protected diketopiperazine <span style="font-weight: bold; "><b>228</b></span> with 2-azidobenzoyl chloride and aza-Wittig cyclisation of the product to give <span style="font-weight: bold; "><b>229</b></span>. Photolytic removal of the 2-nitrobenzyl group from a dilute solution of <span style="font-weight: bold; "><b>229</b></span> in methanol at 254 nm afforded an 87% yield of <span style="font-style: italic; "><i>ent</i></span>-fumiquinazoline G <span style="font-weight: bold; "><b>230</b></span>. It is of interest that Avenda�o and co-workers recently experienced problems in the removal of a 2,4-dimethoxybenzyl protecting group at the end of a synthesis of the fumiquinazoline regioisomer <span style="font-weight: bold; "><b>231</b></span> by a similar aza-Wittig protocol.<small><sup style="color: ;"><a title="E. Caballero, C. Avendano, J. C. Menendez,  Heterocycles 2000 53 1765" href="quinoline2002.htm#cit111">111</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch14"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-s14.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 14 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents and conditions</i></span>: i, NaH, THF, �5 �C, then 2-N<small><sub>3</sub></small>C<small><sub>6</sub></small>H<small><sub>4</sub></small>COCl, THF, rt; ii, Bu<small><sub>3</sub></small>P, C<small><sub>6</sub></small>H<small><sub>6</sub></small>, rt to 75 �C; iii, MeOH, Pyrex, <span style="font-style: italic; "><i>h<img src="https://bitnest.netfirms.com/images/entities/i_char_03bd.gif"></i></span>(254 nm).</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr15"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-u15.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The more complex (�)-fumiquinazolines A, B and I, <span style="font-weight: bold; "><b>232�234</b></span>, have also been synthesised by Snider's group by routes in which most of the effort was, understandably, devoted to constructing the 3-oxotetrahydro-1<span style="font-style: italic; "><i>H</i></span>-imidazo[1,2-<span style="font-style: italic; "><i>a</i></span>]indol-9-yl substituents.<small><sup style="color: ;"><a title="B. B. Snider, H. Zeng,  Org. Lett. 2000 2 4103" href="quinoline2002.htm#cit112">112</a></sup></small> Formation of the 2<span style="font-style: italic; "><i>H</i></span>-pyrazino[2,1-<span style="font-style: italic; "><i>b</i></span>]quinazoline-3,6(1<span style="font-style: italic; "><i>H</i></span>,4<span style="font-style: italic; "><i>H</i></span>)-dione moieties was left to the final stages of the synthesis, and involved methodology similar to that shown in <a title=" Reagents and conditions: i, Methyl anthranilate(R=H)or methyl 5-benzyloxyanthranilate(R=OBn), toluene, rt; 48 h; ii,N-Cbz-L-Ala, DCC, CH2Cl2, 0[degree]C to rt; iii, Ph3P, I2, Pri2NEt, CH2Cl2, rt; iv, 20%piperidine in EtOAc, rt; v, 45%HBr in HOAc, 60[degree]C; vi, Et3N(for R=H)or Pri2NEt(for R=OH), EtOAc, rt; vii, Et3N, DMAP, THF, then 2-N3C6H4COCl, THF, 20[degree]C(for R[prime or minute]=Me); viii, Et3N, DMAP, DMSO-CH2Cl2, then 2-N3C6H4COCl, CH2Cl2, 20[degree]C(for R[prime or minute]=H); ix, Bu3P, C6H6, rt to 60[degree]C." href="quinoline2002.htm#sch13">Scheme 13</a> (<span style="font-style: italic; "><i>cf.</i></span> steps <span style="font-weight: bold; "><b>222</b></span><img src="https://bitnest.netfirms.com/images/entities/char_2192.gif"><span style="font-weight: bold; "><b>224</b></span><img src="https://bitnest.netfirms.com/images/entities/char_2192.gif"><span style="font-weight: bold; "><b>181</b></span>). In the case of fumiquinazoline A, for example, treatment of the precursor <span style="font-weight: bold; "><b>235</b></span> with triphenylphosphine and bromine in the presence of triethylamine followed by aminolysis of the resulting 3,1-benzoxazine with piperidine and final cyclisation gave a mixture of the Cbz-protected product <span style="font-weight: bold; "><b>236</b></span> and its C-4 epimer in overall yields of 49% and 14%, respectively. Removal of the Cbz protecting group from the former by hydrogenolysis over palladium completed the synthesis of (�)-fumiquinazoline A <span style="font-weight: bold; "><b>232</b></span> in 90% yield. The overall yields for (�)-fumiquinazolines B and I from the appropriate precursors analogous to <span style="font-weight: bold; "><b>235</b></span> were 42% and 52%, respectively.</p><p class="otherpara">The synthesis of <span style="font-style: italic; "><i>ent</i></span>-alantrypinone <span style="font-weight: bold; "><b>237</b></span> communicated by Hart and Magomedov in 1999<small><sup style="color: ;"><a title="D. J. Hart, N. A. Magomedov,  Tetrahedron Lett. 1999 40 5429" href="quinoline2002.htm#cit113">113</a></sup></small> and summarised in last year's review in this series (<span style="font-style: italic; "><i>cf.</i></span> Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 2001 18 543see p. 553" href="quinoline2002.htm#cit28j">28j</a>) has been published as a full paper with experimental details and additional observations on aspects of the chemistry.<small><sup style="color: ;"><a title="D. J. Hart, N. A. Magomedov,  J. Am. Chem. Soc. 2001 123 5892" href="quinoline2002.htm#cit114">114</a></sup></small> A related article by these authors on the Morin rearrangement of sulfoxides such as <span style="font-weight: bold; "><b>238</b></span> with trifluoroacetic acid described the isolation of bridged products such as <span style="font-weight: bold; "><b>239</b></span> (21�35%) and <span style="font-weight: bold; "><b>240</b></span> (22�25%), amongst others, as well as the putative mechanism of the process.<small><sup style="color: ;"><a title="J. D. Freed, D. J. Hart, N. A. Magomedov,  J. Org. Chem. 2001 66 839" href="quinoline2002.htm#cit115">115</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr16"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-u16.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><a name="sect1714"><p align="" style="font-weight: bold; margin-top: 0%; margin-bottom: 0%; "><h3><b>3 Acridone alkaloids</b></h3></p></a><p class="firstpara">The known alkaloid isogravacridonechlorine <span style="font-weight: bold; "><b>241</b></span> has been isolated from root extracts of <span style="font-style: italic; "><i>Ruta chalepensis</i></span>.<small><sup style="color: ;"><a title="K. El Sayed, M. A. Al-Said, F. S. El-Feraly, S. A. Ross,  J. Nat. Prod. 2000 63 995" href="quinoline2002.htm#cit16">16</a></sup></small></p><p class="otherpara">Oxidation of the potentially valuable antitumour alkaloid acronycine <span style="font-weight: bold; "><b>242</b></span> and its nitro derivative <span style="font-weight: bold; "><b>243</b></span> with <span style="font-style: italic; "><i>meta</i></span>-chloroperoxybenzoic acid in toluene has yielded the Baeyer�Villiger ring-expansion products <span style="font-weight: bold; "><b>244</b></span> (20% and 30% yields respectively), as well as the hydroxylated compounds <span style="font-weight: bold; "><b>245</b></span> (10%).<small><sup style="color: ;"><a title="P. Magiatis, S. Mitaku, A.-L. Skaltsounis, F. Tillequin, A. Pierre, G. Atassi,  Nat. Prod. Lett. 2000 14 183" href="quinoline2002.htm#cit116">116</a></sup></small> The pyran ring remained unaffected. However, similar oxidation of the <span style="font-style: italic; "><i>cis</i></span>-diol <span style="font-weight: bold; "><b>246</b></span> yielded only the triol <span style="font-weight: bold; "><b>247</b></span> (29%), whereas oxidation of <span style="font-weight: bold; "><b>246</b></span> with lead tetraacetate followed by treatment with sodium borohydride afforded the ring-D expanded hemiacetal <span style="font-weight: bold; "><b>248</b></span> (30%), which could in turn be oxidised to the lactone <span style="font-weight: bold; "><b>249</b></span> with pyridinium chlorochromate (25%). The products showed varying degrees of <span style="font-style: italic; "><i>in vitro</i></span> cytotoxicity towards L-1210 leukemia cells, with <span style="font-weight: bold; "><b>248</b></span> and <span style="font-weight: bold; "><b>249</b></span> being approximately as active as acronycine itself. In related studies, the acronycine-inspired benzo[<span style="font-style: italic; "><i>b</i></span>]xanthenone derivative <span style="font-weight: bold; "><b>250</b></span> was found to be more active than the parent alkaloid in inhibiting the proliferation of the same cell line.<small><sup style="color: ;"><a title="C. Sittisombut, N. Cotes, S. Michel, M. Koch, F. Tillequin, B. Pfeiffer, P. Renard, A. Pierre, G. Atassi,  Chem. Pharm. Bull. 2001 49 675" href="quinoline2002.htm#cit117">117</a></sup></small> Cognate work on benzo[<span style="font-style: italic; "><i>b</i></span>]-fused acridones and pyranoacridones, some of which has previously been discussed in this series of reviews, has since been patented.<small><sup style="color: ;"><a title="M. Koch,F. Tillequin,S. Michel,G. Atassi,A. Pierre,P. RenardandB. Pfeiffer, Eur. Pat. Appl.EP 1,061,081, 20 December 2000(Chem. Abstr., 2001,134, 56826)" href="quinoline2002.htm#cit118">118</a></sup></small></p><p class="otherpara">In efforts to improve the bioavailability of the potent antitumour agent glyfoline <span style="font-weight: bold; "><b>251</b></span>, several water-soluble derivatives <span style="font-weight: bold; "><b>252�255</b></span> were prepared by derivatising the parent alkaloid.<small><sup style="color: ;"><a title="T.-L. Su, C.-T. Lin, C.-H. Chen, M.-T. Lin,  Med. Chem. Res. 2000 10 137" href="quinoline2002.htm#cit119">119</a></sup></small><span style="font-style: italic; "><i>In vitro</i></span> tests proved that all the derivatives were less cytotoxic than glyfoline towards nasopharyngeal carcinoma (NPC) cells. However, only <span style="font-weight: bold; "><b>253</b></span> (<span style="font-style: italic; "><i>n</i></span> = 3) showed significant <span style="font-style: italic; "><i>in vivo</i></span> activity in mice bearing NPC xenografts. Although the effective dose was about half that of glyfoline itself, this compound might still prove to be a useful prodrug in combination chemotherapies.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr17"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2002/b104971m/b104971m-u17.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><rsc:art-back><a name="sect1751"><p align="" style="font-weight: bold; margin-top: 0%; margin-bottom: 0%; "><h3><b>References</b></h3></p></a><table align="center" width="100%" border="0"><tr><td valign="top" align="right"><a name="cit1">1</a></td><td valign="top"></td><td valign="top">C. Ito<span style="">, </span>M. Itoigawa<span style="">, </span>T. Otsuka<span style="">, </span>H. Tokuda<span style="">, </span>H. Nishino and H. Furukawa, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 2000, <span style="font-weight: bold; "><b>63</b></span>, 1344<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280686" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit2">2</a></td><td valign="top"></td><td valign="top">S. Wang<span style="">, </span>X.-B. Ding<span style="">, </span>Y.-F. Chen and D.-Q. Yu, <span style="font-style: italic; "><i>J. Asian Nat. Prod. Res.</i></span>, 2001, <span style="font-weight: bold; "><b>3</b></span>, 89,  (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2001, <span style="font-weight: bold; "><b>135</b></span>, 239248)<rsc:citlink msid="b104971m" citgroupID="cit2" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit3">3</a></td><td valign="top"></td><td valign="top">J. Chen<span style="">, </span>J. S. Tang<span style="">, </span>J. Tian<span style="">, </span>Y. P. Wang and F. E. Wu, <span style="font-style: italic; "><i>Chin. Chem. Lett.</i></span>, 2000, <span style="font-weight: bold; "><b>11</b></span>, 707,  (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2000, <span style="font-weight: bold; "><b>133</b></span>, 347107)<rsc:citlink msid="b104971m" citgroupID="cit3" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit4">4</a></td><td valign="top"></td><td valign="top">I. Jacquemond-Collet<span style="">, </span>S. Hannedouche<span style="">, </span>I. Fourast� and C. Moulis, <span style="font-style: italic; "><i>Fitoterapia</i></span>, 2000, <span style="font-weight: bold; "><b>71</b></span>, 601<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280687" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit5">5</a></td><td valign="top"></td><td valign="top">A. J. El-Rehaily<span style="">, </span>T. A. Al-Howiriny<span style="">, </span>M. S. Ahmad<span style="">, </span>M. A. Al-Yahya<span style="">, </span>F. S. El-Feraly<span style="">, </span>C. D. Hufford and A. T. McPhail, <span style="font-style: italic; "><i>Phytochemistry</i></span>, 2001, <span style="font-weight: bold; "><b>57</b></span>, 597<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280688" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit6">6</a></td><td valign="top"></td><td valign="top">W. Gao<span style="">, </span>Y. Li<span style="">, </span>S. Jiang and D. Zhu, <span style="font-style: italic; "><i>Planta Med.</i></span>, 2000, <span style="font-weight: bold; "><b>66</b></span>, 664<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280689" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit7">7</a></td><td valign="top"></td><td valign="top">H. Morita<span style="">, </span>Y. Hirasawa<span style="">, </span>N. Yoshida and J. Kobayashi, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 2001, <span style="font-weight: bold; "><b>42</b></span>, 4199<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280659" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit8">8</a></td><td valign="top"></td><td valign="top">G. M. Nicholas<span style="">, </span>G. L. Newton<span style="">, </span>R. C. Fahey and C. A. Bewley, <span style="font-style: italic; "><i>Org. Lett.</i></span>, 2001, <span style="font-weight: bold; "><b>3</b></span>, 1543<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=263367" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit9">9</a></td><td valign="top"></td><td valign="top">S. Funayama<span style="">, </span>R. Tanaka<span style="">, </span>Y. Kumekawa<span style="">, </span>T. Noshita<span style="">, </span>T. Mori<span style="">, </span>T. Kashiwagura and K. Murata, <span style="font-style: italic; "><i>Biol. Pharm. Bull.</i></span>, 2001, <span style="font-weight: bold; "><b>24</b></span>, 100<rsc:citlink msid="b104971m" citgroupID="cit9" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit10">10</a></td><td valign="top"></td><td valign="top">S. Funayama<span style="">, </span>K. Murata and T. Noshita, <span style="font-style: italic; "><i>Heterocycles</i></span>, 2001, <span style="font-weight: bold; "><b>54</b></span>, 1139<rsc:citlink msid="b104971m" citgroupID="cit10" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit11">11</a></td><td valign="top"></td><td valign="top">T. Noshita<span style="">, </span>M. Tando<span style="">, </span>K. Suzuki<span style="">, </span>K. Murata and S. Funayama, <span style="font-style: italic; "><i>Biosci. Biotechnol. Biochem.</i></span>, 2001, <span style="font-weight: bold; "><b>65</b></span>, 710<rsc:citlink msid="b104971m" citgroupID="cit11" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit12">12</a></td><td valign="top"></td><td valign="top">M. Kusano<span style="">, </span>H. Koshino<span style="">, </span>J. Uzawa<span style="">, </span>S. Fujioka<span style="">, </span>T. Kawano and Y. Kimura, <span style="font-style: italic; "><i>Biosci. Biotechnol. Biochem.</i></span>, 2000, <span style="font-weight: bold; "><b>64</b></span>, 2559<rsc:citlink msid="b104971m" citgroupID="cit12" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit13">13</a></td><td valign="top"></td><td valign="top">Y. Lin<span style="">, </span>Z. Shao<span style="">, </span>G. Jiang<span style="">, </span>S. Zhou<span style="">, </span>J. Cai<span style="">, </span>L. L. P. Vrijmoed and E. B. G. Jones, <span style="font-style: italic; "><i>Tetrahedron</i></span>, 2000, <span style="font-weight: bold; "><b>56</b></span>, 9607<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=195192" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit14">14</a></td><td valign="top"></td><td valign="top">N. Kakinuma<span style="">, </span>H. Iwai<span style="">, </span>S. Takahashi<span style="">, </span>K. Hamano<span style="">, </span>T. Yanagisawa<span style="">, </span>K. Nagai<span style="">, </span>K. Tanaka<span style="">, </span>K. Suzuki<span style="">, </span>F. Kirikae<span style="">, </span>T. Kirikae and A. Nakagawa, <span style="font-style: italic; "><i>J. Antibiot.</i></span>, 2000, <span style="font-weight: bold; "><b>53</b></span>, 1247<rsc:citlink msid="b104971m" citgroupID="cit14" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit15">15</a></td><td valign="top"></td><td valign="top">S. Takahashi<span style="">, </span>N. Kakinuma<span style="">, </span>H. Iwai<span style="">, </span>T. Yanagisawa<span style="">, </span>K. Nagai<span style="">, </span>K. Suzuki<span style="">, </span>T. Tokunaga and A. Nakagawa, <span style="font-style: italic; "><i>J. Antibiot.</i></span>, 2000, <span style="font-weight: bold; "><b>53</b></span>, 1252<rsc:citlink msid="b104971m" citgroupID="cit15" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit16">16</a></td><td valign="top"></td><td valign="top">K. El Sayed<span style="">, </span>M. A. Al-Said<span style="">, </span>F. S. El-Feraly and S. A. Ross, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 2000, <span style="font-weight: bold; "><b>63</b></span>, 995<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=253864" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit17">17</a></td><td valign="top"></td><td valign="top">N. Fokialakis<span style="">, </span>P. Magiatis<span style="">, </span>N. Aligiannis<span style="">, </span>S. Mitaku<span style="">, </span>F. Tillequin and T. S�venet, <span style="font-style: italic; "><i>Phytochemistry</i></span>, 2001, <span style="font-weight: bold; "><b>57</b></span>, 593<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280690" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit18">18</a></td><td valign="top"></td><td valign="top">N. Fokialakis<span style="">, </span>P. Magiatis<span style="">, </span>A.-L. Skaltsounis<span style="">, </span>F. Tillequin and T. S�venet, <span style="font-style: italic; "><i>Z. Naturforsch., Teil C</i></span>, 2000, <span style="font-weight: bold; "><b>55</b></span>, 874<rsc:citlink msid="b104971m" citgroupID="cit18" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit19">19</a></td><td valign="top"></td><td valign="top">N. Fokialakis<span style="">, </span>P. Magiatis<span style="">, </span>S. Mitaku<span style="">, </span>F. Tillequin and T. S�venet, <span style="font-style: italic; "><i>Chem. Pharm. Bull.</i></span>, 2000, <span style="font-weight: bold; "><b>48</b></span>, 2009<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280691" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit20">20</a></td><td valign="top"></td><td valign="top">N. Fokialakis<span style="">, </span>P. Magiatis<span style="">, </span>A.-L. Skaltsounis<span style="">, </span>F. Tillequin and T. S�venet, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 2000, <span style="font-weight: bold; "><b>63</b></span>, 1004<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280692" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit21">21</a></td><td valign="top"></td><td valign="top">W. N. Setzer<span style="">, </span>M. C. Setzer<span style="">, </span>J. M. Schmidt<span style="">, </span>D. M. Moriarity<span style="">, </span>B. Vogler<span style="">, </span>S. Reeb<span style="">, </span>A. M. Holmes and W. A. Haber, <span style="font-style: italic; "><i>Planta Med.</i></span>, 2000, <span style="font-weight: bold; "><b>66</b></span>, 493<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280693" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit22">22</a></td><td valign="top"></td><td valign="top">M.-J. Cheng<span style="">, </span>I.-L. Tsai and I.-S. Chen, <span style="font-style: italic; "><i>J. Chin. Chem. Soc.</i></span>, 2001, <span style="font-weight: bold; "><b>48</b></span>, 235,  (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2001, <span style="font-weight: bold; "><b>135</b></span>, 105018)<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280694" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit23">23</a></td><td valign="top"></td><td valign="top">M. J. Mashimbye<span style="">, </span>M. C. Maumela and M. C. Raphulu, <span style="font-style: italic; "><i>Niger. J. Nat. Prod. Med.</i></span>, 2000, <span style="font-weight: bold; "><b>4</b></span>, 57,  (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2001, <span style="font-weight: bold; "><b>135</b></span>, 31257)<rsc:citlink msid="b104971m" citgroupID="cit23" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit24">24</a></td><td valign="top"></td><td valign="top">I.-L. Tsai<span style="">, </span>W.-Y. Lin<span style="">, </span>C.-M. Teng<span style="">, </span>T. Ishikawa<span style="">, </span>S.-L. Doong<span style="">, </span>M.-W. Huang<span style="">, </span>Y.-C. Chen and I.-S. Chen, <span style="font-style: italic; "><i>Planta Med.</i></span>, 2000, <span style="font-weight: bold; "><b>66</b></span>, 618<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280695" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit25">25</a></td><td valign="top"></td><td valign="top">D. C. Harrowven<span style="">, </span>M. I. T. Nunn<span style="">, </span>N. J. Blumire and D. R. Fenwick, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 2000, <span style="font-weight: bold; "><b>41</b></span>, 6681<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=204828" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit26">26</a></td><td valign="top"></td><td valign="top">D. C. Harrowven<span style="">, </span>M. I. T. Nunn<span style="">, </span>N. J. Blumire and D. R. Fenwick, <span style="font-style: italic; "><i>Tetrahedron</i></span>, 2001, <span style="font-weight: bold; "><b>57</b></span>, 4447<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280698" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit27">27</a></td><td valign="top"></td><td valign="top">D. C. Harrowven and M. I. T. Nunn, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 1998, <span style="font-weight: bold; "><b>39</b></span>, 5875<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=191157" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit28">28</a></td><td valign="top"></td><td valign="top"><a name="cit28a">(<i>a</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 2000, <span style="font-weight: bold; "><b>17</b></span>, 603<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=38808&amp;rscID=a904850b" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>  see p. 604; <a name="cit28b">(<i>b</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 1999, <span style="font-weight: bold; "><b>16</b></span>, 697<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=38790&amp;rscID=a809408j" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>  see p. 700; <a name="cit28c">(<i>c</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 1995, <span style="font-weight: bold; "><b>12</b></span>, 465<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280700&amp;rscID=NP9951200465" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>  see p. 468; <a name="cit28d">(<i>d</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 2001, <span style="font-weight: bold; "><b>18</b></span>, 543<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=38830&amp;rscID=b005387m" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>  see p. 546; <a name="cit28e">(<i>e</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 2001, <span style="font-weight: bold; "><b>18</b></span>, 543<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=38830&amp;rscID=b005387m" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>  see p. 548; <a name="cit28f">(<i>f</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 2000, <span style="font-weight: bold; "><b>17</b></span>, 603<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=38808&amp;rscID=a904850b" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>  see p. 615; <a name="cit28g">(<i>g</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 2001, <span style="font-weight: bold; "><b>18</b></span>, 543<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=38830&amp;rscID=b005387m" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>  see p. 552; <a name="cit28h">(<i>h</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 2000, <span style="font-weight: bold; "><b>17</b></span>, 603<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=38808&amp;rscID=a904850b" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>  see p. 616; <a name="cit28i">(<i>i</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 1998, <span style="font-weight: bold; "><b>15</b></span>, 595<rsc:citlink msid="b104971m" citgroupID="cit28i" position="1"></rsc:citlink>  see p. 603; <a name="cit28j">(<i>j</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 2001, <span style="font-weight: bold; "><b>18</b></span>, 543<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=38830&amp;rscID=b005387m" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>  see p. 553.</td></tr><tr><td valign="top" align="right"><a name="cit29">29</a></td><td valign="top"></td><td valign="top">M. A. Fakhfakh<span style="">, </span>X. Franck<span style="">, </span>A. Fournet<span style="">, </span>R. Hocquemiller and B. Figad�re, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 2001, <span style="font-weight: bold; "><b>42</b></span>, 3847<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=264947" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit30">30</a></td><td valign="top"></td><td valign="top">Y. Ma and Y. Zhang, <span style="font-style: italic; "><i>J. Chem. Res. (S)</i></span>, 2001, 108<rsc:citlink msid="b104971m" citgroupID="cit30" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit31">31</a></td><td valign="top"></td><td valign="top">S. Sato<span style="">, </span>Y. Kubota<span style="">, </span>H. Kumagai<span style="">, </span>T. Kumazawa<span style="">, </span>S. Matsuba<span style="">, </span>J. Onodera and M. Suzuki, <span style="font-style: italic; "><i>Heterocycles</i></span>, 2000, <span style="font-weight: bold; "><b>53</b></span>, 1523<rsc:citlink msid="b104971m" citgroupID="cit31" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit32">32</a></td><td valign="top"></td><td valign="top">T.-C. Ko<span style="">, </span>M.-J. Hour<span style="">, </span>J.-C. Lien<span style="">, </span>C.-M. Teng<span style="">, </span>K.-S. Lee<span style="">, </span>S.-C. Kuo and L.-J. Huang, <span style="font-style: italic; "><i>Bioorg. Med. Chem. Lett.</i></span>, 2001, <span style="font-weight: bold; "><b>11</b></span>, 279<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280705" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit33">33</a></td><td valign="top"></td><td valign="top">Atta-ur-Rahman<span style="">, </span>N. Sultana<span style="">, </span>M. I. Choudhary<span style="">, </span>P. M. Shah and M. R. Khan, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 1998, <span style="font-weight: bold; "><b>61</b></span>, 713<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280706" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit34">34</a></td><td valign="top"></td><td valign="top"> S. Funayama, Aomori University, personal communication. I am grateful to Professor Funayama for agreeing that the name orixiarine should be used in preference to orijanone<rsc:citlink msid="b104971m" citgroupID="cit34" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit35">35</a></td><td valign="top"></td><td valign="top">S. Funayama<span style="">, </span>K. Murata and S. Nozoe, <span style="font-style: italic; "><i>Phytochemistry</i></span>, 1996, <span style="font-weight: bold; "><b>41</b></span>, 1231<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280707" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit36">36</a></td><td valign="top"></td><td valign="top">M. J. McLaughlin and R. P. Hsung, <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 2001, <span style="font-weight: bold; "><b>66</b></span>, 1049<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280708" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit37">37</a></td><td valign="top"></td><td valign="top">S. A. Barr and D. R. Boyd, <span style="font-style: italic; "><i>J. Chem. Soc., Chem. Commun.</i></span>, 1994, 153<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=211224&amp;rscID=C39940000153" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit38">38</a></td><td valign="top"></td><td valign="top">D. R. Boyd<span style="">, </span>N. D. Sharma<span style="">, </span>S. A. Barr<span style="">, </span>J. G. Carroll<span style="">, </span>D. Mackerracher and J. F. Malone, <span style="font-style: italic; "><i>J. Chem. Soc., Perkin Trans. 1</i></span>, 2000, 3397<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=40937&amp;rscID=b005285j" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit39">39</a></td><td valign="top"></td><td valign="top">G. Bar<span style="">, </span>A. F. Parsons and C. B. Thomas, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 2000, <span style="font-weight: bold; "><b>41</b></span>, 7751<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=63564" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit40">40</a></td><td valign="top"></td><td valign="top">G. Bar<span style="">, </span>A. F. Parsons and C. B. Thomas, <span style="font-style: italic; "><i>Tetrahedron</i></span>, 2001, <span style="font-weight: bold; "><b>57</b></span>, 4719<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=270598" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit41">41</a></td><td valign="top"></td><td valign="top">I. Butensch�n<span style="">, </span>K. M�ller and W. H�nsel, <span style="font-style: italic; "><i>J. Med. Chem.</i></span>, 2001, <span style="font-weight: bold; "><b>44</b></span>, 1249<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280709" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit42">42</a></td><td valign="top"></td><td valign="top">S. G. Jagadeesh<span style="">, </span>G. L. D. Krupadanam and G. Srimannarayana, <span style="font-style: italic; "><i>Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.</i></span>, 2000, <span style="font-weight: bold; "><b>39</b></span>, 475<rsc:citlink msid="b104971m" citgroupID="cit42" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit43">43</a></td><td valign="top"></td><td valign="top">G. Bringmann<span style="">, </span>J. Schlauer<span style="">, </span>H. Rischer<span style="">, </span>M. Wohlfarth<span style="">, </span>J. M�hlbacher<span style="">, </span>A. Buske<span style="">, </span>A. Porzel<span style="">, </span>J. Schmidt and G. Adam, <span style="font-style: italic; "><i>Tetrahedron</i></span>, 2000, <span style="font-weight: bold; "><b>56</b></span>, 3691<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=193577" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit44">44</a></td><td valign="top"></td><td valign="top">G. Bringmann<span style="">, </span>H. Rischer<span style="">, </span>M. Wohlfarth and J. Schlauer, <span style="font-style: italic; "><i>J. Am. Chem. Soc.</i></span>, 2000, <span style="font-weight: bold; "><b>122</b></span>, 9905<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280710" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit45">45</a></td><td valign="top"></td><td valign="top">J. Leonard, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 1999, <span style="font-weight: bold; "><b>16</b></span>, 319<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=38752&amp;rscID=a707500f" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>  and earlier reviews in this series.</td></tr><tr><td valign="top" align="right"><a name="cit46">46</a></td><td valign="top"></td><td valign="top"><a name="cit46a">(<i>a</i>) </a>G. Stork<span style="">, </span>D. Niu<span style="">, </span>R. A. Fujimoto<span style="">, </span>E. R. Koft<span style="">, </span>J. M. Balkovec<span style="">, </span>J. R. Tata and G. R. Dake, <span style="font-style: italic; "><i>J. Am. Chem. Soc.</i></span>, 2001, <span style="font-weight: bold; "><b>123</b></span>, 3239<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280711" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>; <a name="cit46b">(<i>b</i>) </a>correction in   <span style="font-style: italic; "><i>J. Am. Chem. Soc.</i></span>, 2001, <span style="font-weight: bold; "><b>123</b></span>, p. 8644<rsc:citlink msid="b104971m" citgroupID="cit46b" position="2"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit47">47</a></td><td valign="top"></td><td valign="top">J. Gutzwiller and M. R. Uskokovic, <span style="font-style: italic; "><i>J. Am. Chem. Soc.</i></span>, 1978, <span style="font-weight: bold; "><b>100</b></span>, 576<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280712" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit48">48</a></td><td valign="top"></td><td valign="top">K. Tatsuta<span style="">, </span>H. Misawa and K. Chikauchi, <span style="font-style: italic; "><i>J. Antibiot.</i></span>, 2001, <span style="font-weight: bold; "><b>54</b></span>, 109<rsc:citlink msid="b104971m" citgroupID="cit48" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit49">49</a></td><td valign="top"></td><td valign="top">D. L. Boger and S. Ichikawa, <span style="font-style: italic; "><i>J. Am. Chem. Soc.</i></span>, 2000, <span style="font-weight: bold; "><b>122</b></span>, 2956<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=193609" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit50">50</a></td><td valign="top"></td><td valign="top">D. L. Boger<span style="">, </span>S. Ichikawa<span style="">, </span>W. C. Tse<span style="">, </span>M. P. Hedrick and Q. Jin, <span style="font-style: italic; "><i>J. Am. Chem. Soc.</i></span>, 2001, <span style="font-weight: bold; "><b>123</b></span>, 561<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280713" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit51">51</a></td><td valign="top"></td><td valign="top">D. Valognes<span style="">, </span>P. Belmont<span style="">, </span>N. Xi and M. A. Ciufolini, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 2001, <span style="font-weight: bold; "><b>42</b></span>, 1907<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280714" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit52">52</a></td><td valign="top"></td><td valign="top">M. A. Ciufolini<span style="">, </span>D. Valognes and N. Xi, <span style="font-style: italic; "><i>Angew. Chem., Int. Ed.</i></span>, 2000, <span style="font-weight: bold; "><b>39</b></span>, 2493<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280715" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit53">53</a></td><td valign="top"></td><td valign="top">Y. Kashman<span style="">, </span>G. Koren-Goldshlager<span style="">, </span>M. D. G. Gravalos and M. Schleyer, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 1999, <span style="font-weight: bold; "><b>40</b></span>, 997<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=191138" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit54">54</a></td><td valign="top"></td><td valign="top">M. R. Heinrich and W. Steglich, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 2001, <span style="font-weight: bold; "><b>42</b></span>, 3287<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=224207" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit55">55</a></td><td valign="top"></td><td valign="top">M. G. Banwell<span style="">, </span>A. M. Bray<span style="">, </span>A. J. Edwards and D. J. Wong, <span style="font-style: italic; "><i>New J. Chem.</i></span>, 2001, <span style="font-weight: bold; "><b>25</b></span>, 1347<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=224205&amp;rscID=b105045c" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit56">56</a></td><td valign="top"></td><td valign="top">M. R. Heinrich<span style="">, </span>Y. Kashman<span style="">, </span>P. Spiteller and W. Steglich, <span style="font-style: italic; "><i>Tetrahedron</i></span>, 2001, <span style="font-weight: bold; "><b>57</b></span>, 9973<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=224208" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit57">57</a></td><td valign="top"></td><td valign="top">T. Ozawa<span style="">, </span>S. Aoyagi and C. Kibayashi, <span style="font-style: italic; "><i>Org. Lett.</i></span>, 2000, <span style="font-weight: bold; "><b>2</b></span>, 2955<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=195469" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit58">58</a></td><td valign="top"></td><td valign="top">T. Ozawa<span style="">, </span>S. Aoyagi and C. Kibayashi, <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 2001, <span style="font-weight: bold; "><b>66</b></span>, 3338<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=219575" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit59">59</a></td><td valign="top"></td><td valign="top">W. Oppolzer and E. Flaskamp, <span style="font-style: italic; "><i>Helv. Chim. Acta</i></span>, 1977, <span style="font-weight: bold; "><b>60</b></span>, 204<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280716" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit60">60</a></td><td valign="top"></td><td valign="top">W. Oppolzer<span style="">, </span>E. Flaskamp and L. W. Bieber, <span style="font-style: italic; "><i>Helv. Chim. Acta</i></span>, 2001, <span style="font-weight: bold; "><b>84</b></span>, 141<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280717" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit61">61</a></td><td valign="top"></td><td valign="top">G. Mehta and D. S. Reddy, <span style="font-style: italic; "><i>Indian J. Chem., Sect. B Org. Chem. Incl. Med. Chem.</i></span>, 2000, <span style="font-weight: bold; "><b>39</b></span>, 813<rsc:citlink msid="b104971m" citgroupID="cit61" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit62">62</a></td><td valign="top"></td><td valign="top">T. Ibuka and G.-N. Chu, <span style="font-style: italic; "><i>Chem. Pharm. Bull.</i></span>, 1986, <span style="font-weight: bold; "><b>34</b></span>, 2380<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280719" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit63">63</a></td><td valign="top"></td><td valign="top"><a name="cit63a">(<i>a</i>) </a>W. H. Pearson and W. Fang, <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 2000, <span style="font-weight: bold; "><b>65</b></span>, 7158<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280720" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>; <a name="cit63b">(<i>b</i>) </a>correction in  <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 2001, 66, p. 6838<rsc:citlink msid="b104971m" citgroupID="cit63b" position="2"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit64">64</a></td><td valign="top"></td><td valign="top">Y. Ito<span style="">, </span>E. Nakajo<span style="">, </span>M. Nakatsuka and T. Saegusa, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 1983, <span style="font-weight: bold; "><b>24</b></span>, 2881<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280721" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit65">65</a></td><td valign="top"></td><td valign="top">R. Fujimoto<span style="">, </span>Y. Kishi and J. F. Blount, <span style="font-style: italic; "><i>J. Am. Chem. Soc.</i></span>, 1980, <span style="font-weight: bold; "><b>102</b></span>, 7154<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280722" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit66">66</a></td><td valign="top"></td><td valign="top">L.-L. Wei<span style="">, </span>R. P. Hsung<span style="">, </span>H. M. Sklenicka and A. I. Gerasyuto, <span style="font-style: italic; "><i>Angew. Chem., Int. Ed.</i></span>, 2001, <span style="font-weight: bold; "><b>40</b></span>, 1516<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=217441" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit67">67</a></td><td valign="top"></td><td valign="top">R. Fujimoto and Y. Kishi, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 1981, <span style="font-weight: bold; "><b>22</b></span>, 4197<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280723" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit68">68</a></td><td valign="top"></td><td valign="top">H. Morita<span style="">, </span>Y. Sato<span style="">, </span>K.-L. Chan<span style="">, </span>C.-Y. Choo<span style="">, </span>H. Itokawa<span style="">, </span>K. Takeya and J. Kobayashi, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 2000, <span style="font-weight: bold; "><b>63</b></span>, 1707<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280724" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit69">69</a></td><td valign="top"></td><td valign="top">J.-R. Dai<span style="">, </span>B. K. Cart�<span style="">, </span>P. J. Sidebottom<span style="">, </span>A. L. S. Yew<span style="">, </span>S.-B. Ng<span style="">, </span>Y. Huang and M. S. Butler, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 2001, <span style="font-weight: bold; "><b>64</b></span>, 125<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280725" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit70">70</a></td><td valign="top"></td><td valign="top">T. Murakami<span style="">, </span>A. Kishi<span style="">, </span>T. Sakurama<span style="">, </span>H. Matsuda and M. Yoshikawa, <span style="font-style: italic; "><i>Heterocycles</i></span>, 2001, <span style="font-weight: bold; "><b>54</b></span>, 957<rsc:citlink msid="b104971m" citgroupID="cit70" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit71">71</a></td><td valign="top"></td><td valign="top">Y. Deng<span style="">, </span>R. Xu and Y. Ye, <span style="font-style: italic; "><i>J. Chin. Pharm. Sci.</i></span>, 2000, <span style="font-weight: bold; "><b>9</b></span>, 116,  (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2001, <span style="font-weight: bold; "><b>134</b></span>, 83482)<rsc:citlink msid="b104971m" citgroupID="cit71" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit72">72</a></td><td valign="top"></td><td valign="top">R. Patnam<span style="">, </span>F.-R. Chang<span style="">, </span>C.-Y. Chen<span style="">, </span>R.-Y. Kuo<span style="">, </span>Y.-H. Lee and Y.-C. Wu, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 2001, <span style="font-weight: bold; "><b>64</b></span>, 948<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280658" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit73">73</a></td><td valign="top"></td><td valign="top">B. Li<span style="">, </span>W. Chen<span style="">, </span>S. Zheng<span style="">, </span>G. Yang and C. Qiao, <span style="font-style: italic; "><i>Yaoxue Xuebao</i></span>, 2000, <span style="font-weight: bold; "><b>35</b></span>, 508,  (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2001, <span style="font-weight: bold; "><b>134</b></span>, 128466)<rsc:citlink msid="b104971m" citgroupID="cit73" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit74">74</a></td><td valign="top"></td><td valign="top">T. S. Tulyaganov and O. E. Makhmudov, <span style="font-style: italic; "><i>Chem. Nat. Compd.</i></span>, 2000, <span style="font-weight: bold; "><b>36</b></span>, 76,  (<span style="font-style: italic; "><i>Engl. Transl. Khim. Prir. Soedin.</i></span>, 2000, 60)<rsc:citlink msid="b104971m" citgroupID="cit74" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit75">75</a></td><td valign="top"></td><td valign="top">T. S. Tulyaganov and O. M. Nazarov, <span style="font-style: italic; "><i>Chem. Nat. Compd.</i></span>, 2000, <span style="font-weight: bold; "><b>36</b></span>, 393,  (<span style="font-style: italic; "><i>Engl. Transl. Khim. Prir. Soedin.</i></span>, 2000, 323)<rsc:citlink msid="b104971m" citgroupID="cit75" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit76">76</a></td><td valign="top"></td><td valign="top">M. F. Faskhutdinov<span style="">, </span>M. V. Telezhenetskaya<span style="">, </span>M. G. Levkovich and N. D. Abdullaev, <span style="font-style: italic; "><i>Chem. Nat. Compd.</i></span>, 2000, <span style="font-weight: bold; "><b>36</b></span>, 602,  (<span style="font-style: italic; "><i>Engl. Transl. Khim. Prir. Soedin.</i></span>, 2000, 481)<rsc:citlink msid="b104971m" citgroupID="cit76" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit77">77</a></td><td valign="top"></td><td valign="top">R. Gompper<span style="">, </span>H. E. Noppel and H. Schaefer, <span style="font-style: italic; "><i>Angew. Chem., Int. Ed. Engl.</i></span>, 1963, <span style="font-weight: bold; "><b>2</b></span>, 686<rsc:citlink msid="b104971m" citgroupID="cit77" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit78">78</a></td><td valign="top"></td><td valign="top">J. Faust, <span style="font-style: italic; "><i>J. Prakt. Chem.</i></span>, 1977, <span style="font-weight: bold; "><b>319</b></span>, 65<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280727" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit79">79</a></td><td valign="top"></td><td valign="top">H. M�hrle and C. M. Seidel, <span style="font-style: italic; "><i>Arch. Pharm.</i></span>, 1976, <span style="font-weight: bold; "><b>309</b></span>, 542<rsc:citlink msid="b104971m" citgroupID="cit79" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit80">80</a></td><td valign="top"></td><td valign="top"><a name="cit80a">(<i>a</i>) </a>S. Kobayashi<span style="">, </span>M. Ueno<span style="">, </span>R. Suzuki and H. Ishitani, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 1999, <span style="font-weight: bold; "><b>40</b></span>, 2175<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=53520" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>; <a name="cit80b">(<i>b</i>) </a>S. Kobayashi<span style="">, </span>M. Ueno<span style="">, </span>R. Suzuki<span style="">, </span>H. Ishitani<span style="">, </span>H.-S. Kim and Y. Wataya, <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 1999, <span style="font-weight: bold; "><b>64</b></span>, 6833<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=53521" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit81">81</a></td><td valign="top"></td><td valign="top">L. Rahb�k and J. Breinholt, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 1999, <span style="font-weight: bold; "><b>62</b></span>, 904<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=191169" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit82">82</a></td><td valign="top"></td><td valign="top">L. Rahb�k<span style="">, </span>J. Breinholt<span style="">, </span>J. C. Frisvad and C. Christophersen, <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 1999, <span style="font-weight: bold; "><b>64</b></span>, 1689<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=191168" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit83">83</a></td><td valign="top"></td><td valign="top">U. P. Claeson<span style="">, </span>T. Malmfors<span style="">, </span>G. Wilkman and J. G. Bruhn, <span style="font-style: italic; "><i>J. Ethnopharmacol.</i></span>, 2000, <span style="font-weight: bold; "><b>72</b></span>, 1<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280728" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit84">84</a></td><td valign="top"></td><td valign="top"> B. Asmussen, T. Hille, H.-R. Hoffmann and K. Opitz, <span style="font-style: italic; "><i>PCT Int. Appl.</i></span> WO 2000048445, 24 August 2000 (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2000, <span style="font-weight: bold; "><b>133</b></span>, 187985)<rsc:citlink msid="b104971m" citgroupID="cit84" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit85">85</a></td><td valign="top"></td><td valign="top"> B. Asmussen, T. Hille, H.-R. Hoffmann and K. Opitz, <span style="font-style: italic; "><i>PCT Int. Appl.</i></span> WO 2000048582, 24 August 2000 (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2000, <span style="font-weight: bold; "><b>133</b></span>, 172147)<rsc:citlink msid="b104971m" citgroupID="cit85" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit86">86</a></td><td valign="top"></td><td valign="top"> B. Asmussen, T. Hille, H.-R. Hoffmann and K. Opitz, <span style="font-style: italic; "><i>PCT Int. Appl.</i></span> WO 2000048600, 24 August 2000 (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2000, <span style="font-weight: bold; "><b>133</b></span>, 172148)<rsc:citlink msid="b104971m" citgroupID="cit86" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit87">87</a></td><td valign="top"></td><td valign="top"> B. Asmussen, T. Hille, H.-R. Hoffmann and K. Opitz, <span style="font-style: italic; "><i>PCT Int. Appl.</i></span> WO 2000048599, 24 August 2000 (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2000, <span style="font-weight: bold; "><b>133</b></span>, 172207)<rsc:citlink msid="b104971m" citgroupID="cit87" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit88">88</a></td><td valign="top"></td><td valign="top"> T. Hille and W. Wessling, <span style="font-style: italic; "><i>Ger. Offen.</i></span> DE 19924951, 14 December 2000 (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2000, <span style="font-weight: bold; "><b>134</b></span>, 33004)<rsc:citlink msid="b104971m" citgroupID="cit88" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit89">89</a></td><td valign="top"></td><td valign="top">T. Ishihara<span style="">, </span>K. Kohno<span style="">, </span>S. Ushio<span style="">, </span>K. Iwaki<span style="">, </span>M. Ikeda and M. Kurimoto, <span style="font-style: italic; "><i>Eur. J. Pharmacol.</i></span>, 2000, <span style="font-weight: bold; "><b>407</b></span>, 197<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280729" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit90">90</a></td><td valign="top"></td><td valign="top">M. Kataoka<span style="">, </span>K. Hirata<span style="">, </span>T. Kunikata<span style="">, </span>S. Ushio<span style="">, </span>K. Iwaki<span style="">, </span>K. Ohashi<span style="">, </span>M. Ikeda and M. Kurimoto, <span style="font-style: italic; "><i>J. Gastroenterol.</i></span>, 2001, <span style="font-weight: bold; "><b>36</b></span>, 5,  (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2001, <span style="font-weight: bold; "><b>135</b></span>, 116607)<rsc:citlink msid="b104971m" citgroupID="cit90" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit91">91</a></td><td valign="top"></td><td valign="top">X. Xu<span style="">, </span>P. Lu and Y. Zhang, <span style="font-style: italic; "><i>Synth. Commun.</i></span>, 2001, <span style="font-weight: bold; "><b>31</b></span>, 323<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280730" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit92">92</a></td><td valign="top"></td><td valign="top">A. Kamal<span style="">, </span>K. V. Ramana and M. V. Rao, <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 2001, <span style="font-weight: bold; "><b>66</b></span>, 997<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280731" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit93">93</a></td><td valign="top"></td><td valign="top">P. Molina<span style="">, </span>A. T�rraga and A. Gonz�lez-Tejero, <span style="font-style: italic; "><i>Synthesis</i></span>, 2000, 1523<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280732" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit94">94</a></td><td valign="top"></td><td valign="top">T. R. Kelly<span style="">, </span>S. Chamberland and R. A. Silva, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 1999, <span style="font-weight: bold; "><b>40</b></span>, 2723<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=191175" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit95">95</a></td><td valign="top"></td><td valign="top">Y. Takeuchi and T. Harayama, <span style="font-style: italic; "><i>Yuki Gosei Kagaku Kyokaishi</i></span>, 2001, <span style="font-weight: bold; "><b>59</b></span>, 569,  (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2001, <span style="font-weight: bold; "><b>135</b></span>, 107480)<rsc:citlink msid="b104971m" citgroupID="cit95" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit96">96</a></td><td valign="top"></td><td valign="top">Y. Takeuchi<span style="">, </span>M. Hattori<span style="">, </span>H. Abe and T. Harayama, <span style="font-style: italic; "><i>Synthesis</i></span>, 1999, 1814<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=53525" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit97">97</a></td><td valign="top"></td><td valign="top">Y. Takeuchi<span style="">, </span>K. Azuma<span style="">, </span>K. Takakura<span style="">, </span>H. Abe and T. Harayama, <span style="font-style: italic; "><i>Chem. Commun.</i></span>, 2000, 1643<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=6465&amp;rscID=b005028h" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit98">98</a></td><td valign="top"></td><td valign="top">Y. Takeuchi<span style="">, </span>K. Azuma<span style="">, </span>K. Takakura<span style="">, </span>H. Abe<span style="">, </span>H.-S. Kim<span style="">, </span>Y. Wataya and T. Harayama, <span style="font-style: italic; "><i>Tetrahedron</i></span>, 2001, <span style="font-weight: bold; "><b>57</b></span>, 1213<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280733" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit99">99</a></td><td valign="top"></td><td valign="top">Y. Takeuchi<span style="">, </span>K. Azuma<span style="">, </span>H. Abe and T. Harayama, <span style="font-style: italic; "><i>Heterocycles</i></span>, 2000, <span style="font-weight: bold; "><b>53</b></span>, 2247<rsc:citlink msid="b104971m" citgroupID="cit99" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit100">100</a></td><td valign="top"></td><td valign="top">Y. Takeuchi<span style="">, </span>M. Koike<span style="">, </span>K. Azuma<span style="">, </span>H. Nishioka<span style="">, </span>H. Abe<span style="">, </span>H.-S. Kim<span style="">, </span>Y. Wataya and T. Harayama, <span style="font-style: italic; "><i>Chem. Pharm. Bull.</i></span>, 2001, <span style="font-weight: bold; "><b>49</b></span>, 721<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280734" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit101">101</a></td><td valign="top"></td><td valign="top">T. Taniguchi and K. Ogasawara, <span style="font-style: italic; "><i>Org. Lett.</i></span>, 2000, <span style="font-weight: bold; "><b>2</b></span>, 3193<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280735" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit102">102</a></td><td valign="top"></td><td valign="top">H. Ooi<span style="">, </span>A. Urushibara<span style="">, </span>T. Esumi<span style="">, </span>Y. Iwabuchi and S. Hatakeyama, <span style="font-style: italic; "><i>Org. Lett.</i></span>, 2001, <span style="font-weight: bold; "><b>3</b></span>, 953<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280736" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit103">103</a></td><td valign="top"></td><td valign="top"> S. Kobayashi, Y. Wataya and H. Kim, <span style="font-style: italic; "><i>PCT Int. Appl.</i></span> WO 2000052005, 8 September 2000 (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2000, <span style="font-weight: bold; "><b>133</b></span>, 208028).<rsc:citlink msid="b104971m" citgroupID="cit103" position="1"></rsc:citlink></td></tr><tr><td valign="top" align="right"><a name="cit104">104</a></td><td valign="top"></td><td valign="top">O. Okitsu<span style="">, </span>R. Suzuki and S. Kobayashi, <span style="font-style: italic; "><i>Synlett</i></span>, 2000, 989<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=203567" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit105">105</a></td><td valign="top"></td><td valign="top">O. Okitsu<span style="">, </span>R. Suzuki and S. Kobayashi, <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 2001, <span style="font-weight: bold; "><b>66</b></span>, 809<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280737" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit106">106</a></td><td valign="top"></td><td valign="top">M. Sugiura and S. Kobayashi, <span style="font-style: italic; "><i>Org. Lett.</i></span>, 2001, <span style="font-weight: bold; "><b>3</b></span>, 477<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280738" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit107">107</a></td><td valign="top"></td><td valign="top">A. Witt and J. Bergman, <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 2001, <span style="font-weight: bold; "><b>66</b></span>, 2784<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280739" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit108">108</a></td><td valign="top"></td><td valign="top">B. B. Snider and M. V. Busuyek, <span style="font-style: italic; "><i>Tetrahedron</i></span>, 2001, <span style="font-weight: bold; "><b>57</b></span>, 3301<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=269753" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit109">109</a></td><td valign="top"></td><td valign="top"> B. B. Snider, Brandeis University, personal communication. I am grateful to Dr Snider for providing this information<rsc:citlink msid="b104971m" citgroupID="cit109" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit110">110</a></td><td valign="top"></td><td valign="top">B. B. Snider and F. He, <span style="font-style: italic; "><i>Synlett</i></span>, 1997, 483<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=189451" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit111">111</a></td><td valign="top"></td><td valign="top">E. Caballero<span style="">, </span>C. Avenda�o and J. C. Men�ndez, <span style="font-style: italic; "><i>Heterocycles</i></span>, 2000, <span style="font-weight: bold; "><b>53</b></span>, 1765<rsc:citlink msid="b104971m" citgroupID="cit111" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit112">112</a></td><td valign="top"></td><td valign="top">B. B. Snider and H. Zeng, <span style="font-style: italic; "><i>Org. Lett.</i></span>, 2000, <span style="font-weight: bold; "><b>2</b></span>, 4103<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=194531" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit113">113</a></td><td valign="top"></td><td valign="top">D. J. Hart and N. A. Magomedov, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 1999, <span style="font-weight: bold; "><b>40</b></span>, 5429<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=193315" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit114">114</a></td><td valign="top"></td><td valign="top">D. J. Hart and N. A. Magomedov, <span style="font-style: italic; "><i>J. Am. Chem. Soc.</i></span>, 2001, <span style="font-weight: bold; "><b>123</b></span>, 5892<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280740" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit115">115</a></td><td valign="top"></td><td valign="top">J. D. Freed<span style="">, </span>D. J. Hart and N. A. Magomedov, <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 2001, <span style="font-weight: bold; "><b>66</b></span>, 839<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280741" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit116">116</a></td><td valign="top"></td><td valign="top">P. Magiatis<span style="">, </span>S. Mitaku<span style="">, </span>A.-L. Skaltsounis<span style="">, </span>F. Tillequin<span style="">, </span>A. Pierr� and G. Atassi, <span style="font-style: italic; "><i>Nat. Prod. Lett.</i></span>, 2000, <span style="font-weight: bold; "><b>14</b></span>, 183<rsc:citlink msid="b104971m" citgroupID="cit116" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit117">117</a></td><td valign="top"></td><td valign="top">C. Sittisombut<span style="">, </span>N. Cotes<span style="">, </span>S. Michel<span style="">, </span>M. Koch<span style="">, </span>F. Tillequin<span style="">, </span>B. Pfeiffer<span style="">, </span>P. Renard<span style="">, </span>A. Pierr� and G. Atassi, <span style="font-style: italic; "><i>Chem. Pharm. Bull.</i></span>, 2001, <span style="font-weight: bold; "><b>49</b></span>, 675<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280742" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit118">118</a></td><td valign="top"></td><td valign="top"> M. Koch, F. Tillequin, S. Michel, G. Atassi, A. Pierr�, P. Renard and B. Pfeiffer, <span style="font-style: italic; "><i>Eur. Pat. Appl.</i></span> EP 1,061,081, 20 December 2000 (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2001, <span style="font-weight: bold; "><b>134</b></span>, 56826)<rsc:citlink msid="b104971m" citgroupID="cit118" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit119">119</a></td><td valign="top"></td><td valign="top">T.-L. Su<span style="">, </span>C.-T. Lin<span style="">, </span>C.-H. Chen and M.-T. Lin, <span style="font-style: italic; "><i>Med. Chem. Res.</i></span>, 2000, <span style="font-weight: bold; "><b>10</b></span>, 137<rsc:citlink msid="b104971m" citgroupID="cit119" position="1"></rsc:citlink>.</td></tr></table><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span></rsc:art-back><hr><table border="0" width="100%"><tr><td><h3>Footnotes</h3></td></tr><tr><td><a name="fn1"></a><font size="-1"><img src="https://bitnest.netfirms.com/images/entities/char_2020.gif" border="0"> The IUPAC name for propargyl is prop-2-ynyl.</font></td></tr><tr><td><a name="fn2"></a><font size="-1"><img src="https://bitnest.netfirms.com/images/entities/char_2021.gif" border="0"> The IUPAC name for triflate is trifluoromethanesulfonate.</font></td></tr></table><table width="100%"><tr><td><hr></td></tr><tr><td><b>This journal is � The Royal Society of Chemistry 2002</b></td></tr></table></body></html>
<!-- content end -->
	
	


	

<!-- Debugging
2<BR>
2<BR>

-->
	

<!--	
6
Server Software     Microsoft-IIS/4.0<br>
Server name         pubs.rsc.org<br>
Gateway Interface   CGI/1.1<br>
Server Protocol     HTTP/1.0<br>
Server Port         80<br>
Request Method      GET<br>
Path Info           /CFmuscat/direpubs.cfm<br>
Path Translated     e:\e_commerce_content\muscat\direpubs.cfm<br>
Script name         /CFmuscat/direpubs.cfm<br>
Query               REDURL=/ej/NP/2002/b104971m/index.htm&VOLNO=%26nbsp%3B%3Cb%3E19%3C%2Fb%3E&Yr=2002&Fp=742&Ep=760&JournalCode=NP&Iss=6&CFID=450082&CFTOKEN=82896682<br>
Host name           128.111.125.82<br>
Host ip             128.111.125.82<br>
Auth Type           <br>
Remote User         <br>
Auth User           <br>
Remote Ident        <br>
Content Type        <br>
Content Length      0<br>
Http referer        <br>
Http user agent     Mozilla/4.0 (compatible; MSIE 6.0; Windows NT 5.0)<br>
JAS server Used	    jas2<br>
Primary Server          jas2
Secondary Server        jas1 
-->
																				